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Chapter 1 Introduction 
 
1.1 Carbohydrates in nature and the “sugar code” 
 
Carbohydrates have been established as the most abundant – and arguably the most 
structural diverse – organic molecules found in nature. In contrast with proteins and 
nucleic acids, whose biological relevance has a longstanding reputation, carbohydrates 
have been considered always as poor-information and repetitive macromolecules with 
only structural functions. Only recently they have been recognized to play a crucial rule 
in biological processes and in the transfer of biological information. It’s well known in 
fact that oligosaccharides and glycoconjugates (glycolipids, glycoproteins and 
proteoglycans) dominate the landscape of the cell (forming the so called ―gycocalyx‖ 1; 
FIG. 1.1) and are responsible for cell-cell interaction, the recognition of virus and 
bacteria, binding of toxins and are involved in cell growth, cell differentiation and cell 
motility. 
One of the main reason why carbohydrates are widely used in the transfer of biological 
                                                 
1
 It is notable that even though the gycocalyx comprises only about 8-10% of the mass of the plasma 
membrane, in a typical mammalian cell it forms a continuous (albeit not uniform) layer ~8 nm thick 
occupying roughly the same volume as the proteins and lipids of the membrane. 
FIG. 1.1 The glycocalyx 
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information is their structural properties (e.g., glycosidic linkage variations, branching 
and anomeric isomers, sulfation) that makes these molecules extremely complex in 
contrast to nucleotides and amino acids (FIG. 1.2). 
 
FIG. 1.2: Illustration of the chemical complexity of a monosaccharide unit compared to nucleotide and 
amino acid. 
 
In addition to the chemical complexity of oligosaccharides, another factor that has to be 
considered in the study of biological information transfer is the shape they assume in 
solution. In particular the shape of a glycan is determined by the conformation of the 
furanose/pyranose rings and the relative positioning of the ring in the chain. As far as 
the ring conformation is concerned, it has been largely demonstrated that the 4C1 chair 
conformation (1C4 for L-sugars) is the most energetically preferred pyranose ring 
structure. 2 Some exceptions can occur, as in the case of L-iduronic acid in heparan and 
dermatan sulfate that assumes a skew-boat form 2S0 to accommodate mechanical stress, 
conformational flexibility and elasticity. 3 
 
 
FIG. 1.3: Dihedral angles Φ and Ψ define the possible conformation of a disaccharide. 
                                                 
2 a) Abeygunawardana, C.; Bush, C.A. Adv. Biophys. Chem. 1993, 3, 199; b) Brown, G.M., Levy, H.A. Science 
1965, 147, 1038. 
3 a)Casu, B.; Petitou, M.; Provasoli, M.; Sinay, P. Trends Biochem. Sci. 1988, 13, 221; b) Marsalek, P.E.; 
Oberhauser, A.F.; Pang, Y.P.; Fernandez, J.M. Nature 1998, 396, 661. 
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However, the main contribution to the drfinition of the shape of glycans originates 
from the changes of the two dihedral angles (Φ and Ψ, FIG. 1.3). Since the pyranose 
rings linked by glycosidic bond and their exocyclic substituents are rather bulky, their 
size imposes topological restraints on the intramolecular movement of the oligomers. 
This spatial factor that limits the range of interchangeable conformations has been 
inferred by molecular mechanics and dynamic calculations and by experimental 
evidences driving from sophisticated nuclear magnetic resonance. 4 
Table 1.1: some lectins and the oligosaccharide ligand they bind. 
 
The high density of information stored as sequence and shape in oligosaccharide 
provides therefore a ―sugar code” that can be deciphered by a number of proteins called 
                                                 
4 a) Bush, C.A.; Martin-Pastor, M.; Imberty, A. Annu. Rev. Biophys. Biomol. Struct. 1999, 28, 269; b) Imberty, 
A. Curr. Opin. Struct. Biol. 1997, 7, 617. 
Lectin Source and lectin Abbreviations Ligand(s) 
Plant   
Concavalin A ConA Manα1-OCH3 
Griffonia Simplicifolia lectin 4 
 
GS4 Lewis b (Leb) tetrasaccharide 
Ricin  Gal(β1→4)Glc 
Wheat germ agglutinin WGA Neu5Ac(α2→3)Gal(β1→4)Glc 
GlcNAc(β1→4)GlcNAc 
Animal   
Galectin-1  Gal(β1→4)Glc 
Mannose-binding protein A MBP-A High mannose octasaccharide 
Viral   
Influenza virus hemagglutinin HA Neu5Ac(α2→3)Gal(β1→4)Glc 
Polyoma virus protein VP1 Neu5Ac(α2→3)Gal(β1→4)Glc 
Bacterial   
Enterotoxin LT Gal 
Cholera toxin CT GM1 pentasaccharide 
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lectins. 5 These proteins occur in a wide variety of cell-cell recognition, signaling and 
adhesion processes and in intracellular targeting of newly biosynthesized proteins and 
have a molecular complementarity that allows interaction with specific oligosaccharides 
structures (Table 1.1). 6 
 
Lectins that are involved in cell-cell recognition and in 
adhesion in a wide variety of biological processes are 
called selectins (these proteins are mainly situated on 
the plasma membrane). 7 One of the most known and 
studied process in which selectins take part is the 
movement of T-lymphocytes (immune cells) through 
the capillary wall , from blood to tissue at the site of 
infection or inflammation. 8 In the vicinity of the site 
of infections, P-selectins can interact with a specific oligosaccharide unit that is present 
on the surface of the T 
lymphocyte. This interaction 
slows the T-cells as they 
adhere to and roll along the 
endothelial lining of the 
capillary. A second interaction 
between integrin molecules 
and an adhesion protein on the cell surface, stops the T-cells and allows them to move 
                                                 
5 Gabius, H.J.; Siebert, H.C.; André, S.; Jiménez-Barbero, J.; Rüdiger, H. ChemBioChem 2004, 5, 740. 
6 Weiss, W.I.; Drickamer, K. Annu. Rev. Biochem. 1996, 65, 441. 
7 Gabius, H.J., Naturwissenschaften 2000, 87, 108. 
8 Dustin, M.L.; Springer, T.A. Annu. Rev. Immunol. 1991, 9, 27-66. 
FIG. 1.4: Role of lectin-ligand 
interactions in lymphocyte movement 
FIG. 1.5: Examples of mechanism of bacterial adherence 
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through the capillary wall into the infected tissues to initiate the immune attack. Some 
microbial pathogens have lectins that mediate bacterial adhesion to host cells or toxin 
entry into cells.9 Pathogenic strains of Salmonella, for example, produce pili that facilitate 
adherence to human intestinal cell mucosa, thereby causing food poisoning and 
infectious diarrhea (FIG. 1.5a). In most cases these pili are formed by a major subunit 
from which a ―tip-adhesin‖ protrudes and mediates for host-recognition.  
In Bordetella pertussis instead, a 
surface-anchored protein (afimbrial 
adhesin) filamentous hemagglutinin 
(FHA) promotes strong attachment 
of the bacteria to the ciliated 
epithelial cells of the bronchi and 
trachea, triggering local 
inflammation and tissue injury (FIG. 
1.5b).  10 Viruses also exploit surface glycans as binding epitopes. It has been largely 
studied the case of influenza virus that binds to sialic acids remarkably distinguishing 
between α2,3-linked and α2,6-linked sialosides (FIG. 1.6a). 11 Herpes simplex virus 
(HSV) adheres with the surface of the host cell firstly through a low-affinity interaction 
of its surface glycoproteins gB and gC. Then a higher-affinity binding of viral protein 
gD to a member of the tumor necrosis factor–nerve growth factor (TNF/NGF) 
                                                 
9 Lehniger, Principles of Biochemistry, 4th edn,; Nelson, D.L.; Cox, M.M., Editors. Worth Publisher, Inc.; New 
York, 2004. 
10 Essentials of Glycobiology, 2nd edition.Varki A, Cummings RD, Esko JD, et al., editors. Cold Spring 
Harbor (NY), 2009. 
11 a) Suzuki, Y.; Ito, T.; Suzuki, T.; Holland, J.; Robert, E.; Chambers, T.M.; Kiso, M.; Ishida, H.; 
Kawaoka, Y. J. Virol. 2000, 74, 11825-11831; b) Shinya, K.; Ebina, M.; Yamada, S.; Ona, M.; Kasai, N.; 
Kawaoka, Y. Nature 2006, 440, 435. 
FIG. 1.6: Mechanism of viral entry into host cell 
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receptor family promotes membrane fusion (FIG. 1.6b). 12 Studies on the mechanism of 
the entry of human immunodeficiency virus (HIV) seems to involve the surface 
glycoprotein gp120 that binds sequentially to the CD4 receptor on T cells and then to a 
coreceptor such as chemokine receptor CCR4. After this interaction a conformational 
change in gp120 is triggered and the HIV factor is capable of initiating membrane 
fusion.13 (FIG. 1.6c). 
  
                                                 
12 Lycke, E.; Johansson, M.; Svennerholm, B.; Lindahl, U. J. Gen. Vir. 1991, 72, 1131; b)Turner, A.; Bruun, 
B.; Minson, T.; Browne, H. J. Virol. 1998, 72, 873, c) Spear, P.G. Cell Microbiol. 2004; 6: 401–410. 
13 Ji, X.; Chen, Y.; Faro, J.; Gewurz, H.; Bremer, J.; Spear, G.T. Curr Protein Pept Sci. 2006; 7: 317–324. 
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1.1.1 Multivalency: the way carbohydrates interact 
 
As mentioned above, protein-carbohydrate interactions are critical in several biological 
processes such as bacterial and viral pathogenesis and the inflammatory response. 
Despite the importance of these specific recognition processes, individual protein-
carbohydrate interactions often are of low affinity and worse broad specifity: proteins 
often bind with little discrimination to a set of related monovalent carbohydrate 
structures. 14  This feature is incompatible with the relevance of carbohydrates mediated 
processes and the way Nature has developed to obtain stable and functional complexes 
is the formation of multiple carbohydrate interactions that could operate in each 
recognition event to give the necessary functional affinity. 15 This means that multiple 
receptors must be arranged in such a way as to bind efficiently to multiple saccharide 
ligands. The requirement for the spatial arrangement of the receptors and the binding 
sites on the ligand to be compatible means that the specificity in multivalent binding 
could be achieved, not only via complementarity between individual receptor–ligand 
pairs, but also by controlling the spatial arrangement between individual recognition 
elements of multivalent ligand (FIG. 1.7). It is worth noting that although many studies 
have been done, there is not a complete mechanistic description of multivalent binding 
because of the complexity of such systems. For a divalent ligand, it seems that the free 
energy of binding to a multivalent receptor will be greater than the sum of the 
contributions of each individual site. This primarily results from the fact that once the 
                                                 
14 Kiessling, L.L.; Pohl, N.L. Curr. Biol. 1996, 3, 71. 
15 Lundquist, J.J.; Toone, E. J. Chem. Rev. 2002, 102, 555. 
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ligand has attached itself to a cell by one site, it is closer to the second site and will 
suffer a smaller entropy loss by binding to it. 16 
It has been largely shown 17 that multivalency has several functional advantages in 
biological processes. In a polyvalent system, for example, the strength of a signal can 
vary greatly, depending on the number of ligand-receptor pairs that participate. This 
capability to generate a broad range of signal strengths might, in principle, provide a 
capability to generate a graded (or graduated) response to a biological signal. 
 
FIG.1.7: Specific recognition in multivalent interactions. Cells can use several strategies to bind to a multivalent 
ligand: (a) forming a cluster of many monovalent receptors on a small area of the cell surface, (b) using oligomeric 
receptors, or (c) using receptors with more than one saccharide binding type. Multivalent ligands with incompatible 
relative orientations (d) or spacing (e) of the saccharide units in the multivalent array will not bind tightly. 
 
One example of this type of graded response might be the clearance of pathogens by 
antibody-mediated attachment to macrophages. Where a single antibody is unable to 
cause a macrophage to ingest a pathogen, more antibodies should strengthen the degree 
of polivalency and therefore increase the likelihood that the pathogen will be recognized 
and cleared (FIG. 1.8a). 18 On the other hand, multivalency can be used also for 
                                                 
16 (a) Houseman, B.T.; Mrksich, M. Top. Curr. Chem. 2002, 218, 1; (b) Lee, R.T.; Lee, Y.C. Glycoconjugate J. 
2000, 17, 543. 
17 Mammen, M.; Choi, S.K.; Whitesides, G.M. Angew. Chem. Int. Ed. 1998, 37, 2754. 
18 Indik, Z.K.; Park, J.C.; Hunter, A.D.; Schreiber, A.D. Blood 1995, 86, 4389, 4399. 
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preventing undesired interactions (especially those that are themselves multivalent). For 
example (FIG. 1.8b) mucins (proteins presenting oligosaccharides terminating in sialic 
acid) can bind to influenza and other SA-binding viruses and thereby inhibit their 
attachment to target cells. In this case multivalency can be used both for tight binding to 
pathogen and for steric stabilization of the pathogen surface. In FIG. 1.8c is shown also 
an example of the so called ―conformal contact‖ that occurs when the formation of a 
multivalent bound allows an intimate contact between the two cells in order to make the 
communication processes more rapid and efficient. 
Since multivalency is involved in the interaction of carbohydrates structures with their 
receptors, multivalent compounds are synthesized and tested for several biological 
applications. 19 Examples include carbohydrate functionalized gold nanoparticles whose 
antiadhesive properties involving cancer cell lines have been reported by Penades and 
                                                 
19 Wolfenden, M.L.; Cloniger, M.J. Bioconjugate Chem. 2006, 17, 958. 
FIG. 1.8: Examples of multivalency in Nature: (a) A bacterium  coated with IgG antibodies is eliminated from the 
circulation through phagocytosis by a macrophage. The multivalent binding of the antibody coated bacterium to 
multiple Fc receptors of a macrophage activates the phagocytotic process; (b) Prevention of the attachement of 
influenza virus to the surface of a cell due to the multivalent binding of mucins with the sialyl groups to hemagglutinins 
on the surface of virus; (c) Conformal contact of large biological surfaces by multivalent binding. 
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co-workers. 20 Also Kihlberg and co-workers reported antiviral properties of a 
 
FIG. 1.9: Structure of the PPE polymer. 
human serum albumin as scaffold with up to 19 sialyllactose motifs attached. The 
glycoprotein was designed to inhibit binding of an adenovirus involved in epidemic 
koratoconjunctivitus and was found to generate a 1000-fold potency increase in the IC50 
value. 21 
Recently Disney and co-workers 22 reported the synthesis 
of a mannose-functionalized polymer (poly (p-phenylene 
ethynylene) PPE, FIG.1.9) which allowed multivalent 
detection of Escherichia Coli bacteria. Through laser 
scanning confocal microscopy it was possible to detect 
fluorescent bacterial aggregate due to the multivalent 
interactions between the mannose binding bacterial pili 
and the functionalized polymer (FIG. 1.10). Several 
                                                 
20 Rojo, J.; Diaz, V.; de la Fuente, J.M.; Segura, I.; Barrientos, A.G.; Riese, H.H.; Bernad, A.; Penades, S. 
ChemBioChem 2004, 5, 291. 
21 Johnasson, S.M.C.; Arnberg, N.; Elofsson, M.; Wadell, G.; Kihlberg, H. ChemBioChem 2005, 6, 368. 
22 Disney, M.D.; Zheng, J.; Swager, T.M.; Seeberger, P.H. J. Am. Chem. Soc. 2004, 126, 13343. 
FIG. 1.10: A fluorescent bacterial 
aggregate due to multivalent 
interactions between the mannose-
binding bacterial pili and the 
polymer. 
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experiments with diluted solutions of mannose-binding E. coli were performed and it 
was clearly shown that fluorescently stained clusters could be observed with as little as 
104 bacteria.23 
The multivalent binding of the polymer was demonstrated by testing it for inhibition of 
ConA-induced hemagglutination of sheep erythrocytes. The concentration of mannose 
displayed by the PPE to inhibit hemagglutination was more than 500-fold less than the 
monomeric mannose derivatives, indicating that polymers can bind Con A in a 
multivalent manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
23 A review of some methods for pathogen detection : Willis, R.C. Modern Drug Discovery, 2004, 36. 
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1.2 Synthetic Aspects 
 
1.2.1 Protecting Groups in Carbohydrate Chemistry 
 
In organic chemistry protecting groups are often divided in two categories: permanent 
protecting groups (which will remain through all the synthetic steps and will be 
removed at the end of the synthesis) and temporary protecting groups (whose 
removal occurs generally during the synthesis for the liberation of the functionality). 
The protecting groups used in carbohydrate chemistry are the same as in the other areas 
of organic chemistry. The conditions for their introduction and removal and their 
stability and orthogonality are also the same. 24 The main difference in carbohydrate 
chemistry is the vast number of protecting groups needed and the continuous research 
of regioselective protections. It is worth noting that in carbohydrate chemistry 
protecting groups not only protect, but they also confer other effects on the molecule: 
for example, they increase or decrease the reactivity and they can also participate in 
reactions, thus affecting the stereochemical outcomes. 
The most important protecting groups in carbohydrate chemistry are obviously the 
hydroxyl protecting groups, including the anomeric hemiacetals ones. Amino-protecting 
groups (for amino-deoxy sugars) for the synthesis of aminosugars-containing 
oligosaccharides are also of interest. 
 
 
                                                 
24 Information can be found in books on protecting groups: (a) Greene, T.; Wuts, P.G.M. Protective Groups 
in Organic Synthesis, 4th ed., Wiley, New York, 2007; (b) Kocienski, P. Protecting Groups, Georg Thieme 
Verlag, Stuttgart, 2000, corrected edition. 
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1.2.1.1 Hydroxyl protecting groups 
 
This kind of protecting groups are the most widely used in carbohydrate chemistry 
because of the large number of hydroxyl groups to protect. 
For a permanent protection of the free hydroxyl groups only acetate and benzoate esters 
and benzyl ethers are typically used due to their stability and efficient 
introduction/deprotection properties needed to make them suitable for these purposes. 
As opposed to the small selection of permanent protecting groups, there is a wide 
choice of temporary protecting groups and new protection methods are continuosly 
being developed. 
 
1.2.1.1.1 Esters protecting groups 
 
The most common esters protecting groups are reported in the FIG. 1.11. Standard 
conditions for esterification, which can be performed also on reducing sugars, are the 
acyl chloride (especially for benzoates) or the anhydride (especially for acetates) in 
pyridine. The acetylation can be performed also in acid conditions using in situ generated 
HI for the activation of the acetic anhydride. 25 In addition esters (especially acetates) 
have a tendency to migrate both in acidic and basic conditions. 26 For example, in cis-
                                                 
25  Ravidranathan Kartha, K.P.; Field, R.A. Tetrahedron 1997, 53, 11753. 
26 Haines, A. Adv. Carbohydr. Chem. Biochem. 1976, 22, 11. 
FIG. 1.11: Esters protecting groups in common use 
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hydroxyls there is normally a preferred migration from the axial position to the 
equatorial one and in 4,6-diols the migration goes from O-4 to O-6 preferentially. 
Esters can be easily cleaved using base conditions such as NaOMe, KOH and NH3 but 
they can be also cleaved using acid conditions (MeOH/HCl). 27 The relative order of  
stability of the most common ester groups reflects both steric and electronic aspects and 
is as follows: 
t-BuCO > PhCO > MeCO > ClCH2CO 
It is worth noting that acetates can be also used as temporary protecting groups in 
presence of benzoates because they can be selectively removed both under acid 
conditions (MeOH/HCl) 27 and in basic conditions (Mg(OMe)2/MeOH). 
28 
As far as the cleavage of chloroaetate esters is concerned, several mild reagents have 
been reported such as 2-mercaptoethylamine, thiourea or hydrazinedithiocarbonate 
(H2NNHC(=S)SH). 
29 
 
1.2.1.1.2 Ethers protecting groups 
 
The most common ether protecting groups are reported in FIG. 1.12 They include 
benzyl and p-methoxybenzyl, allyl, trityl and silyl ethers. 
Benzyl ethers are widely used as permanent protecting groups for their well-known 
stability. Their installation can be performed under strongly base conditions (benzyl 
bromide and sodium hydride in a nonprotic polar solvent). It has been also 
demonstrated that benzylation can be performed with benzyl trichloroacetimidate and a 
                                                 
27 Byramova, N.E.; Ovchinnikov, M.V.; Backinowsky, L.V.; Kochetov, N.K. Carbohydr. Res. 1983, 124, C8. 
28 Josephson, S.; Bundle, D.R. Can. J. Chem. 1979, 53, 3073. 
29 (a) Kihlberg, J.; Frejol, T.; Jansson, K.; Magnusson, G. Carbohydr. Res. 1986, 152, 113; (b) Trumtel. M.; 
Tavecchia, P.; Veyrières, A.; Sinaÿ, P. Carbohydr. Res. 1989, 191, 29. 
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catalytic amount of acid (generally TfOH) with good yields. 30 . Benzyl ethers are usually 
cleaved through catalytic hydrogenolysis employing various Pd-catalysts. An alternative 
is a Birch-type reduction (Na/liquid ammonia) which is surprisingly mild towards other 
functionalities such as phosphates and even the hemiacetals of reducing sugars. 31 
There is a clear distinction between in the reaction conditions for the installation of the 
p-methoxybenzyl and allyl ethers (usually formed under strongly basic conditions – p-
methoxybenzyl and allyl bromide with sodium hydride) and the trityl and silyl ethers 
(usually formed under weakly basic conditions – typically with trityl or silyl chloride in 
pyridine). 
The p-methoxybenzyl group can be easily removed under oxidative conditions with 
DDQ 32 or CAN 33 in wet dichloromethane or acetonitrile, while allyl ethers are typically 
cleaved with a two stage deprotection: initial rearrangement of the allyl ether using 
strong base or metal-complex catalysts (e.g. Wilkinson’s catalyst) is followed by Lewis 
                                                 
30 Wessel, H.P.; Iversen, T.; Bundle, D.R. J. Chem. Soc. Perkin Trans. 1 1985, 2247. 
31 Iseloh, U.; Dudkin, V.; Wang, Z.G.; Danishefsky, S. Tetrahedron Lett. 2002, 43, 7027. 
32 (a) Johansson, R.; Samuelsson, B. J. Chem. Soc. Perkin Trans. 1 1984, 2371; (b) Nakajima, N.; Abe, R.; 
Yonemitsu, O. Chem. Pharm. Bull. 1988, 36, 4244. 
33 (a) Oikawa, Y.; Yoshioka, T.; Yonemitsu, O. Tetrahedron Lett. 1982, 23, 885; (b) Horita, K.; Yoshioka, T.; 
Tanaka, T.; Oikawa, Y.; Yonemitsu, O. Tetrahedron 1986, 42, 3021; (c) Garregg, P.J.; Olsson, L.; Oscarson, 
O. J. Carbohydr. Chem. 1993, 12, 955. 
FIG.1. 12: Commonly used ether protecting groups 
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acid-catalyzed hydrolysis of the obtained vinyl-ether. Recently SmI2 was reported as an 
efficient deallylation reagent following a radical mechanism (it is worth noting that in 
these conditions anomeric allyl groups are relatively stable).  34 
TBDMS and TBDPS are the most common silyl ethers used in carbohydrate chemistry 
for their acid stability. A problem of this kind of protecting group is that they, like 
esters, can migrate to neighboring free hydroxyl groups under mild base conditions.35 
Silyl ethers can be easily cleaved by treatment with fluoride ion (HF/acetonitrile; 
TBAF/THF). 
Trityl protecting groups are cleaved by acid hydrolysis . Higher is the number of mono- 
or di-methoxy substituents on the trityl, more labile is the group toward acid hydrolysis. 
Noteworthy, no trityl protecting groups are able to withstand classical glycosylation 
conditions. 
 
1.2.1.1.3 Acetals and ketals protecting groups 
 
Among the known acetals and ketals protecting groups (FIG. 1.13), in carbohydrate 
chemistry benzylidene and isopropylidene acetals are the most widely used ones for 
simultaneous protections of two hydroxyl groups. They are introduced by standard 
conditions (the aldehyde or the dimethoxy-acetal and some acid catalysis) and are 
removed by acid hydrolysis (regioselective opening of these protecting groups will be 
discussed afterwards). Benzylidene acetals are formed preferentially as six-membered 
dioxane cycles (i.e. 4,6-O-benzylidene derivatives), while isopropylidene acetals are more  
                                                 
34 Dahlén, A.; Sundgren, A,; Lahmann, M., Oscarson, S.; Hilmersson, G. Org. Lett. 2003, 5, 4058. 
35 Jones, S.S.; Reese, C.B. J. Chem. Soc. Perkin Trans. 1 1979, 2762. 
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FIG. 1.13: Acetal and ketal protecting groups in common use. 
 
 
FIG. 1.14: Acetal and ketal formation on methyl α-D- mannopyranoside 
 
FIG. 1.15: Acetal and ketal formation on methyl α-D- galactopyranoside 
FIG. 1.16: Formation and opening of 1,6-anhydro derivative 
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stable as five-membered dioxolane rings formed on cis-diols. Examples of acetals 
formation and not selective deprotection are reported in FIG.1.14 and FIG.1.15An 
important alternative for benzylidene acetal is the more acid labile p-
methoxybenzylidene acetal that can be cleaved selctively in the presence of the 
benzylidene one. In contrast to benzylidene, isopropylidene and p-methoxybenzylidene 
acetals, that exhibit all the same regioselectivity for vicinal cis-diols, the newly developed 
butane-2,3-diacetal (BDA) shows completely different regioselectivity providing 
simultaneous protection of trans-diols. 36 
Silyl acetals are also used as a valid alternative to the acetals discussed thus far and they 
can be removed by treatment with fluoride ion. 
 
1.2.1.2 Anomeric protecting groups 
 
In general anomeric position is the first one to be protected during a series of protecting 
groups manipulations. The anomeric centre can be protected as an alkyl, benzyl or allyl 
glycoside by a classical Fischer reaction in which a monosaccharide is suspended in an 
alcohol and treated with a catalytic amount of an acid. An acyl group can be also used 
for the protection of the anomeric centre, it can be removed under milder basic 
conditions (e.g. hydrazine acetate or ammonium carbonate in DMF, 37 piperidine in 
THF). 
                                                 
36 Ley, S.V.; Baeschlin, D.K.; Dixon, D.J.; Foster, A.C.; Ince, S.J.; Priepke, H.W.M.; Reynolds, D.J. Chem. 
Rev. 2001, 101, 53. 
37 (a) Excoffer, G.; Gagnaire, D.; Utille, J.P. Carbohydr. Res. 1975, 39, 368; (b) Nudelman, A.; Herzig, J.; 
Gottlieb, H.E.; Kerinan, E.; Sterling, J. Carbohydr. Res. 1987, 162, 145; (c) Gurjar, M.K.; Saha, U.K. 
Tetrahedron 1992, 48. 4039; (d) Nakano, T.; Ito, Y., Ogawa, T. Carbohydr. Res. 1993, 243, 43. 
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More specific anomeric protecting groups are the 2-trimethylsilylethyl (TMSE) 38 and   
p-methoxyphenyl glycosides, 39 both introduced by glycosylation reactions on protected 
derivatives. The former is cleaved by treatment with BF3∙OEt2 while the second is 
cleaved by CAN-oxidation similarly to p-methoxylbenzyl ethers. 
1,6-Anhydro bridges can be considered as a protecting group for the anomeric centre 
(and the 6-hydroxyl group). 1,6-Anhydro derivatives are formed by an internal 
displacement where the leaving group can be in either the 1- or the 6- position. 40 
Examples are the treatment with bases of phenyl β-glycosides or 6-O-tosyl-derivatives 
with a free hemiacetals group or the treatment with Lewis acids of methyl glycosides at 
high temperatures (FIG. 1.16). 41 The 1,6-anhydro-bridge is stable to most reaction 
conditions but very susceptible to mild acetolysis conditions to give the 1,6-diacetates. 
 
1.2.1.3 Amino protecting groups 
 
The most common protecting groups for amino functions in carbohydrate chemistry 
are represented in FIG. 1.17. It is worth noting that an important feature of the 
protecting groups used for the amino function at position 2 is to allow the 
stereoselective formation of the correct anomer during glycosylation reactions (i.e., 
participating groups such as amides or carbamates for 1,2-trans-linkages and 
nonparticipating groups for 1,2-cis-linkages). Presently there is one generally useful 
amine precursor that is nonparticipating that is the azido (N3) group. 
                                                 
38 Jansson, K.; Ahlfors, S.; Frejd, T.; Kihlberg, J.; Magnusson, G.; Dahmen, J.; Noori, G.; Stenwall, K. J. 
Org. Chem. 1988, 53, 5629. 
39 Zhang, Z.; Magnusson, G. Carbohydr. Res. 1996, 295, 41. 
40 Cerny, M.; Stanek, J. Adv. Carbohydr. Chem. Biochem. 1977, 34, 23. 
41 Aberg, P.; Ernst, B. Acta Chem. Scand. 1994, 48, 228. 
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Among the amide type protecting groups the acetyl group is usually discarded since, in 
glycosylation reactions, it participates forming a stable oxazoline ring instead of the 
desired glycoside. For this reason there is a wide interest in the development of 2-amino 
protecting groups with the ability to participate but not form oxazolines. 42 
 
FIG. 1.17: Amino protecting groups in common use. 
 
The first developed protecting group is the phthalimido that can be incorporated 
treating the substrate with phthalic anhydride in basic conditions. 43 A drawback of this 
method is the hard basic condition (typical hydrazine, hydroxylamine and alkyldiamine) 
needed for its removal, which results in low yields of the unprotected derivatives. For 
this reason other phtaloyl-based protecting groups such as the tetrachlorophtalimides 
(TCP) 44 and dimethylmaleoides (DMM) were developed: 45 they are formed in similar 
conditions but they can be removed under milder basic conditions. Another frequently 
                                                 
42 (a) Banoub, J.; Boudlanger, P.; Lafont, D. Chem. Rev. 1992, 92, 1167; (b) Bongat, A.F.G.; Demchenko, 
A.V. Carbohydr. Res. 2007, 342, 364. 
43 Debenham, J.; Rodebaugh, R.; Fraser-Reid, B. Liebigs. Annal. 1997, 791. 
44
 Debenham, J.; Rodebaugh, R.; Roberts C.l.; Fraser-Reid, B. J. Am. Chem. Soc. 1995, 117, 3302. 
45 (a) Aly, M.R.E; Castro-Palomino, J.C.; Ibrahim, E.S.I.; El-Ashry, E.S.H.; Schmidt, R.R. Eur. J. Org. 
Chem. 1998, 11, 2305; (b) Aly, M.R.E; Ibrahim, E.S.I.; El-Ashry, E.S.H.; Schmidt, R.R. Carbohydr. Res. 
2001, 331, 129. 
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participating protecting group in oligosaccharide synthesis is the trichloroethylcarbamate 
(Troc) group. 46 
The azido group can be easily introduced through a diazo-transfer reaction using triflyl 
azide 47 or imidazole-1-sulfonyl azide hydrochloride 48 and converted in the amino free 
group under hydrogenolysis conditions. 
 
1.2.1.4 Selective Protection and Deprotection Methodologies 
 
1.2.1.4.1 Selective Protection Methodologies 
 
The purpose of developing selective protection for the preparation of building blocks 
useful for the synthesis of oligosaccharide structures has been carried out over the years 
but it is still an important topic in the carbohydrate chemistry. In the scheme below are 
represented the most commonly utilized protection methodologies: 
 
 
 
 
 
 
 
 
 
 
                                                 
46 Ellervik, U.; Magnusson, G. Carbohydr. Res. 1996, 280, 251. 
47 (a) Yan, R.B.; Yang, F.; Wu, Y.; Zhang, L.H.; Ye, X.S. Tetrahedron Lett. 2005, 46, 8993; (b) Titz, A.; 
Radic, Z.; Scwardt, O.; Ernst, B. Tetrahedron Lett. 2006, 47, 2383. 
48 Goddard-Borger, E. D.; Stick, R. V. Org. Lett., 2007, 9, 3797. 
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 Different reactivity of the OH groups: 
 
To simplify, the reactivity order of hydroxyl groups in saccharides is primary OH > 
equatorial OH > axial OH, mainly 
due to steric factors. 26 Thus using 
a bulky reagent (e.g. 
triphenylmethyl or tert-
butyldiphenylsilyl chloride, FIG. 
1.18) under various basic 
conditions it is possible to obtain 
the 6-O-monoprotected hexose 
derivative in high yields. This is especially useful if the anomeric position is already 
protected.  
Additionally, primary hydroxyl groups can be selectively benzoylated using special 
reagents as benzoyl cyanide/triethylamine 49 or 1-acyloxy-1H-benzotriazoles. 50 Finally, 
regioselective acylations catalyzed by lipases are possible with the most common site of 
reaction at primary hydroxyls. 51 
 
 Stannyl activation: 
By reacting the hydroxyl groups of saccharides with alkyl tin oxide reagents, stannylene 
ethers and acetals are formed. The formation of such derivatives enhances the 
nucleophilicity of the oxygen atoms in a regioselective way and makes the consecutive 
                                                 
49 Rio, S.; Beau, J.M.; Jacquinet, J.C. Carbohydr. Res. 1994, 255, 103. 
50 Pelyvàs, I.F.; Lindhorst, T.K.; Streicher, H.; Thiem, J. Synthesis 1991, 1015. 
51 Kadereit, D.; Waldmann, H. Chem. Rev. 2001, 101, 3367. 
FIG. 1.18: Examples of selective protection of primary hydroxyl 
groups 
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alkylation or acylation of saccharides possible. 52 The regioselectivity associated with 
stannyl activation is irrespective of which type of alkyltin derivative is used. The most 
common alkyl tin oxide reagent is dibutyltin oxide producing dibutyl stannylene acetals 
that, after treatment with an appropriate electrophile, give access to esters or silyl or 
alkyl ethers. The structure of the intermediate stannylene is not yet well understood. 53 
The outcome of the reaction is not always predictable because of the selectivity depends 
on several parameters (the electrophile, additives, etc) but, generally speaking, dibutyl tin 
acetals derived from mixed primary and secondary diols are selectively alkylated at the 
primary positions. A tin acetal derived from a cis-1,2-cyclohexanoid diol is selectively 
                                                 
52 Grindley, T.B. Adv. Crbohydr. Chem. Biochem. 1998, 53, 17. 
53 (a) David, S.; Pascard, C.; Cesaria, M. J. Neouveau Chim. 1979, 3, 63; (b) Cameron, T. S.; Bakshi, P. K.; 
Thangarasa, R.; Gridley, T. B. Can. J. Chem. 1992, 70, 1623; (c) Nagy, L.; Gyurcsik, B.; Burger, K.; 
Yamashita, S.; Yamaguchi, T.; Wakita, H.; Nomura, M. Inorg. Chim. Acta 1995, 230, 105, (d) Li, S.L.; Lan, 
Y.Q.; Ma, J.F.; Yang, J.; Zahng, M.; Su, Z.M. Inorg. Chem. 2008, 47, 2931. 
FIG. 1.19: Examples of stannyl activated regioselective protection 
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alkylated at the equatorial position, whereas regioselectivities are generally poor for 
equatorial-equatorial diols. As far as the formation of esters via stannylene is concerned, 
the regioselectivities are generally poorer as those observed with alkylations 54 and so the 
methods is not very common (FIG.1.19). 
 
 Phase-Transfer Alkylation and Acylation: 
 
In this method a two-phase system (H2O/CH2Cl2) is used. The aqueous phase contains 
a base (NaOH, 5%) and the organic phase an electrophile, usually an alkyl halide. The 
diol to be protected is usually partitioned between the two phases. In the water phase 
one of the two hydroxyl groups is selectively deprotonated and with the assistance of a 
phase-transfer reagent (usually a tetrabutylammonium salt) the molecule is transported 
in the organic phase where it is selectively alkylated or acylated. Regarding 
regioselectivity, primary hydroxyl groups are preferentially protected and in the case of 
2,3 diols the oxygen at position 2 is selectively protected because of its higher acidity 
due to the proximity of the ring oxygen (FIG. 1.20). 
 
FIG. 1.20 Examples of phase-transfer benzylations 
                                                 
54 Ysuda, Y.; Haque, M.E.; Yoshimoto, K. Chem. Pharm. Bull. 1983, 31, 1612. 
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Owing to the strongly basic conditions, this method is incompatible with acylations. 
However it is reported a selective tosylation with high regioselectivities through phase-
transfer techniques. 55 
 
 Cu(II) Activation: 
 
Dianions can be easily obtained treating diols with a strong base such as NaH. Once 
they are formed, it is possible to complexate them by copper(II) ions. Reaction of the 
complexes with various electrophile agents (alkyl halides, acyl chlorides) can lead to the 
formation of selectively protected sugar derivatives. Using this method disubstituted 
products are obtained in low yields and it is worth noting that the regioselectivity is 
completely reversed to those observed in the phase transfer methodologies (i.e., 4,6-diols 
give mainly 4-substitution and 2,3-diols give mainly 3-substitution, FIG. 1.21).
 
FIG. 1.21: Examples of regioselective protection from copper complexes 
Using this technique both selective alkylations (allylation, benzylation) and acylations 
(acetylation, benzoylation and pivaloylation) are possible but often the outcomes 
depends on reaction conditions and on structural features. 56 
                                                 
55 Garegg, P.J.; Iversen, T.; Oscarson, S. Carbohydr. Res. 1976, 53, C-5. 
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 Reductive Opening of  Cyclic Acetals: 
 
The importance of cyclic acetals as protecting groups is strongly increased since it has 
been possible to open up the acetal ring regioselectively in order to obtain alkyl ethers 
and a free hydroxyl group. 57  
All the methods for the reductive opening of acetals are based on a combination of an 
hydride reagent with a Lewis acid (or a proton acid): firstly, LiAlH4/AlCl3 were used for 
the reductive opening of benzylidene acetals. This method yields 4-O-benzyl derivatives 
with high selectivity especially if there is a bulky substituent in the 3-position. 58 In 
dioxolane acetals of cis-diols (e.g., 2,3-manno- or 3,4-galacto-), the selectivity depends on 
the configuration of the acetal: exo-phenyl derivative gives the equatorial benzyl ether 
while the endo-derivative gives the axial one with absolute selectivity. This methodology 
is not always applicable because of the incompatibility of several protecting groups with 
the reagents system used (FIG. 1.22). For these reasons several procedures for reductive 
benzylidene opening have been developed that give preferentially the 4-O-benzyl or the 
6-O-benzyl derivatives (Table1.2). 
The same procedures (with slight modifications) have been used also for the 
regioselective opening of other types of acetal protecting groups such as p-
methoxybenylidene acetals and allyl-type acetals (FIG.1.22). 
Subsequently, there has been a continuous development of new reagents, all of which 
are variations of the same general theme (Lewis acid/hydride reagent) , optimizing yield 
and selectivity for specific derivatives. 
                                                                                                                                          
56 Osborn, H.M.I.; Brome, V.A.; Harwood, L.M.; Suthers, W.G. Carbohydr. Res. 2001, 332, 157. 
57 Gelas, J, Adv. Carbohydr. Chem. Biochem. 1981, 39, 71; Garegg, P.J. in Preparative Carbohydrate Chemistry, 
Hanessian, S, Ed., Marcel Dekker, New York, 1997, p. 53. 
58 de Ninno, M.P.; Etienne, J.B.; Duplantier, K.C. Tetrahedron Lett. 1995, 36, 669. 
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Benzylidene acetals can also be opened under oxidative conditions to give benzoyl 
esters halogen derivatives(FIG.1.23a) (which are useful for the synthesis of deoxy-
sugars). 59 or simply hydroxyl benzoates (FIG.1.23b). 60 
 
Lewis Acid / 
Proton Acid 
Reducing Agent Solvent Product 
Ph2BBr PhS or BH3∙THF CH2Cl2 6-OH 61 
Bu2BOTf BH3∙THF CH2Cl2 6-OH 62 
AlCl3 Me3NBH3 PhCH3 or CH2Cl2 
THF 
6-OH 
  4-OH 63 
BF3∙OEt2 Me2NHBH3 CH2Cl2 
CH3CN 
6-OH 
  4-OH 64 
HCl NaCNBH3 THF 4-OH 65 
CF3COOH Et3SiH CH2Cl2 6-OH 58 
CF3SO3H NaCNBH3 THF 4-OH 61 
Cu(OTf)2 BH3∙THF CH2Cl2 6-OH 66 
Table 1.2: Methods currently used for regioselective opening of benzylidene acetals. 
 
 
                                                 
59 (a) Chen, Y.; Wang, P. G. Tetrahedron Lett. 2001, 42, 4955;(b) Karimi, B.; Rajabi, J. Synthesis 2003, 2373; 
(c) Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A. Tetrahedron Lett. 1999, 40, 8439; (d) Ponminor 
Senthil, K.; Amit, B.; Sundarababu, B. Angew. Chem., Int. Ed. 2010, 49, 804; (e) Stevénin, A.; Boyer, F.D.; 
Beau, J.M. J. Org. Chem. 2010, 75, 1783. 
60 Deslongchamps, P.; Moreau, C.; Fréhel, D.; Chênevert, R. Can. J. Chem. 1975, 53, 1204. 
61 Guindon, Y.; Girard, Y.; Berthiaume, S.; Gorys, V.; Lemieux, R.; Yoakim, C. Can. J. Chem. 1990, 68, 
897. 
62 Jiang, L.; Chan, T.H. Tetrahedron Lett. 1998, 39, 355. 
63 Ek, M.; Garegg, P.J.; Hultberg, H.; Oscarson, S. J. Crobohydr. Chem. 1983, 2, 305 
64 Oikawa, M.; Liu, W.C.; Nakai, Y.; Koshida, S.; Fukase, K.; Kusumoto, S. Synlett 1996, 1179. 
65 Garegg, P.J.; Hultberg, H.; Wallin, S. Carbohydr. Res. 1982, 108, 97. 
66 Shie, C.R.; Tzeng, Z.H.; Kulkarni, S.S.; Uang, B.J.; Hsu, C.Y.; Hung, S.C. Angew. Chem. Int. Ed. 2005, 44, 
1665. 
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FIG. 1.22: Examples of regioselective reductive benzylidene opening 
 
 
 
 
 
 
 
FIG. 1.23: Examples of oxidative opening of benzylidene acetals
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 Cyclic Orthoester Opening: 
 
Cyclic orthoesters cannot be considered as a class of protecting groups because of their 
extreme acid lability. They are however useful intermediates for the synthesis of building 
blocks for glycosylation reactions. One of the major advantage of the orthoester method 
is that they can be opened by mild hydrolysis to give the corresponding ester derivative 
exposing a free hydroxyl group. 67 Usually, the opening of the orthoester ring of a vicinal 
cis-diol gives the ester on the axial protecting group. Care has to be taken in the opening 
process to avoid acyl migration to the unprotected hydroxyl group (this process is 
however slow in acid solutions and can be avoided using orthobenzoates instead of 
orthoacetates). 
 
FIG. 1.24: Examples of orthoesters formation end openings. 
In 4,6-O-orthoesters, the opening reaction gives a mixture of 4-O protected sugar and 6-
O-protected sugar; this feature is not relevant when a 6-O-acetate is desired because the 
acetate group can easily migrate from position 4-O to position 6-O. 68 When 2,3-O-
                                                 
67 Lemieux, R U, Driguez, H, J. Am. Chem. Soc. 1975, 97, 4069. 
68 Oscarson, S, Szönyi, M, J. Carbohydr. Chem. 1989, 8, 663. 
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orthoesters of thioglycosides are used, care must be taken to avoid participation of the 
sulfur affording the formation of 2-thiolated-O-alkyl glycosides. 69 
 
1.2.1.4.2 Selective Deprotection Methodologies 
 
Selective deprotection methodologies are not as common as selective protection ones 
and several efforts are made to improve their efficiency. In literature, however are 
reported few standards methods that utilize this approach. For example a well-known 
example is represented by the selective removal of the primary benzyl ethers by 
acetolysis (FIG. 1.25). 70 
 
FIG. 1.25: Regioselective deprotection of aprimary hydroxyl group 
It has also been reported a debenzylation procedure that allows the selective removal of 
benzyl groups in anhydro-sugars with a catalysis promoted by Lewis acids. The outcome 
of the deprotection was dependent on the Lewis acid and on the configuration of the 
sugar (FIG. 1.26). 71 
Also primary acetyl groups can be selectively removed utilizing lipases but the 
applicability of the method is too substrate-dependent to be considered of general 
relevance. 
 
                                                 
69 (a) Pozsgay, V, A. Carbohydr. Res. 1992, 235, 295; (b) Auzanneau, F I, Bundle, D R, Carbohydr. Res. 1991, 
212, 13. 
70 Yang, G.; Ding, X.; Kong, F. Tetrahedron Lett. 1990, 31, 1331. 
71 Boons, G.J.; Hale, K.J. in Organic Synthesis with Carbohydrates, Sheffield Academic Press 2000, pp. 29. 
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FIG. 1.26: Lewis acid catalyzed debenzylation. 
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1.2.2 The Formation of the Glycosidic Linkage 
 
Interglycosidic bond formation is generally achieved by condensing a fully protected 
glycosyl donor, which bears a potential leaving group (LG) at its anomeric centre, with a 
suitable glycosyl acceptor that contains often only one free hydroxyl group (FIG. 1.27). 72 
 
FIG. 1.27: Basic glycosylation rection mechanism 
The reaction is usually performed in presence of an activator called ―promoter‖, whose 
function is to assist the departure of the leaving group. The promoter is often used in 
catalytic amounts, although in some instances they are used in stoichiometric amounts. 
Other additives such as molecular sieves or any base that may act as acid scavenger are 
used. An aspect to be considered is without doubt the electronic feature of the 
protecting groups on both glycosyl acceptor and glycosyl donor. On this point is based 
the ―armed-disarmed strategy‖ elaborated by Fraser-Reid and coworkers in 1988: 73 It 
was noted that ester-type protecting groups(OAc, OBz, etc.) strongly lowered the 
reactivity of n-pentenyl glycosyl donors, in comparison to the effect of ether-type 
protecting groups. A justification of such an observation, was that electron-withdrawing 
groups such as esters protecting groups decrease the electron density and then the 
nucleophilicity of leaving group. 
Recently, Demchenko and coworkers classified glycosyl donors as superarmed, armed, 
moderately armed and disarmed. The classification took place from the observation that 
perbenzylated S-benzoxazolyl glycosides were less reactive than perbenzylated glycosyl 
                                                 
72 Mydock, L.K.; Demchenko, A.V. Org. Biomol.Chem. 2010, 8, 497. 
73 Mootoo, R.U.; Konradsson, P.; Udodong, U.; Faser-Reid, B. J. Am. Chem. Soc. 1988, 110, 5583. 
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donors with an ester protecting group at C-2 (FIG. 1.28). This difference in reactivity 
was explained by the assistance of the departure of the leaving group by the ester 
protecting group at C-2 (this effect is called ―neighboring group participation‖ and 
has relevant effects on the stereochemical outcome of a glycosylation reaction, as it will 
be discussed in next section). 74 The increased reactivity could be explained therefore in 
term of the ―O-2/O-5 cooperative effect‖: the stabilization for the glycosylation 
intermediate could be achieved through two possible sources of electron pair donation. 
The first comes from a lone pair on the neighboring endocyclic ring oxygen, O-5 and 
the second deriving from the anchimeric assistance of the protecting group at C-2. 75 It 
is obvious that electron-withdrawing groups will decrease the amount of the first 
electron donation. 
 
1.2.2.1 Stereochemical Aspects of Glycoside Bond Formation 
 
As anticipated before, the formation of a new glycosidic linkage is one of the most 
challenging aspects of oligosaccharide synthesis and there are many factors that affect 
the outcome of a glycosylation reaction in terms of yield and α:β ratio. In relation to the 
                                                 
74 (a) Mydock, L.K.; Demchenko, A.V. Org. Lett. 2008, 10, 2107,(b)Mydock, L.K.; Demchenko, A.V. Org. 
Lett. 2008, 10, 2103; (c) Premathilake, H.D.; Mydock, L.K.; Demchenko, A.V.  J. Org. Chem. 2010, 75, 
1095. 
75 Crich, D.; Li, M. Org. Lett. 2007, 9, 4115. 
FIG. 1.28: Mixed protecting groups and O2/O-5 cooperative effect 
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orientation of the substituent at the neighboring carbons, the glycosidic linkages can be 
divided in 1,2-trans and 1,2-cis glycosidic bonds. The ease of formation of these bonds is 
strictly related to the strength of the anomeric effect, which is comparatively stronger in 
the α-manno-type than in the α-gluco-type sugars, and on the protecting group pattern on 
the glycosyl donor. Thus, the ease of glycoside bond formation decreases from the α-
manno- by the β-gluco-, to the α-gluco- and, finally, to the β-manno-type (FIG. 1.29). 
The reason why 1,2-trans glycosidic bonds are simpler to obtain is the possibility to 
install at the C-2 position a protecting group (a classical example is the acyl protecting 
group) that assists the departure of an activated leaving group forming a more stable 
dioxolenium ion (FIG. 1.30). Consequently the glycosyl acceptor can only attack from 
the back side to form the 1,2-trans glycoside. A drawback in the use of the participating 
protecting group is the possible formation of an orthoester that prevents the formation 
of a 1,2-trans glycoside. 76 
                                                 
76 Zeng, Y.; Ning, J.; Kong, F. Carbohydr. Res. 2003, 338, 307; (b) Zeng, Y.; Ning, J.; Kong, F. Tetrahedron 
Lett. 2002, 43, 3729; (c) Seeberger, P.H.; Eckhardt, M.; Gutteridge, C.E.; Danishefsky, S.J. J. Am. Chem. 
Soc. 1997, 119, 10064. 
FIG. 1.29: Types of glycosidic bond. 
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FIG. 1.30: Mechanism of the neighboring-group parteciaption. 
Beside acyl groups, other participating groups have been used for the synthesis of 1,2-
trans glycosidic bond: among these the dialkyl phosphates protecting groups, 77 the 2-
pyridylmethyl group 78 and a wide number of ―improved‖ esters groups (such as 4-
acetoxy-2,2-dimethylbutanoyl ester (ADMB), 79 3-(2-hydroxyphenyl)-3,3-
dimethylpropanoate (DMBPP) and 3-(2-hydroxy-4,6-dimethylphenyl)-3,3-
dimethylpropanoate groups (TMBPP) 80 and methylsulfonylethoxycarbonyl (Msc) 81) 
that have the advantage to decrease the amount of orthoester formation. 
It is worth noting that nowadays protecting groups are designed not only for the 
obtainment of 1,2-cis glycosides. This is the case of the chiral auxiliary groups developed 
by Boons and coworkers in 2005 for stereoselective glycosylation reactions. 82 The 
                                                 
77 Yamada, T.; Takemura, K.; Yoshida, J.; Yamago, S. Angew. Chem Int. Ed. 2006, 45, 7575. 
78 Smoot, J.T.; Pornsuriyasak, P.; Demchenko, A.V. Angew. Chem. Int. Ed. 2005, 44, 7123. 
79 Yu, H.; Williams, D.L.; Ensley, H.E. Tetrahedron Lett. 2005, 46, 3417. 
80 Crich, D.; Cai, F. Org. Lett. 2007, 9, 1613. 
81 Ali, A.; van den Berg, R.; Overkleeft, H.S.; Filippov, D.V.; Van der Marel, G.A.; Codee, J. Tetrahedron 
Lett. 2009, 50, 2185. 
82 Kim, J.H.; Yang, H.; Boons, G.J. Angew. Chem. Int. Ed. 2005, 44, 947. For applications of this 
methodology, see: Kim, J.H.; Yang, H.; Boons, G.J. J. Am. Chem. Soc. 2005, 127, 12090. 
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auxiliary group is formed by a 1-phenyl-ethyl moiety with a nucleophilic group at one 
end. According to the configuration of the chiral centre, the auxiliary can lead to the 
preferential formation of a cis- or trans-decalin system because of steric interactions (FIG. 
1.31). The attack of the nucleophile on this will give the 1,2-cis glycoside or the 1,2-trans 
glycoside. This technique has been successfully applied for the synthesis of branched 
oligosaccharides 83 and of a repeating unit of a α-glucan pentasaccharide found in A. 
carmichaeli. 84 
All the examples considered up to know were based on the participation of a group on 
the C-2. Participating protecting groups at other positions than C-2 also exist and are 
called ―remote participation groups‖. 85 They are largely used and, although it is hard to say 
                                                 
83 Boltje, T.J.; Kim, J.; Park, J.; Boons, G.J. Nat. Chem. 2010, 2, 552. 
84 Zaho, C.; Li, M.; Luo, Y.; Wu, W. Carbohydr. Res. 2006, 341, 485. 
85 (a) Amin, M.N.; Ishiwata, A.; Ito, Y. Tetrahedron, 2007, 63, 8181; Park, J.; Boltje, T.; Boons, G.J. Org. 
Lett. 2008, 10, 4367; (b) Crich, D.; Hu, T.S.; Cai, F. J. Org. Chem. 2008, 73, 8942; (c) Baek, J.Y.; Lee, B.; Jo, 
M.G.; Kim. K.S. J. Am. Chem. Soc. 2009, 131, 17705. 
FIG. 1.31: Mechanism of chiral auxiliary group participating. 
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how these groups work, their application is surely helpful in the development of 
stereocontrolled oligosaccharide synthesis. 
When there is no a participating groups on the glycosyl donor, the anomeric outcome of 
the glycosylations is markedly influenced by the nature of the solvent (the so called 
―solvent participation‖). Ether-type solvents have a tendency to shift 
stereoselectivities through the formation of α-glycosides because of the preferential 
formation of the β-
oxonium ion 
intermediate (for 
reverse anomeric 
effect) that reacts to 
form the α-glyoside. 
86 Nitrile-type 
solvents have a well-
known tendency to 
form β-glycosides. It 
is not known yet 
which mechanism is involved in this case but it seems that acetonitrile, as polar solvent, 
favors an SN1 mechanism implying the formation of an oxonium ion that is solvated 
preferentially at the α-face forming the kinetically controlled α-nitrilium-nitrile complex. 
This complex finally gives the β-glycoside after the attack of the glycosyl acceptor (in 
this case the equilibration process to the most thermodynamically stable β-nitrilium-
                                                 
86 Lemieux, R. U. Pure Appl. Chem., 1971, 25, 527. 
FIG. 1.32: Solvent effect in glycosylation reaction 
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nitrile for reverse anomeric effect is slower than for ether-type oxonium ion). For these 
reasons the glycosyl acceptor attack forms the β-glycoside (FIG. 1.32). 87 
 
1.2.2.2 Glycosyl Donors and Activation Conditions 
 
Glycosyl donors are usually divided according to the heteroatom attached to the 
anomeric centre. A rough classification of different types of glycosyl donors is 
represented in (FIG. 1.33). The number of glycosyl donors and activation conditions is 
still increasing and several efforts are made to elaborate methodologies of wide 
applicability. 88 Here will be discussed only the most common and used glycosyl donors: 
glycosyl halides, thioglycosides, trichloroacetimidates and N-phenyltrifluoroacetimidates. 
 
 
FIG. 1.33: Types of glycosyl donors. 
 
1.2.2.2.1 Glycosyl halides 
 
Glycosyl bromides and chlorides are the first class of glycosyl donors used in 
glycosylation reactions. Glycosyl bromide can be easily obtained by treatment of a per-
                                                 
87 Vankar, D.; Vankar, P. S.; Behrendt, M.; Schmidt, R. R. Tetrahedron 1992, 47, 9985.   
88 For recent reviews see: (a) Zhu, X.; Schmidt, R.R. Angew. Chem. Int. Ed. 2009, 48, 1900; (b) Nicolaou, 
K.C.; Mitchell, H.J. Angew. Chem. Int. Ed. 2001, 40, 1576. 
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O-acetylated sugar with a solution of HBr in acetic acid. The more stable α-anomer is 
usually obtained in high yield. Glycosyl chloride can be obtained instead by treatment of 
aldosyl acetates with aluminum chloride or phosphorous pentachloride. A milder and 
more versatile procedure for the synthesis of glycosyl chloride is based on the Vilsmeier-
Haack 89 reagent (Me2N
+=CHClCl-) formed by reaction of N,N-dimethylformamide 
(DMF) with oxalyl chloride [ClC(O)C(O)Cl)]. In general glycosyl bromides are more 
reactive than glycosyl chloride. Glycosylation reactions involving glycosyl chlorides and 
glycosyl bromides are performed with a heavy metal salt as promoter (the procedure is 
known as Koenigs-Knorr reaction). Most used promoters are Ag2CO3 or Ag2O, 
90 silver 
imidazolate, 91 Hg(CN)2 and HgBr2, 
92 HgO and HgBr2 
93 and AgClO4. 
94 It is worth 
noting that besides heavy metals salts, glycosyl chlorides and bromides could be 
activated also with Lewis acids such as SnCl4, BF3∙OEt2, 
95 ZnCl2, ZnCl2 –TrCl, 
96 
Sn(OTf)2, 
97 Cu(OTf)2 
98 or InCl3. 
99 
Glycosyl fluorides are very stable compared to glycosyl chlorides and bromides and for 
a long time they were not considered as glycosyl donors. However, Mukaiyama and 
coworkers demonstrated that these compounds could be activated with AgClO4/SnCl2. 
100 Several methods for the activation of glycosyl fluorides have been reported 101 and 
                                                 
89 Spohr, U.; Lemieux, R.U. Carbohydr. Res. 1988, 174, 211. 
90 (a) Koenigs, W; Knorr, E, Ber. Dtsch. Chem. Ges. 1901, 34, 957; (b) Wulff, G, Röhle, G, Angew. Chem. Int. 
Ed. Engl. 1974, 13, 157; (c) Igarashi, K, Adv. Carbohydr. Chem. Biochem. 1977, 34, 243. 
91 Garegg, P. J.; Johansson, R.; Samuelsson, B. Acta Chem. Scand. B 1982, 36, 249. 
92 Helferich, B.; Berger, A. Chem. Ber. 1957, 90, 2492. 
93 Schroeder, L.R.; Green, J.W. J. Chem. Soc. C 1966, 530. 
94 Bredereck, H.; Wagner, A.; Geissel, D.; Ott, H. Chem. Ber. 1962, 95, 3064. 
95 Ogawa, T.; Matsui, M., Carbohydr. Res. 1976, 51, C13. 
96 Higashi, K.; Nakayama, K.; Soga, T.; Shioya, E.; Uoto, K.; Kusama, T. Chem. Pharm. Bull. 1990, 38, 
3280. 
97 (a) Lubineau, A.; Malleron, A. Tetrahedron Lett. 1985, 26, 1713; (b) Lubineau, A.; Le Gallic, J.; Malleron, 
A. Tetrahedron Lett. 1987, 28, 5041. 
98 Yamada, H.; Hayashi, T. Carbohydr. Res. 2002, 337, 581. 
99 Mukherjee, D.; Ray, P. K.; Chowdhury, U.S. Tetrahedron 2001, 57, 7701. 
100 Mukaiyama, T.; Murai, Y.; Shoda, S, Chem. Lett. 1981, 431. 
101 Toshima, K. Carbohydr. Res. 2000, 327, 15-26. 
Chapter 1 :Introduction 
 
44 
 
now commonly used promoters are BF3∙OEt2, 
102 Cp2MCl2-AgClO4 (M=Hf, Zr), 
103 and 
Cp2HfCl2-AgOTf. 
104 Several methods are reported for the synthesis of glycosyl 
fluorides but the most common procedure is based on the reaction between a 
thioglycoside with NBS and (diethylamino)sulfur trifluoride (DAST) 105 or the reaction 
of a lactol with DAST or 2-fluoro-1-methylpyridinium p-toluensulfonate. 106 
Glycosyl iodides have been considered for a long time too unstable to be of synthetic 
utility and only recently it has been shown that they can offer some advantages respect 
to glycosyl bromides and chlorides in terms of time, efficiency and selectivity. 107 
Glycosylation reactions involving glycosyl iodides occurs usually with a SN2 
displacement of the anomeric iodide and this feature is of particular interest when there 
                                                 
102 (a) Nicolaou, K.C.; Chucholowski, A.; Dolle, R.E.; Randall, J.L. J. Chem. Soc., Chem. Commun. 1984, 
1155; (b) Kunz, H.; Sager, W. Helv. Chim. Acta 1985, 68, 283. 
103 (a) Matsumoto, T.; Maeta, H.; Suzuki, K.; Tsuchihashi, G. Tetrahedron Lett. 1988, 29, 3567; (b) Suzuki, 
K.; Maeta, H.; Matsumoto, T.; Tsuchihashi, G. Tetrahedron Lett. 1988, 29, 3571; (c) Matsumoto, T.; Maeta, 
H.; Suzuki, K.; Tsuchihashi, G., Tetrahedron Lett. 1988, 29, 3575; (d) Matsumoto, T.; Katsuki, M.; Suzuki, 
K. Chem. Lett. 1989, 437–440. 
104 (a) K. Suzuki, H. Maeta, T. Suzuki, T. Matsumoto, Tetrahedron Lett. 1989, 30, 6879; (b) Nicolaou, K.C.; 
Caulfield, T.J.; Kataoka, H.; Stylianides, N.A. J. Am. Chem. Soc. 1990, 112, 3693; (c) K.C. Nicolaou, K.C.; 
Hummel, C.W.; Iwabuchi, Y. J. Am. Chem. Soc. 1992, 114, 3126. 
105 Nicolaou, K.C.; Dolle, R.E..; Papahatjis, D.P.; Randall, J.L. J. Am. Chem. Soc. 1984, 106, 4189. 
106 Posner, G.H.; Haines, S:R: Tetrahedron Lett. 1985, 26, 5; (b) Rosenbrook, W.; Riley, D.A.; Lartley, P.A. 
Tetrahedron Lett. 1985, 6, 3. 
107 (a) Miquel, N.; Vignando, S.; Russo, G.; Lay, L. Synlett 2004, 2, 341; (b) van Well, R.M.; Kartha, K.P.R.; 
Field, R.A. J. Carbohydr. Chem. 2005, 24, 463; (c) Adinolfi, M.; Iadonisi, A.; Ravidà, A.; Schiattarella, M. 
Tetrahedron Lett. 2003, 44, 7863. 
FIG. 1.34: Examples of glycoside synthesis with glycosyl iodides as donors. 
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is not a participating protecting group at C-2 108 as it can be shown in FIG. 1.34a. Very 
recently the high selectivity of glycosyl iodides in glycosylation reactions has been also 
utilized for the synthesis of morphine-6-glucurunide, an important starting material for 
pharmacological evaluation. 109 
 
1.2.2.2.2 Thioglycosides 
 
Thioglycosides are also very common in carbohydrates synthesis; the advantage of 
thioglycosides is that the thioether group on the anomeric position is stable under a 
wide range of protecting group manipulations, thus acting itself as a temporary 
protecting group. 
Thioglycosides are often prepared treating a per-O-acetylated sugar with a thiol in 
presence of an activator (e.g. BF3∙OEt2). 
110 Other procedures involve the initial 
formation of a S-glycosyl isothiouronium intermediate salt which is then S-alkylated by 
treatment with a mild base and an appropriate alkyl halide (usually the isothiouronium 
intermediate is formed from a glycosyl bromide 111 or per-O-acetylated glycosyl iodide). 
112 This procedure has the advantage to avoid the use of thiols that are well-known 
smelly reactants. 
                                                 
108 Lam, S.N.; Gervay-Hague, J. Org. Lett. 2003, 5, 4219. 
109 Bickley, J.; Cottrell, J.R.; Ferguson, J.R.; Field, R.A.; Harding, J.R.; Hughes, D.L.; Kartha, K.P.R.; Law, 
J.L.; Scheinmann, F.; Stachulski, A.V. Chem. Comm. 2003, 1266. 
110 (a) Tai, C.A.; Kulkarni, S.S.; Hung, S.C. J. Org.Chem. 2003, 68, 8719, (b) Hasegawa, J.Y.; Hamada, M.; 
Miyamoto, T.; Nishide, K.; Kajimoto, T.; Uenishi, J.I.; Node, M. Carbohydr. Res. 2005, 340, 2360; (c) 
Kajimoto, T.; Ishioka, Y.; Katoh, T.; Node, M. Bioorg. Med. Chem. Lett. 2006, 16, 57736. 
111 Ibatullin, F.M.; Selivanov, S.I.; Shavva, A.G. Synthesis 2001, 419; (b) Ibatullin, F.M.; Shabalin, K.A.; 
Jänis, J.V.; Shavva, A.G. Tetrahedron Lett. 2003, 44, 7961. 
112 Valerio, S.; Iadonisi, A.; Adinolfi, M.; Ravidà. A. J. Org. Chem. 2007, 72, 6097. 
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Despite their stability, thioglycosides can be activated using mild thiophilic reagents 
(usually soft electrophiles) (FIG. 1.35). The sulfonium ion (B) is then a better leaving 
group and the oxonium ion (C) is rapidily formed. 113 
The first method for the activation of thioglycosides was reported by van Boom and co-
workers and is based on the use of a stoichiometric amount of N-iodocuccinimide 
(NIS) with a catalytic amount of triflic acid used as promoter. 114 Other in situ generating 
iodonium systems have been proposed (e.g. NIS/AgOTf) 115 and many variants have 
been developed. For example, Mukaiyama and coworkers have introduced a new 
activation methodology based on the use of either NIS or NBS and a catalytic amount 
of TrB(C6F5)4 as promoter systems. 
116 Recently, also bromonium ion (generated in situ 
by the reaction of N-bromosuccinimide and a catalytic amount of Bi(OTf)3) has been 
employed for the activation of thioglycosides. 117 Other activation methods are based 
nowadays on soft sulfur electrofile. Initially sulfonium or sulfenyl triflates (DMTST, 
MeSOTf and PhSOTf) were used but recently sulfenamide activators in combination 
with Lewis acids were proposed. 118 Sulfinates in combination with Tf2O have received 
much attention because it has been demonstrated that these sulfinyl systems are able to 
                                                 
113 Several methods are reported for the activation of thioglycosides; for a recent list of activation 
methods (1998-2007) see ref. 89a. 
114 Veeneman, G. H.; van Leeuwen, S. H.; van Boom, J. H. Tetrahedron Lett. 1990, 31, 1331. 
115 Konradsson, P.; Udodong, U.E.; Fraser-Reid, B. Tetrahedron Lett. 1990, 31, 4313. 
116 Takeuchi, K.; Tamura, T.; Mukaiyama, T. Chem. Lett. 2000, 124. 
117 Valerio, S.; Iadonisi, A.; Adinolfi, M.; Ravidà, A. J. Org. Chem. 2007, 72, 6097. 
118 (a) Jona, H.; Takeuchi, K.; Saitoh, T.; Chem. Lett. 2000, 124; (b) Durón, S.G.; Polat, C.H.; Wong, C.H. 
Org. Lett. 2004, 6, 839. 
FIG. 1.35 Activation of thioglycosides by electrophilic agents. 
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activate thioglycosides also at low temperature. 119 Sulfinyl-systems mediated 
glycosylations have been used for the synthesis of numerous complex structures. 120 An 
interesting example of these reactions is shown in FIG. 1.36, in which a tetrasaccharide 
was constructed one-pot in less than 2 h from the thioglycoside building blocks by using 
benzensulfinyl morpholine/Tf2O as promoter in the preactivation steps. 
121 
 
FIG. 1.36: Oligosaccharides synthesis with thioglycosides as donors. 
 
 
 
 
 
 
                                                 
119 Codée, J.D.C., van den Bos, L.J.; Litjens, R.E.J.N.; Overkleeft, H.S.; van Boeckel, C.A.A.; van Boom, 
J.H.; van der Marel, G.A. Tetrahedron 2004, 60, 1057; (b) van den Bos, L.J.; Duivenvoorden, B.A.; de 
Konong, M.C.; Filippov, D.V.; Overkleeft, H.S.; van der Marel, G.A. Eur. J. Org. Chem. 2007, 116. 
120 Crich, D.; Li, H. J. Org. Chem. 2002, 67, 4640. 
121 Wang, C.; Wang, H.; Huang, X.; Zhang, L.H.; Ye, X.S. Synlett 2006, 2846. 
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1.2.2.2.3 O-Glycosyl Imidates 
 
O-Glycosyl imidates (and in particular trichloracetimidates and more recently also N-
phenyltrifluoroacetimidates) 122 are probably the most common glycosyl donors used in 
glycosylation reactions. 
Glycosyl trichloroacetimidates are usually prepared by treatment with the electron-
deficient trichloroacetonitrile (Cl3CCN) that adds to the hydroxyl of lactols under basic 
conditions. In presence of a weak base (e.g. K2CO3), it is possible to isolate the β-imidate 
as the kinetic product because in these conditions the β-alkoxide forms preferentially. 
Using a strong base (DBU or NaH) alkoxide equilibration occurs with the more stable 
α-alkoxide predominating and giving the α-trichloroacetimidate. 123 
Recently also polymer-supported DBU 124 and TBD (1,5,7-triazabicyclo[4.4.0]dec-5-ene) 
125 have been employed for the synthesis of trichloroacetimidates. 
The most common activation catalysts for trichloroacetimidates are TMSOTf 126 and 
BF3∙OEt2 (using the latter promoter at very low temperature and in absence of a 
                                                 
122 Yu, B.; Tao, H. Tetrahedron Lett. 2001, 42, 2405. 
123 Schmidt, R.R. in Preparative Carbohydrate Chemistry (Ed.; Hanessian S.) 1997, Marcel Dekker, INC.; p. 
283. 
124 Ohashi, I.; Lear, M.J.; Yoshimura, F.; Hirama, M. Org. Lett. 2004, 6, 719. 
125 Oikawa, M.; Tanaka, N.; Fukuda, N.; Kusumoto, S. Tetrahedron Lett. 2004, 45, 4039. 
FIG. 1.37: Introducion of an anomeric trichloroacetimidate 
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participating substituent it is possible to have a SN2-type glycosylation reaction with 
inversion of configuration of the anomeric centre involved in the glycosylation). 127 It is 
worth noting that the trichloroacetamide released after the activation is not basic and 
the acid is not consumed by the leaving group. 
Several other promoters have been developed including protic and Lewis acids (such as 
TfOH, 128 pyridinium p-toluensulfonate (PPTS), 129 and ZnBr2). 
130 
Various metal triflates (Sm(OTf)3, 
131 Sn(OTf)2, 
132 Yb(OTf)3, 
133 and Cu(OTf)2 
134 ) are 
used nowadays for the activation of trichloroacetimidates. The advantage of this 
reagents is that they can be easily stored without particular precautions and sometimes 
give better results in terms of yield and stereoselectivity: for example, AgOTf was used 
as catalyst and found more efficient in TMSOTf-sensitive glycosylation reactions. 135 
More recently, silica supported perchloric acid (HClO4-SiO2), 
136 HB(C6F5)4, 
137 
I2/Et3SiH system 
138 and acid washed molecular sieves 139 were used as efficient 
promoters in various glycosylation reactions with trichloroacetimidates as glycosyl 
donors. 
                                                                                                                                          
126 (a) Schmidt, R.R.; Grundler, G. Angew. Chem. Int. Ed. 1982, 21, 781; (b) Grundler, G; Schmidt, R.R. 
Liebigs Ann. Chem. 1984, 2, 1826. 
127 Schmidt, R.R.; Michel, J. Angew. Chem. Int. Ed. 1980, 19, 731 
128 Fügedi, P. J. Carbohydr. Chem. 1987, 6, 377; (b) Fügedi, P.; Nánási, P.; Szejtli, J. Carbohydr. Res. 1988, 175, 
173. 
129 (a) Nicolaou, K.C.; Daines, R.A.; Chakraborty, T.K.; Ogawa, Y. J. Am. Chem. Soc. 1987, 109, 2821; (b) 
Nicolaou, K.C.; Daines, R.A.; Ogawa, Y.; Chakraborty, T.K. J. Am. Chem. Soc. 1988, 110, 1988. 
130 Urban, F.J.; Moore, B.S.; Breitenbach, R. Tetrahedron Lett. 1990, 31, 4421. 
131 Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A. Tetrahedron Lett. 2000, 41, 9005. 
132 (a) Castro-Palomino, J.C.; Schmidt, R.R. Tetrahedron Lett. 1995, 36, 5343; (b) Bartek, J.; Müller, R.; 
Kosma, P. Carbohydr. Res. 1998, 308, 259. 
133 Adinolfi, M.; Barone, G.; Iadonisi, A.; Mangoni, L.; Schiattarella, M. Tetrahedron Lett. 2001, 42, 5967. 
134 Yamada, H.; Hayashi, T. Carbohydr. Res. 2002, 337, 581. 
135 Wei, G.; Gu, G.; Du, Y. J. Carbohydr. Chem. 2003, 22, 385. 
136 Du, Y.; Wei, G.; Cheng, S.; Hua, Y.; Linhardt, R.J. Tetrahedron Lett. 2006, 47, 307. 
137 Jona, H.; Mandai, H.; Mukaiyama, T. Chem. Lett. 2001, 426. 
138
 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Synlett. 2002, 269. 
139
 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Org. Lett. 2003, 5, 987. 
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Besides the introduction of new promoters, a new technique in the glycosylation 
reaction is the so called inverse procedure (FIG. 1.38). 140 According to this procedure, the 
donor is added to a mixture of glycosyl acceptor and promoter in order to minimize the 
decomposition products (such as orthoesters). 141 In the inverse procedure it is thought 
that acceptor molecules aggregate around the catalyst and the intramolecular 
glycosylation takes place. 
Glycosyl trichloroacetimidates have been largely used up to now in the synthesis of a 
large numbers of biological relevant molecules such as calicheamicin, 142 eleutherobin, 143 
glycosphingolipids 144 and vancomycin. 145 
Glycosyl N-phenyltrifluoroacetimidates (PTFAI) are generally prepared treating an 
anomeric hemiacetal with N-phenyltrifluoroacetyl chloride with a base (K2CO3, 
146 
DBU, 147 DIPEA, 148 NaH 149 or Cs2CO3) 
150 in CH2Cl2 or THF (FIG. 1.39). This type of 
                                                 
140 Schmidt, R.R.; Toepfer, A. Tetrahedron Lett. 1991, 32, 3353. 
141 (a) Ferguson, J.R.; Harding, J.R.; Lumbard, K.W.; Scheinmann, F.; Stachulski, A.V. Tetrahedron Lett. 
2000, 41, 389; (b) de Paz, J.L.; Ojeda, R.; Reichardt, N.; Martìn-Lomas, M. Eur. J. Org. Chem. 2003, 3308; 
(c) Fürstner, A.; Jeanjean, F.; Razon, P.; Wirtz, R.; Mynott, R. Chem. Eur. J. 2003, 9, 320. 
142 Halcomb, R.L; Boyer, S.H.; Danishesky , S.J. Angew. Chem. Int. Ed. 1992, 31, 338; (b) Nicolau, K.C.; 
Schreiner, E.P.; Iwabuchi, Y.; Suzuki, T. Angew. Chem. Int. Ed. 1992, 31, 340. 
143 (a) Nicolaou, K.C.; van Delft, F.L.; Ohshima, T.; Vourloumis, D.; Xu, J.; Hosokawa, S.; Pfefferkorn, S.; 
Kim, S.; Li, T. Angew. Chem. Int. Ed. 1997, 36, 2520; (b) Nicolaou, K.C.; Ohshima, T.; Hosokawa, S.; van 
Delft, F.L.; Vourloumis, D.; Xu, J.; Pfefferkorn, S.; Kim, S. J. Am. Chem. Soc. 1998, 120, 8674. 
144 Toepfer, A.; Schmidt, R.R. Tetrahedron Lett. 1992, 33, 5161; (b) Mayer, T.G.; Kratzer, B.; Schmidt, R.R. 
Angew. Chem. Int. Ed. 1994, 33, 2177. 
145 Nicolaou, K.C.; Mitchell, H.J.; van Delft, F.L.; Rübsam, F.; Rodriguez, R.M. Angew. Chem. Int. Ed. 1998, 
37, 1871. 
146 Yu, B.; Tao, H. J. Org. Chem. 2002, 67, 9099. 
147 Doi, T.; Kinbara, A.; Inoue, H.; Takahashi, T. Chem.-Asian J. 2007, 2, 188. 
148 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Tetrahedron Lett.. 2002, 43, 5573. 
149 Comegna, D.; Bedini, E.; di Nola, A.; Iadonisi, A.; Parrilli, M. Carbohydr. Res. 2007, 342, 1021. 
150 Tanaka, H.; Iwata, Y.; Takahashi, D.; Adachi, M.; Takahashi, T. J. Am. Chem. Soc. 2005, 127, 1630. 
FIG. 1.38:Yield difference between normal and inverse procedure. 
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glycosyl donors can be activated by the same activators used for the activation of 
trichloroacetimidates but often they require more forceful conditions. This difference in 
reactivity was used to activate a 
trichloroacetimidate glycosyl 
donor in presence of a PTFA in 
a multistep procedure. 151 
The great diffusion of this type 
of glycosyl donors can be 
explained in term of a greater 
stability respect to the trichloracetimidates 152 and of a minimization of the by-products 
often encountered with trichloroacetimidates donors: in the course of a 
trichloroacetimidate glyco-
sylation, trichloroacetamide 
liberated from the donor can 
give N-glycosides. The use of 
PTFAI donors have 
demonstrated to minimize the 
amount of by-products in the 
synthesis of β-mannosides 153 
and in the synthesis of cell-wall 
                                                 
151 Adinolfi, M.; Iadonisi, A.; Ravidà, A. Synlett 2006, 583. 
152 For a recent minireview on PTFAI donors see: (b) Yu, B.; Sun, J. ChemCommun. 2010, 46, 4668. 
153 Tanaka, S.I.; Takashina, M.; Tokimoto, H.; Fujimoto, Y.; Tanake, K.; Fukase, K. Synlett 2005, 2325. 
FIG. 1.39: Preparation of glycosyl PTFAI donors. 
FIG. 1.40: Synthesis of O-antigen trisaccaride from Xanthomonas 
Campestris 
Chapter 1 :Introduction 
 
52 
 
polysaccharide fragment of Bacillus anthracis. 154 PTFAI donors has been extremely useful 
in glycosylation rections involving deoxysugars 150 as, for example, in the synthesis of the 
O-antigen from Xanthomonas campestris pv campestris (FIG. 1.40). 155 In the first 
glycosylation reaction also TCAI and phosphate donors were used but the yield and the 
stereoselectivity were not successful while the use of PTFAI with a non-participating 
benzylsulfonyl group at C-2 position provided the desired disaccharide in a 99% yield 
and an α:β ratio of 2:3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
154 Vasan, M.; Rauvolfova, M.; Wolfert, M.A.; Christine, L.; Kannenberg, E.L.; Quinn, C.P.; Carlson, 
R.W.; Boons, G.J. ChemBioChem 2008, 9, 1716. 
155 Comegna, D.; Bedini, E.; Parrilli, M. Tetrahedron 2008, 64, 3381. 
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1.3 Aim of the thesis 
For the reasons set out in the previous section, several efforts have been made from the 
scientific community to have a better understanding of how carbohydrates interact in 
biological systems and which role they play. 
In this thesis some synthetic aspects of carbohydrates will be treated. In particular in 
Chapter 2 it will be explored the mechanism and synthetic potentials of the acetolysis 
reaction on 6-deoxysugars. 
In Chapter 3 it will be proposed a new synthetic methodology for the obtainment of 
peptidoglycan fragments in order to have a better understanding through biological 
essays of how the peptidoglycan is recognized both in plants and in mammals and how 
possible modifications affect its biological activity. 
In Chapter 4 it is proposed a new route for the synthesis of a class of glycomometics in 
which the two saccharide units are linked together by an urea-linkage without using the 
anomeric centre. The chemistry and the self-assembling properties of gluco- and galacto- 
urea-derivatives will be then evaluated. 
Portions of this work have been adapted from the following articles that were co-
written by the author: 
 
1) Cirillo, L.; Parrilli, M.; Bedini, E. ―Acetolysis of 6-Deoxysugar Disaccharide 
Building Blocks: exo versus endo Activation‖; Eur. J. Org. Chem. 2008, 5704-5714; 
2) Cirillo, L.; Di Nola, A.; Bedini, E.; Parrilli, M. ―The role of sugar configuration 
in the acetolysis of 6-deoxyhexose methyl glycosides‖; Carbohydr. Res. 2009, 344, 
2406-2411; 
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3) Cirillo, L.; Bedini, E.; Molinaro, A.; Parrilli, M. ―Synthesis of a β-GlcN-(1→4)-
MurNAc building block en route to N-deacetylated peptidoglycan fragments‖; 
Tetrahedron Lett. 2010, 51, 1117; 
4) Cirillo, L.; Silipo, A.; Bedini, E.; Parrilli, M. ―A urea-linked glucosamine dimer as 
building block for the synthesis of linear and cyclic neosaccharides‖; Eur. J. Org. 
Chem. 2010, 4062; 
5) Bedini, E.; Cirillo, L.; Cumpstey, I.; Parrilli, M. ―Acetolysis of 6-deoxysugars 
governed by armed-disarmed effect‖; Carbohydrate Chem.: Proven Methods, 2011, 1, 
(Ed: Kovac, P.; Taylor and Francis, Boca Raton, FL, USA) in press. 
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Chapter 2: Acetolysis of 6-deoxysugars 
 
2.1 Introduction 
 
Acetolysis is a widely used reaction in both analytical and synthetic carbohydrate 
chemistry, consisting in the cleavage of the glycosidic bond and the temporary 
acetylation of the hydroxyls groups thus formed and/or present before solvolysis. 
Acetolysis finds extensive application to the selective depolymerization of 
polysaccharides and provides useful information for their structural elucidation. 
156 In synthetic carbohydrate chemistry, its main applications are to convert alkyl or aryl 
glycosides of mono- and oligosaccharides into 1-O-acetylated derivatives, which are 
useful building blocks for the synthesis of other glycosyl acceptors and glycosyl donors. 
Owing to the importance of acetolysis reactions in glycochemistry, several studies on 
the mechanism of these reactions exist in literature. 157 The first step is the activation of 
endocyclic or exocyclic anomeric oxygen toward glycoside cleavage promoted by 
acetylium ion, which is formed from Ac2O in acidic conditions. It has been shown that 
endo-activation proceeds more rapidly, nonetheless the distribution of acetolysis 
products is usually governed not by kinetic but by thermodynamic conditions, providing 
1-O-Ac-pyranoside product A after acetic acid attack on the oxocarbenium ion (FIG. 
2.1). On the contrary, the activation at the endo-site first affords acyclic acetyl methyl 
                                                 
156 The Polysaccharides; Aspinall, G.O., Ed.; Academic Press: London, United Kingdom, 1982; Vol.1, pp 64-
66. 
157 (a) Guthrie, R. D.; McCarthy, J. F. Adv. Carbohydr. Chem. Biochem. 1967, 22, 11; (b) Lichtenthaler, F. W.; 
Bambach, G. Carbohydr. Res. 1979, 68, 305; (c) Dasgupta, F.; Singh, P. P.; Srivastava, H. C. Ind. J. Chem. 
1988, 27B, 527; (d) Kanie, O.; Takeda, T.; Ogihara, Y. Carbohydr. Res. 1990, 197, 289; (e) McPhail, D. R.; 
Lee, J. R.; Fraser-Reid, B. J. Am. Chem. Soc. 1992, 114, 1905; (f) Kaczmarek, J.; Preyss, M.; Lönnberg, H.; 
Szafranek, J. Carbohydr. Res. 1995,279, 107; (g) Miljkovic´ , M.; Yeagley, D.; Deslongchamps, P.; Dory, Y. 
L. J. Org. Chem. 1997, 62, 7597; (h) Kaczmarek, J.; Kaczyński, Z.; Trumpakaj, Z.; Szafranek, J.; Bogalecka, 
M.; Lönnberg, H. Carbohydr. Res. 2000, 325, 16; (i) Forsman, J. J.; Wärnå, J.; Murzin, D. Y.; Leino, R. 
Carbohydr. Res. 2009, 344, 1102. 
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acetal B, which can be activated in turn by a second acetylium ion to give acyclic diacetyl 
acetal D and/or 1-O-Ac-furanoside derivative E. In acidic conditions, both B and D 
derivatives are in equilibrium with the aldehyde form, C. In the literature there are only 
a few scattered examples of acetolysis of common hexose glycosides affording 
predominantly endo-activation mechanism products. 158 
It is obvious that, in the case of 6-deoxyhexoses, acetolysis with activation at endo-site 
should be more easily achieved because the lack of the electron-withdrawing oxygen 
atom at the 6-position enhances the nucleophilicity of the endocyclic oxygen. Indeed, 
some examples were reported in literature on the acetolysis of 6-deoxyhexose glycosides 
affording B-, C-, D-, or E-like derivatives as the main products. 159 
 
FIG. 2.1: Endo- versus exo-activation in acetolysis reactions 
Investigations on the mechanism of acetolysis reactions on deoxyhexose, and above all 
6-deoxyhexose, will be of great interest because of the large diffusion of such 
                                                 
158 (a) Angibeaud, P.; Bosso, C.; Utille, J.-P. Carbohydr. Res. 1990, 198, 403; (b) Wang, L.-X.; Lee, Y. C. J. 
Chem. Soc., Perkin 1 1996, 581; (c) Bozó, É.; Boros, S.; Kuszmann, J. Carbohydr. Res. 2001, 332, 325; (d) Wu, 
Q. P.; Zhou, M.-X.; Xi, X.-D.; Song, D.; Wang, Y.; Liu, H.-X.; Li, Y.-Z.; Zhang, Q.-S. Tetrahedron Lett. 
2008, 49, 2714. 
159 (a) Paulsen, H.; Lorentzen, J.P. Carbohydr. Res. 1987, 165, 207; (b) Banaszek, A.; Ciunik, Z. Tetrahedron 
Lett. 1997, 38, 273; (c) Banaszek, A. Carbohydr. Res. 1998, 306, 379. 
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carbohydrates in O-antigen lipopolysaccharides, 160 glycoproteins, glycolipids, and in 
other glycoconjugates such as cardioglycosides, natural antibiotics and anticancer agents. 
161 Recently, it has been reported 162 that the outcome of acetolysis reaction with 
10/10/1 (v/v/v) Ac2O/AcOH/TFA on fully protected methyl glycosides disaccharides 
can be correlated to the arming-disarming properties of the protection groups on the 2-
O-positions (FIG. 2.2): using an opportune protecting group strategy and the reported 
procedure, it was possible to obtain the 1-O-Ac-pyranoside derivative (A-like product) 
without cleaving the interglycosidic bond. The results were not dependent on the 
configuration of the moieties which formed the disaccharides. 
 
FIG. 2.2: Acetolysis reactions governed by arming/disarming effect. 
 
                                                 
160 P.E. Jansson in Endotoxin in Health and Disease (Eds.: H. Brade, D.C. Morrison, S. Vogel), Marcel 
Dekker, New York, 1999, p.155. 
161 He, X.M.; Liu, H.W. Annu. Rev. Biochem. 2002, 71, 701 
162 Bedini, E.; Comegna, D.; di Nola, A.; Parrilli, M. Tetrahedron Lett. 2008, 49, 2546. 
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In the same paper it was made a screening of acetolysis conditions that would allow a 
kinetically controlled endo-activation mechanism. Several acetolysis conditions were 
tested on a model disaccharide (1, Table 2.1) and using a slight modification 163 of the 
known procedure consisting in ZnCl2 in 2:1 (v/v) Ac2O/AcOH 
164 (10 instead of 20 eq. 
of ZnCl2, 5°C instead of room temperature) the 1-O-Ac-furanoside derivative (4) was 
obtained in good yield (76%) together with a small quantity of 1-O-Ac-pyranoside (16%) 
(also in this case the glycosidic linkage between the two sugar residues was not affected 
and acetolysis occurred only at the residue with an arming benzyl group at the 2-O 
position). 
In next sections it will be therefore discussed the possibility to obtain kinetically 
controlled B-, C-, D-, E-like disaccharide products and which role the configuration of 
the sugar has in the outcome of the acetolysis reactions. 
 
2.2 Results and Discussion 
 
In order to investigate the role of sugar configuration in driving the acetolysisreaction, 
per-O-benzylated methyl glycosides of the most common natural 6-deoxysugars 
(compounds 5, 6, 7, 8 and 9, FIG. 2.3) and a set of 6-deoxysugar disaccharide methyl 
glycosides were synthesized through standard procedures. In particular disaccharide 
products were obtained by the standard glycosylation reaction of L-rhamnose 
thioglycoside 10 165 with the known glycosyl with the known glycosyl acceptors 11, 166 12, 
13, 167 14, 168 15, and the novel acceptor 17 (obtained by  phase   transfer obtained by the 
                                                 
163 Lam, S.N.; Gervay-Hague, J. Carbohydr. Res. 2002, 337, 1953. 
164 Yang, G.; Ding, X.; Kong, F. Tetrahedron Lett. 1997, 38, 6725. 
165 Valero, S.; Iadonisi, A.; Adinolfi, M.; Ravidà, A. J. Org. Chem. 2007, 72, 6097. 
166 Maddali, U.B.; Ray, A.K.; Roy, N. Carbohydr. Res. 1990, 208, 59. 
167 Smith III, A.B.; Rivero, R.A.; Hale, K.J.; Vaccaro, H.A. J. Am. Chem. Soc. 1991, 113, 2092. 
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Table 2.1: Screening of acetolysis conditions on model compound 1: [a] Reaction conditions: A: 
10/10/1 (v/v/v) Ac2O/AcOH/TFA, 70°C; B: 10/10/1 (v/v/v) Ac2O/AcOH/TFA, 5°C; C: 100/1 
(v/v) Ac2O/H2SO4, 0°C; D: ZnCl2 (10 eq), 2:1 (v/v) Ac2O/AcOH, 5°C. [b] Isolated yield. 
 
 
 
 
 
 
 
Model disaccharide 
Entry Protocol [a] Product (% Yield)[b] 
 
 
1 
 
 
A 
 
 
2 
 
B 
 
No reaction 
 
 
3 
 
 
C 
 
 
 
4 
 
 
D 
 
 
 
phase transfer benzylation of diol 16). 169 Glycosylations under the NIS/TfOH protocol 
proceeded in moderate to excellent yields to give the disaccharide methyl glycosides 18-
24. Disaccharides 25 and 26 were obtained by de-O-benzensulfonylation of 18 6 with 
sodium amide and subsequent acetylation or benzoylation of the resulting alcohol 19. It 
is worth noting that all the disaccharides were synthesized with a disarming ester 
protecting group at the 2-positions of the non-pseudo-reducing unit in order to avoid 
the acetolytic cleavage of glycosidic linkage. 
                                                                                                                                          
168 Yang, C.; Cao, L.; Kong, F. J. Carbohydr. Chem. 1992, 11, 379. 
169 Liptàk, A.; Nánási, P.; Neszmélyi, A.; Wagner, H. Tetrahedron 1980, 36, 1261. 
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The obtained products were then subjected to acetolysis reaction by the ZnCl2 protocol 
described above as well as with the 10/10/1 (v/v/v) Ac2O/AcOH/TFA procedure at 
70°C. The results are summarized in Tables 2.2-2.4, and are divided according to the 
configuration of the sugar moiety involved in the acetolysis reaction: as expected, the 
latter protocol allowed selective acetolysis through an exo activation mechanism 
 
FIG. 2.3: 6-deoxymethyl glycosides used in acetolysis reaction 
both in monosaccharide methyl glycoside and in the monose unit of the disaccharides 
protected with an arming benzyl group at the 2-O position; on the contrary the outcome 
of the acetolysis reactions with ZnCl2 in 2:1 (v/v) Ac2O/AcOH was strictly dependent 
on the sugar configuration. In fact on rhamno-configured units, acetolysis with ZnCl2 
always afforded the products under kinetic control: per-O-benzylated rhamnose methyl 
glycoside 5 gave the 1-O-acetylated furanoside 29 (E-like product) as the main product 
(63%, entry 1 Table 2.2). In the same way, in the case of disaccharides with a rhamno-
configured unit at the pseudo-reducing end, a preference was noted for an endo-type 
activation mechanism: compounds 20, 25 and 26 were transformed into 1-O-Ac-
furanoside disaccharide derivatives (E-like products) in good yields (entries 2, 5,6; Table 
2.2), whereas compounds 27 and 28 gave predominantly the
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FIG. 2.4: Synthesis of a set of 6-deoxysugar disaccharide methyl glycosides. Reagents and conditions: (a) NIS, 
TfOH, AW-300 MS (4Å), CH2Cl2, -20°C, 20: 49%; 21: 83%; 22: 82%, 23: 87%; 24: 88%; 25: 40%; BnBr, KOH, 
TBAI, toluene, room temp. 72%; (c) i. PdCl2, 1:1 (v/v) CH2Cl2/MeOH, room temp.; ii. Ac2O, py, room temp. 75% 
(after two steps); (d) NaNH2, DMF, 70°C, 64%; (e) Ac2O, py, room temp. 99%; (f) BzCl, py, room temp. 83%.
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open-chain 1-O-acetyl-1-O-methyl acetals (B-like products) 33 and 35 (entries 3, 4; 
Table 2.2). 1-O-Ac-pyranoside derivatives were isolated as minor products (15-25% 
yields). In the case of substrate 28, the formation of the B-like derivative 35 could be 
supposedly due to the lower electron-donating effect of the acetyl-protecting group at 
the 4A-O position of 28 compared with the benzyl group at the same position in 
compounds 20, 25 and 26. This avoids the conversion of B-like products into E-like 
products, whereas this transformation is rather easier in the presence of a benzyl group 
at the O-4A-position. The preference for compound 27 to afford the B-like derivative 
cannot be easily rationalized and several factors (such as possible complexation of the 
allyl group with Zn2+) should be taken in account. 
In contrast to rhamno-configured species, all the experiments with fuco-configured species 
(6, 7, 23 and 24) with ZnCl2 protocol proceeded through an exo-activation mechanism 
giving the thermodynamically controlled 1-O-Ac-pyranoside derivatives 40 and 41 
(Table 2.3). 
As far as the quinovo-configured species are concerned, the behavior in the acetolysis 
reaction with ZnCl2 protocol was strictly dependent on the configuration of the methyl 
aglycon: α-configured species 8 and 21 were acetolyzed by an exo-activation mechanism, 
which furnished 1-O-Ac-pyranoside derivatives 45 and 48 respectively, whereas β-
derivatives 9 and 22 gave open chain derivatives 42, 43, 45 and E-like derivatives 44, 47. 
These results suggest that the role of sugar configuration is crucial for driving the 
acetolysis using ZnCl2 protocol toward am exo- or endo-activation mechanism. The 
preference for a mechanism with activation at the endocyclic or exocyclic oxygen atom 
is strongly dictated by the anomeric configuration. The exocyclic oxygen is involved in 
n→σ* donation to the C1-O bond only in the α-anomer. 
2e The overall effect is a general 
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increased nucleophilicity of the endocyclic oxygen in the β-anomers, which explains the 
preference of β-quinovo-configured methyl glycosides to give endo-derived products with 
respect to the α-counterparts. In the β-fucoside case the main stereoelectronic effect is 
the strong through-space donation of the axially oriented O-4 substituent 170 into the 
oxocarbenium ion formation, which highly enhances the first rate constant for the exo-
activation involving galacto-configured alkyl glycosides with respect to gluco-configured 
counterparts; 2g the result is that both fucoside anomers afford exclusively 1-O-Ac-
pyranosides through an exo-activation mechanism. With the α-methyl glycosides, the 
role of configuration at O-2 seems to be very important too. Indeed compounds having 
an axial O-2 such as the rhamno-configured products afford products derived by an endo-
activation, whereas α-methyl glycosides having an equatorial O-2 gave 1-O-Ac-
pyranosides in high yields through an exo-activation mechanism. This could be ascribed 
to the destabilization effect of the axial hydroxyl group at position 2 on the incipient 
oxocarbenium ion for its major electron withdrawing properties. 171 Interestingly, the 
analogies of the results on mono- and disaccharides 172 suggests that a potential Zn(II)-
sugar complexation has a minor effect on the competition between exo- and endo-
mechanism, because the geometry of such coordination should be highly dependent on 
saccharide structure. 
 
 
                                                 
170 Jensen, H.H.; Lyngbye, L.; Bols, M. Angew. Chem. Int. Ed. 2001, 40, 3447. 
171 McDonnell, C.; López, O.; Murphy, P.; Fernández Bolaños, J.G.; Hazell, R.; Bols, M. J. Am. Chem. Soc. 
2004, 126, 12374. 
172 Bedini, E.; Cirillo. L.; Cumpstey, I.; Parrilli, M. In Carbohydrate Chemistry: Proven Methods; Kovac, P. Ed.; 
Taylor & Francis: Boca Raton, FL, USA, in press. 
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Table 2.2: Acetolysis of 6-deoxysugar rhamno configured methyl glycosides: a Isolated yield; b Anomeric ratio 
measured by 1H NMR spectroscopy; c Anomeric ratio measured by isolation of the two anomers. 
Entry Methyl 
Disaccaride 
Products (% yield) a 
Protocol A: ZnCl2 (10eq.), 
Ac2O, 5°C  
Protocol B: 1:1:0.1 v/v/v 
Ac2O/AcOH/TFA 
1 5 
 
 
  29, 63%; 30 22% b 30, 62% 
2 20 
  
  31, 64%; α/β =2.:1 b 32, 55% 
3 27 
  
  33, 77%; dr=6:1 b 34, 73% 
4 28 
 
 
 
Not determined 
  35, 66%; dr=1.3:1 b  
5 25 
  
  36, 71% c 37, 74%; α/β =2.5:1 
6 26 
  
  38, 62% 39, 75%; α/β =2:1b 
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Table 2.3: Acetolysis of 6-deoxysugar fuco configured methyl glycosides: a Isolated yeld; b Anomeric ratio 
measured by 1H NMR spectroscopy. 
Entry Methyl 
Disaccaride 
Products (% yield) a 
Protocol A: ZnCl2 
(10eq.), Ac2O, 5°C  
Protocol B: 1:1:0.1 v/v/v 
Ac2O/AcOH/TFA 
1 6 
 
 
 
40, 72%; α/β =5:1 b 
  40, 83%; α/β =3:1 b  
2 7 40, 99%; α/β =4:1 b 40, 98%; α/β =4:1 b 
3 24  
 
 
  41, 73%; α/β =3:1 b 41, 83%; α/β =3:1 b 
4 23 41, 82%; α/β =6:1 b 41, 87%; α/β =6:1 b 
 
Table 2.4 Acetolysis of 6-deoxysugar quinovo configured methyl glycosides: a Isolated yeld; b Anomeric ratio 
measured by 1H NMR spectroscopy. 
Entry Methyl 
Disaccaride 
Products (% yield) a 
Protocol A: ZnCl2 (10eq.),  
Ac2O, 5°C  
Protocol B: 1:1:0.1 v/v/v 
Ac2O/AcOH/TFA 
1 9 
 
 
  42,15%     43,23%    44, 24%; α/β =2:1 b 45, 59%; α/β =3.5:1 b 
2 8 45, 64%; α/β =2:1 b 45, 72%; α/β =3:1 b 
3 22 
 
 
  46, 43%;                47, 41%; α/β =4:1 b 48, 56%; α/β =4.5:1 b  
4 21 48, 96%; α/β =6:1 b 48, 96%; α/β =6:1 b 
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2.3 Conclusions 
 
In conclusion it has been demonstrated that under Ac2O/AcOH/TFA reaction 
conditions the sugar configuration has not effect on the outcome of the acetolysis 
reaction because these conditions promote an exo-activation mechanism regardless of 
the configuration of the sugar. In the case of ZnCl2 promoted acetolysis reaction, the 
product distribution is indeed strongly influenced by the 6-deoxyhexose configuration 
which has a primary role in determining the endo- or the exo- activation mechanism. 
 
2.4 Experimental Section 
 
General methods: 1H and 13C NMR spectra were recorded with Varian XL-200 (1H: 
200 MHz; 12C: 50 MHz), Varian Gemini-300 (1H: 300 MHz; 13C:75 MHz), Bruker DRX-
400 (1H: 400 MHz; 13C:100 MHz), or Varian INOVA 500 (1H: 500 MHz; 13C:125 MHz) 
instruments in CDCl3 (CHCl3 as internal standard: 
1H: CHCl3 at δ=7.26 ppm; 
13C: 
CDCl3 at δ=77.0 ppm). Assignment of the proton chemical shifts was based on 1D 
HOHAHA experiments. Positive MALDI-TOF MS spectra were recorded with an 
Applied Biosystem Voyager DE-PRO MALDI-TOF mass spectrometer in the positive 
mode: compounds were dissolved in CH3CN at concentration of 1 mg/mL and one 
microliter of these solutions were mixed with one microliter of a 20 mg/mL solution of 
2,5-dihydroxybenzoic acid in 7:3 CH3CN/water. Optical rotations were measured with a 
JASCO P-1010 polarimeter. Analytical thin-layer chromatography (TLC) was performed 
on aluminum plates precoated with Merck Silica Gel 60 F254 as the adsorbent. The plates 
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were developed with a 10% H2SO4 ethanolic solution and by heating to 130°C. Column 
chromatography was performed on Merck Kiesegel 60 (63-200 mesh). 
 
Methyl 4-O-Allyl-2-O-benzyl-α-L-rhamnopyranoside (17): Diol 16 (301 mg, 1.38 
mmol) was dissolved in toluene (15 mL) and treated with TBAI (476 mg, 1.28 mmol), 
BnBr (328 μL, 2.75 mmol), and then KOH (690 mg, 10.8 mmol). The mixture was 
stirred at room temp. for 30 min and then treated with 1:1 AcOEt/water (25 mL) and 
stirred overnight. After that the organic layer was collected, dried with anhydrous 
Na2SO4, filtered, and concentrated. The residue was subjected to column 
chromatography (7 to 10% ethyl acetate in petroleum ether) to afford 17 (310 mg, 72%) 
as a yellowish oil. [α]D = –9 (c = 0.8, CH2Cl2). 1H NMR (200 MHz, CDCl3): δ = 7.34 (m, 
5 H, Ar-H), 5.93 (m, 1 H, OCH2CH=CH2), 5.26 (dq, Jvic=17.4, Jgem=Jlong-range=1.4 Hz, 1 H, 
trans OCH2CH=CHH), 5.13 (d, Jvic=10.2, Jgem=Jlong-range=1.4 Hz, 1 H, cis 
OCH2CH=CHH), 4.73 (dt, Jgem=11.6 Hz, 1 H, OCHHPh), 4.68 (d, J1,2=1.4 Hz, 1 H, 1-
H), 4.58 (d, Jgem=11.6 Hz, 1 H, OCHHPh), 4.33 (ddt, Jgem=12.4, Jvic=5.6, Jlong-range=1.4 Hz, 
1 H, OCHHCH=CH2), 4.13 (ddt, Jgem=12.4, Jvic=5.6, Jlong-range=1.4 Hz, 1 H, 
OCHHCH=CH2), 3.83 (br. m, 1 H, 3-H), 3.69 (dd, J2,3 = 3.6, J2,1=1.6 Hz, 1 H, 2-H), 3.59 
(dq, J5,4 =9.2, J5,6=6.2 Hz, 1 H, 5-H), 3.31 (s, 3 H, OCH3), 3.18 (t, J4,3=J4,5 = 9.2 Hz, 1 H, 
4-H), 1.31 (d, J6,5=6.2 Hz, 3 H, 6-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 137.7 (Cipso-
Bn), 135.0 (OCH2CH=CH2), 128.5–127.8 (C-Ar), 116.8 (OCH2CH=CH2), 98.0 (C-1) 
81.9, 78.5, 73.8, 73.0, 71.4, 67.0 (C-2, C-3, C-4, C-5, OCH2Ph, OCH2CH=CH2), 54.6 
(OCH3), 18.0 (C-6) ppm. MS (MALDITOF): calcd. for C17H24O5 [M]
+ 308.16; found 
330.99 [M + Na]+. C17H24O5 (308.37): calcd. C 66.21, H 7.84; found C 66.00, H 7.70. 
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Typical Glycosylation Procedure: A mixture of the acceptor (173 μmol) and 
thioglycoside donor (222 μmol) was co-evaporated three times with toluene (2 mL). The 
residue was dried, mixed with NIS (282 μmol), and freshly activated with AW-300 
molecular sieves (4 Å) under Ar, cooled to –20 °C, and suspended in CH2Cl2 (3.0 mL). 
A 0.57 M solution of TfOH in CH2Cl2 (100 μL, 57 μmol) was added. After 1 h stirring 
at –20 °C, the mixture was diluted with CH2Cl2 and washed with 1:1 (v/v) 1 M 
NaHCO3/10% Na2S2O3. The organic layer was collected, dried with anhydrous Na2SO4, 
filtered, concentrated, and purified by chromatography(ethyl acetate in toluene). 
 
Methyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2-O-allyl-4-O-benzyl-α-L-
rhamnopyranoside (20): [α]D=–50.6 (c = 1.8, CH2Cl2). 
1H NMR (200 MHz, CDCl3): δ 
= 7.30 (m, 5 H, Ar-H), 5.96 (m, 1 H, OCH2CH=CH2), 5.39–5.26 (m, 3 H, 2B-H, 3B-H, 
trans OCH2CH=CHH), 5.23 (d, Jvic = 10.4 Hz, 1 H, cis OCH2CH=CHH), 5.04 (t, J4,3 = 
J4,5 = 9.5Hz, 1 H, 4B-H), 5.03 (s, 1 H, 1B-H), 4.80 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 
4.65 (s, 1 H, 1A-H), 4.62 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.22 (dd, Jgem =13.0, Jvic = 5.6 
Hz, 1 H, OCHHCH=CH2), 4.07 (dd, Jgem = 13.0, Jvic = 5.6 Hz, OCHHCH=CH2), 4.04–
3.97 (m, 2 H, 3A-H, 5B-H), 3.65–3.56 (m, 3 H, 2A-H, 4A-H, 5A-H), 3.32 (s, 3 H, OCH3), 
2.06, 2.05, 1.97 (3 s, 9 H, 3 COCH3), 1.30 (d, J6,5 = 5.7 Hz, 3 H, 6A-H), 1.21 (d, J6,5 = 
6.3Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 169.9–169.8 (3 CO), 138.1 
(Cipso-Bn), 134.9 (OCH2CH=CH2), 128.3–127.5 (C-Ar), 117.4 (OCH2CH=CH2), 99.1, 
98.4 (C-1A, C-1B), 80.6, 78.3, 77.7, 75.3, 72.0, 71.1, 69.8, 69.1, 67.9, 66.8 (C-2A, C-2B, C-
3A, C-3B, C-4A, C-4B, C-5A, C-5B, OCH2Ph, OCH2CH=CH2), 54.6 (OCH3), 20.8–20.7 (3 
CH3CO), 17.9, 17.4 (C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. For C29H40O12 [M]
+ 
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580.25; found 603.00 [M + Na]+. C29H40O12 (580.62): calcd. C 59.99, H 6.94; found C 
60.09, H 6.99. 
 
Methyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2,4-di-O-benzyl- 
α-D-quinovopyranoside (21): [α]D = –17.3 (c = 1.8, CH2Cl2). 
1H NMR (200 MHz, 
CDCl3): δ = 7.34–7.26 (m, 10 H, Ar-H), 5.38–5.27 (m, 3 H, 1B-H, 2B-H, 3B-H), 4.97 (t, 
J4,3 = J4,5 = 10.0 Hz, 1 H, 4B-H), 4.84 (d, Jgem = 11.2 Hz, 1 H, OCHHPh), 4.68 (d, Jgem = 
12.0 Hz, 1 H, OCHHPh), 4.61 (d, Jgem = 11.2 Hz, 1 H, OCHHPh), 4.55 (d, Jgem = 12.0 
Hz, 1 H, OCHHPh), 4.45 (d, J1,2 = 3.4 Hz, 1 H, 1A-H), 4.11 (t, J3,4 = J3,2 = 9.4 Hz, 1 H, 
3A-H), 4.02 (dq, J5,4 = 10.0, J5,6 = 6.2 Hz, 1 H, 5B-H), 3.76 (dq, J5,4 = 9.4, J5,6 = 6.4 Hz, 1 
H, 5A-H), 3.51 (dd, J2,3 = 9.4, J2,1 = 3.4Hz, 1 H, 2A-H), 3.30 (s, 3 H, OCH3), 3.09 (t, J4,3 = 
J4,5 = 9.4 Hz, 1 H, 4A-H), 2.07, 1.99, 1.91 (3 s, 9 H, 3 CH3CO), 1.27 (d, J6,5 = 6.4 Hz, 3 H, 
6A-H), 0.88 (d, J6,5 = 6.2Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ= 170.1, 
169.9, 169.8 (3 CO), 137.9, 137.6 (2 Cipso-Bn), 128.4–127.2 (C-Ar), 97.6, 97.1 (C-1A, C-
1B), 82.4, 81.0, 75.6, 74.9, 72.7, 70.9, 69.7, 69.2, 66.5, 66.1 (C-2A, C-2B, C-3A, C-3B, C-4A, 
C-4B, C-5A, C-5B, 2 OCH2Ph), 54.9 (OCH3), 20.7–20.6 (3 CH3CO), 17.8, 16.9 C-6A, C-
6B) ppm. MS (MALDI-TOF): calcd. for C33H42O12 [M]
+630.27; found 653.11 [M + Na]+. 
C33H42O12 (630.68): calcd. C62.85, H 6.71; found C 62.59, H 6.59. 
 
Methyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2,4-di-O-benzyl-β-D-
quinovopyranoside (22): [α]D = –50.3 (c = 3.0, CH2Cl2). 
1H NMR (200 MHz, CDCl3): 
δ = 7.33–7.26 (m, 10 H, Ar-H), 5.38 (d, J1,2 = 1.0 Hz, 1 H, 1B-H), 5.32–5.23 (m, 2 H, 2B-
H, 3B-H), 4.98–4.81 (m, 3 H, 4B-H, 2 OCHHPh), 4.70 (d, Jgem = 11.4 Hz, 1 H, 
OCHHPh), 4.56 (d, Jgem = 11.8 Hz, 1 H, OCHHPh), 4.27 (d, J1,2 = 7.8 Hz, 1 H, 1A-H), 
Chapter 2:Acetolysis of 6-deoxysugar 
 
70 
 
4.03 (dq, J5,4 = 10.0, J5,6 = 6.2 Hz, 1 H, 5BH), 3.83 (t, J3,4 = J3,2 = 9.2Hz, 1 H, 4A-H), 3.54 
(s, 3 H, OCH3), 3.48–3.38 (m, 2 H, 2A-H, 5A-H), 3.15 (t, J3,2 = J3,4 = 9.2 Hz, 1 H, 3A-H), 
2.03, 1.97, 1.90 (3 s, 9 H, 3 CH3CO), 1.37 (d, J6,5 = 6.0 Hz, 3 H, 6A-H), 0.87 (d, J6,5 = 6.2 
Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 170.1, 169.8, 169.7 (3 CO), 138.0, 
137.7 (2 Cipso-Bn), 128.2–127.3 (C-Ar), 104.2, 97.2 (C-1A, C-1B), 82.9, 82.0, 76.3, 75.2, 
74.3, 71.1, 70.8, 69.4, 69.1, 66.1 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 2 
OCH2Ph), 56.9 (OCH3), 20.7–20.6 (3 CH3CO), 17.8, 16.9 (C-6A, C-6B) ppm. MS 
(MALDI-TOF): calcd. for C33H42O12 [M]
+ 630.27; found 652.89 [M + Na]+. C33H42O12 
(630.68): calcd. C 62.85, H 6.71; found C 62.70, H 6.67. 
 
Methyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2,4-di-O-benzyl-α-D-
fucopyranoside (23): [α]D = –71.0 (c = 2.1, CH2Cl2). 
1H NMR (300 MHz, CDCl3): δ = 
7.43–7.28 (m, 10 H, Ar-H), 5.46 (dd, J3,4 = 9.9, J3,4 = 3.3 Hz, 1 H, 3B-H), 5.18 (dd, J2,3 = 
3.3, J2,1 = 1.8 Hz, 1 H, 2B-H), 5.08 (t, J4,3 = J4,5 = 9.9 Hz, 1 H, 4B-H), 5.01 (s, 1 H, 1B-H), 
4.90 (d, Jgem = 11.7 Hz, 1 H, OCHHPh), 4.79 (d, Jgem = 12.0 Hz, 1 H, OCHHPh), 4.67 
(m, 2 H, 1A-H, OCHHPh), 4.59 (d, Jgem = 12.0 Hz, 1 H, OCHHPh), 4.20 (dq, J5,4 = 9.9, 
J5,6 = 6.0 Hz, 1 H, 5B-H), 4.15 (dd, J3,2 = 10.2, J3,4 = 2.7Hz, 1 H, 3A-H), 3.98 (dd, J2,3 = 
10.2, J2,1 = 3.6Hz, 1 H, 2A-H), 3.84 (q, J5,6 = 6.0 Hz, 1 H, 5A-H), 3.68 (d, J3,4 = 2.7 Hz, 1 
H, 4A-H), 3.35 (s, 3 H, OCH3), 2.16, 2.02, 2.00 (3 s, 9 H, 3 CH3CO), 1.16 (d, J6,5 = 
6.0Hz, 3 H, 6A-H), 1.12 (d, J6,5 = 6.0Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ 
= 170.4, 170.0, 169.9 (3 CO), 138.3, 138.2 (2 Cipso-Bn), 129.0–127.7 (C-Ar), 98.4, 93.9 (C-
1A, C-1B), 75.5, 74.6, 74.5, 74.4, 73.3, 71.1, 70.3, 68.9, 66.6, 65.8 (C-2A, C-2B, C-3A, C-3B, 
C-4A, C-4B, C-5A, C-5B, 2 OCH2Ph), 55.3 (OCH3), 20.9, 20.7, 20.6 (3 CH3CO), 17.5, 16.7 
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(C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. for C33H42O12 [M]
+ 630.27; found 653.01 
[M + Na]+. C33H42O12 (630.68): calcd. C 62.85, H 6.71; found C 62.82, H 6.72. 
 
Methyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2,4-di-O-benzyl-β-D-
fucopyranoside (24): [α]D = –61.0 (c = 2.0, CH2Cl2). 
1H NMR (300 MHz, CDCl3): δ = 
7.42–7.27 (m, 10 H, Ar-H), 5.40 (dd, J3,4 = 9.9, J3,4 = 3.3 Hz, 1 H, 3B-H), 5.18 (dd, J2,3 = 
3.3, J2,1 = 1.8 Hz, 1 H, 2B-H), 5.03 (t, J4,3 = J4,5 = 9.9 Hz, 1 H, 4B-H), 4.96 (s, 1 H, 1B-H), 
4.93 (d, Jgem = 10.5 Hz, 1 H, OCHHPh), 4.91 (d, Jgem = 11.4 Hz, 1 H, OCHHPh), 4.71 (d, 
Jgem = 10.5 Hz, 1 H, OCHHPh), 4.60 (d, Jgem = 11.4 Hz, 1 H, OCHHPh), 4.26 (d, J1,2 = 
7.2 Hz, 1 H, 1A-H), 4.16 (dq, J5,4 = 9.9, J5,6 = 6.0 Hz, 1 H, 5BH), 3.74 (m, 2 H, 2A-H, 3A-
H), 3.56 (s, 1 H, 4A-H), 3.55 (s, 3 H, OCH3), 3.48 (q, J5,6 = 6.3 Hz, 1 H, 5A-H), 2.15, 2.01, 
2.00 (3 s, 9 H, 3 CH3CO), 1.23 (d, J6,5 = 6.3 Hz, 3 H, 6A-H), 0.96 (d, J6,5 = 6.0Hz, 3 H, 6B-
H) ppm. 13C NMR (CDCl3, 50 MHz): δ = 170.2, 169.9, 169.7 (3 CO), 138.6, 138.2 (2 
Cipso-Bn), 129.0–127.4 (C-Ar), 105.0, 94.0 (C-1A, C-1B), 77.7, 77.3, 75.3, 75.1, 75.0, 71.6, 
70.4, 70.2, 69.0, 66.4 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 2 OCH2Ph), 56.9 
(OCH3), 20.9–20.8 (3 CH3CO), 17.2, 17.0 (C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. 
for C33H42O12 [M]
+ 630.27; found 653.15 [M + Na]+. C33H42O12 (630.68): calcd. C 62.85, 
H6.71; found C 62.75, H 6.62. 
 
Methyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-4-O-allyl-2-O-benzyl-α-L-
rhamnopyranoside (27): [α]D = –40.1 (c = 2.0, CH2Cl2). 
1H NMR (300 MHz, CDCl3): δ 
= 7.41–7.28 (m, 5 H, Ar-H), 5.87 (m, 1 H, OCH2CH=CH2), 5.34 (m, 2 H, 1B-H, 3B-H), 
5.24 (d, Jvic = 16.8 Hz, 1 H, OCH2CH=CHH), 5.10 (d, Jvic = 9.9 Hz, 1 H, 
OCH2CH=CHH), 5.01 (m, 2 H, 2B-H, 4B-H), 4.75 (d, Jgem = 12.3 Hz, 1 H, OCHHPh), 
Chapter 2:Acetolysis of 6-deoxysugar 
 
72 
 
4.66 (br. s, 1 H, 1A-H), 4.64 (d, Jgem = 12.3 Hz, 1 H, OCHHPh), 4.25 (dd, Jgem = 12.2, Jvic = 
5.7 Hz, 1 H, OCHHCH=CH2), 4.10 (dd, Jgem = 12.4, Jvic = 5.7 Hz, 1 H, 
OCHHCH=CH2), 3.94 (dd, J3,4 = 9.3, J3,2 = 3.3 Hz, 1 H, 3A-H), 3.80 (dq, J5,4 = 9.6, J5,6 = 
6.3 Hz, 1 H, 5B-H), 3.65 (dd, J2,3 = 3.0, J2,1 = 1.8 Hz, 1 H, 2A-H), 3.58 (dq, J5,4 = 9.6, J5,6 = 
6.3 Hz, 1 H, 5A-H), 3.46 (t, J4,3 = J4,5 = 9.6 Hz, 1 H, 4A-H), 3.30 (s, 3 H, OCH3), 2.10, 
2.02, 1.97 (3 s, 9 H, 3 CH3CO), 1.29 (d, J6,5 = 6.3 Hz, 3 H,6A-H), 1.09 (d, J6,5 = 6.3 Hz, 3 
H, 6B-H) ppm. 
13C NMR (CDCl3,75 MHz): δ = 169.7 (3 CO), 138.0 (Cipso-Bn), 
134.6(OCH2CH=CH2), 128.3–127.5 (C-Ar), 116.7 (OCH2CH=CH2), 99.2, 98.3 (C-1A, 
C-1B), 80.4, 78.3, 77.7, 74.1, 72.4, 71.1, 69.8, 69.0, 68.0, 66.8 (C-2A, C-2B, C-3A, C-3B, C-
4A, C-4B, C-5A, C-5B, OCH2Ph, OCH2CH=CH2), 54.6 (OCH3), 20.7–20.6 (3 CH3CO), 
17.8, 17.4 (C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. For C29H40O12 [M]
+ 580.25; 
found 603.18 [M + Na]+. C29H40O12 (580.62): calcd. C 59.99, H 6.94; found C 59.75, H 
6.82. 
 
Methyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-4-O-acetyl-2-O-benzyl-α-
L-rhamnopyranoside (28): Compound 27 (30.4 mg, 52.2 μmol) was dissolved in 1:1 
(v/v) CH2Cl2/MeOH (0.6 mL) and then treated with PdCl2 (3.7 mg, 20.9 μmol). The 
mixture was vigorously stirred at room temp. for 2 h and then filtered through a Celite 
pad, diluted with CH2Cl2, and washed with water. The organic phase was collected, dried 
with anhydrous Na2SO4, filtered, and concentrated. The residue was dissolved in 1:1 
(v/v) Ac2O/py (1.0 mL) and stirred at room temp. overnight. The solution was then 
concentrated. The residue was diluted with CH2Cl2 and the resulting solution washed 
with 1 M HCl. The organic phase was collected, dried with anhydrous Na2SO4, filtered, 
and concentrated. The residue was purified by chromatography (10 to 50% ethyl acetate 
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in petroleum ether) to give 28 (22.9 mg, 75%) as a yellowish oil. [α]D = –34.7 (c = 1.1, 
CH2Cl2). 
1H NMR (200 MHz, CDCl3): δ = 7.37 (m, 5 H, Ar-H), 5.30 (dd, J3,4 = 10.0, J3,2 
= 3.2 Hz, 1 H, 3B-H), 5.21 (t, J4,3 = J4,5 = 9.8 Hz, 1 H, 4A-H), 5.12 (dd, J2,3 = 3.2, J2,1 = 
2.0Hz, 1 H, 2B-H), 5.02 (t, J4,3 = J4,5 = 10.0 Hz, 1 H, 4B-H), 4.89 (d, J1,2 = 1.6 Hz, 1 H, 1B-
H), 4.74–4.68 (m, 3 H, 1A-H, OCH2Ph), 4.00 (dd, J3,4 = 9.8, J3,2 = 3.2Hz, 1 H, 3A-H), 3.82 
(dq, J5,4 = 9.8, J5,6 = 6.2 Hz, 1 H, 5A-H), 3.70 (m, 2 H, 2A-H, 5B-H), 3.33 (s, 3 H, OCH3), 
2.13, 2.12, 2.03, 1.99 (4 s, 12 H, 4 CH3CO), 1.20 (d, J6,5 = 6.2 Hz, 3 H, 6B-H), 1.07 (d, J6,5 
= 6.2 Hz, 3 H, 6A-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 170.2, 170.1, 170.0, 169.6 (4 
CO), 138.0 (Cipso-Bn), 128.5–127.6 (C-Ar), 98.6, 98.5 (C-1A, C-1B), 76.9, 72.7, 72.6, 71.2, 
71.1, 70.2, 68.6, 66.9, 66.8 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, OCH2Ph), 54.9 
(OCH3), 20.9– 20.7 (4 CH3CO), 17.6, 17.4 (C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. 
for C28H38O13 [M]
+ 582.23; found 605.09 [M + Na]+. C28H38O13 (582.59): calcd. C 57.72, 
H 6.57; found C 57.57, H 6.62. 
 
Methyl 3-O-Allyl-4-O-benzyl-α-D-rhamnopyranosyl-(1→3)-2,4-di-O-benzyl-α-D-
rhamnopyranoside (19): Compound 18 (250 mg, 317 μmol) was dissolved in dry DMF 
(5.0 mL) under Ar and then NaNH2 (542 mg, 13.9 mmol) was added. The mixture was 
stirred at 70 °C for 48 h and then diluted with MeOH. AcOH was added dropwise until 
the pH was neutral. The solution was concentrated and the residue was dissolved in 
CH2Cl2 and washed with 1 M NaHCO3 and brine. The organic layer was collected, 
dried with anhydrous Na2SO4, filtered, and concentrated. The residue waspurified by 
chromatography (8 to 16% ethyl acetate in toluene) to afford 19 (129 mg, 64%) as a 
yellowish oil. [α]D = +26.5 (c = 2.0, CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.37–7.19 
(m, 15 H, Ar-H), 5.91 (m, 1 H, OCH2CH=CH2), 5.26 (dd, Jvic = 17.2, Jgem = 1.6 Hz, 1 H, 
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trans OCH2CH=CHH), 5.16–5.13 (m, 2 H, cis OCH2CH=CHH, 1B-H), 4.87 (d, Jgem = 
11.0 Hz, 1 H, OCHHPh), 4.78 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.70 (s, 2 H, 
OCH2Ph), 4.64 (s, 1 H, 1A-H), 4.63 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.62 (d, Jgem = 
11.6 Hz, 1 H, OCHHPh), 4.07 (dd, Jgem = 11.8, Jvic = 6.6Hz, 1 H, OCHHCH=CH2), 4.05 
(dd, Jgem = 11.8, Jvic = 6.6 Hz, 1 H, OCHHCH=CH2), 4.00 (d, J2,1 = 1.3 Hz, 1 H, 2B-H), 
3.80 (m, 1 H, 5B-H), 3.75–3.61 (m, 3 H, 3A-H, 3B-H, 2A-H), 3.66 (m, 1 H, 5A-H), 3.58 (t, 
J4,5 = J4,3 = 9.3 Hz, 1 H, 4B-H), 3.42 (t, J4,5 = J4,3 = 9.3 Hz, 1 H, 4A-H), 3.31 (s, 3 H, 
OCH3), 1.32 (d, J6,5 = 5.8 Hz, 3 H, 6A-H), 1.25 (d, J6,5 = 6.0 Hz, 3 H, 6B-H) ppm. 
13C 
NMR (CDCl3, 50 MHz): δ = 138.7, 138.2, 138.1 (3 Cipso-Bn), 134.6 (OCH2CH=CH2), 
128.4–127.8 (C-Ar), 117.2 (OCH2CH=CH2), 100.8, 98.6 (C-1A, C-1B), 81.1, 79.9, 79.5, 
77.3, 76.7, 75.3, 75.1, 72.7, 70.9, 69.0, 67.9, 67.8 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-
5A, C-5B, 3 OCH2Ph, OCH2CH=CH2), 54.9 (OCH3), 18.2 (C-6A, C-6B) ppm. MS 
(MALDI-TOF): calcd. for C37H46O9 [M]
+ 634.31; found 657.33 [M + Na]+. C37H46O9 
(634.76): calcd. C 70.01, H 7.30; found C 70.18, H 7.45. 
 
Methyl 2-O-Acetyl-3-O-allyl-4-O-benzyl-α-D-rhamnopyranosyl-(1→3)-2,4-di-O-
benzyl-α-D-rhamnopyranoside (25): Alcohol 19 (67.0 mg, 106 μmol) was dissolved in 
1:1 Ac2O/pyridine (1.5 mL). The solution was stirred overnight at room temp. and then 
co-evaporated four times with toluene. The residue was dissolved in CH2Cl2 and washed 
with water. The organic layer was collected, dried with anhydrous Na2SO4, filtered, and 
concentrated. The residue was purified by chromatography (6% ethyl acetate in toluene) 
to give 25 (71.0 mg, 99%) as a colorless oil. [α]D = +28.2 (c = 0.9, CH2Cl2). 
1H NMR 
(300 MHz, CDCl3): δ = 7.41–7.26 (m, 15 H, Ar-H), 5.87 (m, 1 H, OCH2CH=CH2), 5.44 
(br. s, 1 H, 2B-H), 5.25 (d, Jvic = 17.4 Hz, 1 H, trans OCH2CH=CHH), 5.13–5.10 (m, 2 H, 
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cis OCH2CH=CHH, 1A-H), 4.94 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.83 (d, Jgem = 11.0 
Hz, 1 H, OCHHPh), 4.72 (s, 2 H, OCH2Ph), 4.66–4.61 (m, 3 H, 2 OCHHPh, 1B-H), 
4.16–4.06 (m, 2 H, OCHHCH=CH2, 3A-H), 3.98 (dd, Jgem = 12.0, Jvic = 5.4 Hz, 1 H, 
OCHHCH=CH2), 3.88 (dd, J3,2 = 3.3, J3,4 = 9.3Hz, 1 H, 3B-H), 3.85 (m, 1 H, 5B-H), 3.71 
(br. s, 1 H, 2A-H), 3.65 (t, J4,5 = J4,3 = 9.0 Hz, 1 H, 4B-H), 3.41 (m, 1 H, 5A-H), 3.36 (t, 
J4,5 = J4,3 = 9.6 Hz, 1 H, 4A-H), 3.31 (s, 3 H, OCH3), 2.09 (s, 3 H, COCH3), 1.32 (d, J6,5 = 
5.4 Hz, 3 H, 6A-H), 1.29 (d, J6,5 = 5.7 Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 75 MHz): δ 
= 169.9 (CO), 138.8, 138.1, 138.0 (3 Cipso-Bn), 134.6 (OCH2CH=CH2), 128.4–127.5 
(CAr), 117.1 (OCH2CH=CH2), 99.2, 98.5 (C-1A, C-1B), 81.0, 80.9, 79.9, 77.7, 77.4, 77.0, 
75.2, 72.8, 70.6, 69.1, 68.2, 67.9 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 3 
OCH2Ph, OCH2CH=CH2), 54.6 (OCH3), 20.9 (CH3CO), 18.0, 17.9 (C-6A, C-6B) ppm. 
MS (MALDI-TOF): calcd. for C39H48O10 [M]
+ 676.32; found 699.29 [M + Na]+. 
C39H48O10 (676.79): calcd. C 69.21, H 7.15; found C 69.15, H 7.09. 
 
Methyl 3-O-Allyl-2-O-benzoyl-4-O-benzyl-α-D-rhamnopyranosyl- (1→3)-2,4-di-
O-benzyl-α-D-rhamnopyranoside (26): Alcohol 25 (86.3 mg, 136 μmol) was 
dissolved in pyridine (1.0 mL), treated with BzCl (40 μL, 345 μmol), and stirred 
overnight at room temp. The mixture was diluted with CH2Cl2 and washed with 1 M 
HCl and water. The organic layer was collected, dried with anhydrous Na2SO4, filtered, 
concentrated, and purified by chromatography (6 to 9% ethyl acetate in toluene) to give 
25 (83.0 mg, 83%) as a colorless oil. [α]D = –0.8 (c = 0.9, CH2Cl2). 
1H NMR (200 MHz, 
CDCl3): δ = 8.06–7.24 (m, 20 H, Ar-H), 5.88 (m, 1 H, OCH2CH=CH2), 5.71 (dd, J2,1 = 
1.6, J2,3 = 3.0 Hz, 1 H, 2B-H), 5.24 (dd, Jvic = 15.6, Jgem = 1.8 Hz, 1 H, trans 
OCH2CH=CHH), 5.26 (br. s, 1 H, 1B-H), 5.09 (dd, Jvic = 10.2, Jgem = 1.8 Hz, 1 H, cis 
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OCH2CH=CHH), 4.98 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.92 (d, Jgem = 11.0 Hz, 1 H, 
OCHHPh), 4.77 (s, 2 H, OCHHPh), 4.67–4.62 (m, 3 H, 2 OCHHPh, 1A-H), 4.22 (dd, 
Jgem = 11.5, Jvic = 5.2 Hz, 1 H, OCHHCH=CH2), 4.16–3.88 (m, 4 H, OCHHCH=CH2, 
3A-H, 5A-H, 5B-H), 3.77 (dd, J2,1 = 2.0, J2,3 = 3.0Hz, 1 H, 2A-H), 3.71–3.67 (m, 2 H, 3B-H, 
4A-H), 3.54 (t, J4,5 = J4,3 = 9.2 Hz, 1 H, 4B-H), 3.33 (s, 3 H, OCH3), 1.36–1.30 (m, 6 H, 
6A-H, 6B-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 165.4 (CO), 138.7, 138.1, 138.0 (3 
Cipso-Bn), 134.7 (OCH2CH=CH2), 133.0 (Cipso-Bz), 129.8–127.5 (C-Ar), 117.0 
(OCH2CH=CH2), 99.2, 98.6 (C-1A, C-1B), 80.9, 80.0, 77.7, 77.5, 75.3, 75.1, 72.8, 70.5, 
69.6, 69.5, 68.3, 67.9 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 3 OCH2Ph, 
OCH2CH=CH2), 54.6 (OCH3), 18.2, 17.9 (C-6A, C- 6B) ppm. MS (MALDI-TOF): calcd. 
for C44H50O10 [M]
+ 738.34; found 761.39 [M + Na]+. C44H50O10 (738.86): calcd. C 71.52, 
H 6.82; found C 71.45, H 6.77. 
 
Typical Acetolysis Procedure (ZnCl2 Protocol): Methyl glycoside (66 μmol) was 
dissolved in a 2:1 (v/v) Ac2O/AcOH mixture (1.0 mL), cooled to 5 °C, and then treated 
with freshly fused ZnCl2 (660 μmol). The solution was stirred at 5 °C until TLC (ethyl 
acetate in toluene) showed the disappearance of the starting material. The solution was 
then diluted with CH2Cl2 and washed with 1 M NaHCO3 and then collected, dried with 
anhydrous Na2SO4, filtered, and concentrated. The residue was purified by 
chromatography (ethyl acetate in toluene). 
 
Typical Acetolysis Procedure (TFA Protocol): Methyl glycoside (66 μmol) was 
dissolved in a 1:1:0.1 (v/v/v) Ac2O/AcOH/TFA mixture (2.1 mL). The solution was 
stirred at 70 °C until TLC (ethyl acetate in toluene) showed disappearance of the starting 
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material. The reaction was quenched by cooling to room temp. The mixture was diluted 
with CH2Cl2 and washed with 1 M NaHCO3. The organic layer was collected, dried with 
anhydrous Na2SO4, filtered, and concentrated. The residue was purified by 
chromatography (ethyl acetate in toluene). 
 
1,5-di-O-acetyl-2,3-di-O-benzyl-α-L-rhamnofuranose (29): [α]D -11.8 (c 1.6; 
CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.35-7.30 (m, 10H, H-Ar), 6.29 (d, 1H, J1,2 2.3 
Hz, H-1), 5.27 (quintet, 1H, J5,6=J5,4 6.0 Hz, H-5), 4.71 (d, 1H, Jgem 1.6 Hz, OCHHPh), 
4.68 (d, 1H, Jgem 11.6 Hz, OCHHPh), 4.63 (d, 1H, Jgem 11.6 Hz, OCHHPh), 4.50 (d, 1H, 
Jgem 11.6 Hz, OCHHPh), 4.23 (m, 2H, H-3, H-4), 4.02 (dd, 1H, J2,3 4.4 Hz, J2,1=2.3 Hz, 
H-2), 2.07, 1.92 (2s, 6H, 2 CH3CO), 1.32 (d, 3H, J6,5 6.4 Hz, H-6); 
13C NMR (100 MHz, 
CDCl3) δ 170.0, 169.8 (2 CO), 137.7, 137.4 (2 Cipso-Bn), 128.5-127.5 (C-Ar), 99.3 (C-1), 
81.7, 81.6, 76.8, 73.2, 72.6, 69.2 (C-2, C-3, C-4, C-5, 2 OCH2Ph), 21.2 (2 CH3CO), 16.1 
(C-6). MALDI TOF-MS: calcd for C24H28O7 (m/z), 428.18; found, 450.99 [M+Na]
+. 
Anal Calcd for C24H28O7: C, 67.28; H, 6.59. Found: C, 67.46; H, 6.50. 
 
Acetyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-5-O-acetyl-2-O-allyl-α-L-
rhamnofuranoside (31): 1H NMR (400 MHz, CDCl3): δ = 6.27 (d, J1,2 = 4.5 Hz, 1 Hβ, 
1A-β-H), 6.19 (d, J1,2 = 2.9Hz, 1 Hα, 1A-α-H), 5.87 (m, 1 Hβ + 1 Hα, OCH2CH=CH2), 5.39 
(dd, J3,4 = 9.9, J3,2 = 3.6 Hz, 1 Hα, 3B-β-H), 5.32 (dd, Jvic = 17.2, Jgem = 1.5 Hz, 1 Hα + 1 Hβ, 
trans OCH2CH=CHH), 5.26–5.18 (m, 3Hα + 2Hβ, cis OCH2CH=CHH, 2B-α-H, 2B-β-H, 
3B-α-H), 5.18–5.01 (m, 2Hα + 2Hβ, 4B-α-H, 4B-β-H, 5A-α-H, 5A-β-H), 4.78 (d, J1,2 = 1.5 Hz, 1 
Hα, 1B-α-H), 4.74 (d, J1,2 = 1.7 Hz, 1 Hβ, 1B-β-H), 4.46 (dq, J5,4 = 9.9, J5,6 = 6.2 Hz, 1 Hβ, 5B-
β-H), 4.35 (t, J3,2 = J3,4 = 4.9 Hz, 1 Hα, 3A-α-H), 4.26–4.19 (m, 2 Hα + 1 Hβ, 3A-β-H, 4A-α-H, 
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5B-α-H), 4.13–4.03 (m, 2 Hα + 2 Hβ, OCH2CH=CH2), 3.99 (dd, J2,3 = 5.9, J2,1 = 4.5 Hz, 1 
Hβ, 2A-β-H), 3.94 (dd, J2,3 = 4.6, J2,1 = 2.9 Hz, 1 Hα, 2A-α-H), 3.91 (t, J4,3 = J4,5 = 5.9 Hz, 1 
Hβ, 4A-β-H), 2.18 (s, 3 Hβ, CH3CO), 2.13 (2 s, 3 Hα + 3 Hβ, CH3CO), 2.08 (s, 3 Hα, 
CH3CO), 2.04 (2 s, 6 Hα, CH3CO), 2.03 (s, 3 Hβ, CH3CO), 2.01 (s, 3 Hβ, CH3CO), 1.99 
(s, 3 Hβ, CH3CO), 1.98 (s, 3 Hα, CH3CO), 1.35 (d, J6,5 = 6.2 Hz, 3 Hβ, 6A-β-H), 1.31 (d, J6,5 
= 6.3 Hz, 3 Hα, 6A-α-H), 1.17 (d, J6,5 = 6.2 Hz, 3 Hα, 6B-α-H), 1.16 (d, J6,5 = 6.2 Hz, 3 Hβ, 
6B-β-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 170.1–169.6 (5 COα + 5 COβ), 133.8 (α 
OCH2CH=CH2), 133.6 (β OCH2CH=CH2), 118.4 (α OCH2CH=CH2), 117.7 (β 
OCH2CH=CH2), 99.5, 98.4 (C-1A-α, C-1B-α), 98.8, 93.0 (C-1A-β, C-1B-β), 81.7, 81.0, 78.6, 
71.7, 71.0, 69.9, 68.8, 68.7, 67.0 (α C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 
OCH2CH=CH2), 82.8, 78.2, 72.4, 72.1, 71.5, 70.6, 68.8, 68.7, 66.7 (β C-2A, C-2B, C-3A, 
C-3B, C-4A, C-4B, C-5A, C-5B, OCH2CH=CH2), 21.3–20.7 (5 CH3COα + 5 CH3COβ), 
17.6, 16.3 (C-6A-α, C-6B-α), 17.5, 16.7 (C-6A-β, C-6B-β) ppm. MS (MALDI-TOF): calcd. for 
C25H36O14 [M]
+ 560.21; found 582.90 [M + Na]+. C25H36O14 (560.55): calcd. C 53.57, H 
6.47; found C 53.70, H 6.40. 
 
Acetyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2-O-allyl-4-O-benzyl-α-L-
rhamnopyranoside (32): [α]D = –39.2 (c = 1.4, CH2Cl2). 
1H NMR (300 MHz, CDCl3): δ 
= 7.32 (m, 5 H, Ar-H), 6.09 (d, J1,2 = 2.1 Hz, 1 H, 1A-H), 5.98 (m, 1 H, OCH2CH=CH2), 
5.40–5.34 (m, 3 H, 2B-H, 3B-H, trans OCH2CH=CHH), 5.26 (dd, Jvic = 10.5, Jgem = 1.2 
Hz, 1 H, cis OCH2CH=CHH), 5.08 (t, J4,3 = J4,5 = 9.9 Hz, 1 H, 4B-H), 5.05 (br. s, 1 H, 1B-
H), 4.84 (d, Jgem = 11.1 Hz, 1 H, OCHHPh), 4.64 (d, Jgem = 11.1 Hz, 1 H, OCHHPh), 
4.27 (dd, Jgem = 12.9, Jvic = 5.4 Hz, 1 H, OCHHCH=CH2), 4.12–3.98 (m, 3 H, 3A-H, 5B-
H, OCHHCH=CH2), 3.77 (dq, J5,4 = 9.6, J5,6 = 6.3 Hz, 1 H, 5A-H), 3.67 (dd, J2,3 = 3.0, J2,1 
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= 2.1 Hz, 1 H, 2A-H), 3.63 (t, J4,3 = J4,5 = 9.6 Hz, 1 H, 4A-H), 2.09, 2.07, 2.06, 1.99 (4 s, 
12 H, 4 CH3CO), 1.31 (d, J6,5 = 6.3 Hz, 3 H, 6A-H), 1.20 (d, J6,5 = 6.3 Hz, 3 H, 6BH) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 170.0, 169.9, 169.8, 169.1 (4 CO), 137.8 (Cipso-Bn), 
134.3 (OCH2CH=CH2), 128.4–127.8 (C-Ar), 117.9 (OCH2CH=CH2), 99.4 (C-1B), 91.2 
(C-1A), 79.7, 78.5, 76.7, 75.6, 71.8, 70.9, 70.6, 69.8, 69.0, 66.9 (C-2A, C-2B, C-3A, C-3B, C-
4A, C-4B, C-5A, C-5B, OCH2Ph, OCH2CH=CH2), 21.0–20.8 (4 CH3CO), 18.0, 17.5 (C-6A, 
C-6B) ppm. MS (MALDITOF): calcd. for C30H40O13 [M]
+ 608.25; found 630.74 [M + 
Na]+. C30H40O13 (608.63): calcd. C 59.20, H 6.62; found C 59.11, H 6.70. 
 
2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-1,5-di-O-acetyl-4-O-allyl-2-O-
benzyl-1-O-methyl-D-rhamnose Acetal (33): 1H NMR (500 MHz, CDCl3) (major 
diastereoisomer): δ = 7.32 (m, 5 H, Ar-H), 5 . 9 9 ( d , J 1 , 2 = 7.0 Hz, 1 H, 1A - H ) , 5 . 8 
5 (m, 1 H, OCH2CH=CH2), 5.35 (dd, J2,3 = 3.0, J2,1 = 1.5 Hz, 1 H, 2B-H), 5.24 (dd, J3,4 = 
10.2, J3,2 = 3.0 Hz, 1 H, 3B-H), 5.19 (d, Jvic = 17.5 Hz, 1 H, trans OCH2CH=CHH), 5.08 
(m, 2 H, 1B-H, 4B-H), 5.04 (d, Jvic = 10.5 Hz, 1 H, trans OCH2CH=CHH), 4.81 (dq, J5,6 = 
6.6, J5,4 = 1.8 Hz, 1 H, 5A-H), 4.62 (s, 2 H, OCH2Ph), 4.15 (m, 3 H, OCH2CH=CH2, 5B-
H), 3.80 (m, 2 H, 3A-H, 4A-H), 3.52 (m, 4 H, 2A-H, OCH3), 2.12 (s, 6 H, 2 CH3CO), 2.07 
(s, 3 H, CH3CO), 2.02 (s, 3 H, CH3CO), 1.97 (s, 3 H, CH3CO), 1.04 (d, J6,5 = 6.2 Hz, 3 
H, 6B-H), 1.02 (d, J6,5 = 6.6 Hz, 3 H, 5A-H) ppm. 
13C NMR (CDCl3, 75 MHz) (major 
diastereoisomer): δ = 170.5, 170.2, 169.9, 169.8, 169.7 (5 CO), 137.5 (Cipso-Bn), 134.8 
(OCH2CH=CH2), 128.5–127.9 (C-Ar), 116.5 (OCH2CH=CH2), 98.7, 98.0 (C-1A, C-1B), 
80.6, 78.8, 77.7, 73.7, 73.5, 71.0, 70.8, 69.8, 69.6, 67.1 (C-2A, C-2B, C-3A, C-3B, C-4A, C-
4B, C-5A, C-5B, OCH2Ph, OCH2CH=CH2), 57.7 (OCH3), 21.3, 21.2, 20.9, 20.8, 20.7 (5 
CH3CO), 17.4, 13.7 (C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. for C33H46O15 [M]
+ 
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682.28; found 704.73 [M + Na]+. C33H46O15 (682.71): calcd. C 58.06, H 6.79; found C 
57.88, H 6.65. 
 
Acetyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-4-O-allyl-2-O-benzyl-α-L-
rhamnopyranoside (34): [α]D = –32 (c = 0.9, CH2Cl2). 
1H NMR (200 MHz, CDCl3): δ 
= 7.39 (m, 5 H, Ar-H), 6.15 (d, J1,2 = 2.0 Hz, 1 H, 1A-H), 5.89 (m, 1 H, OCH2CH=CH2), 
5.34–5.03 (m, 6 H, 1B-H, 2B-H, 3B-H, 4B-H, OCH2CH=CH2), 4.82 (d, Jgem = 12.0 Hz, 1 
H, OCHHPh), 4.62 (d, Jgem = 12.0 Hz, 1 H, OCHHPh), 4 . 3 0 ( dd , J gem = 1 2 . 8 , J vic = 
5. 6 Hz, 1 H, OCHHCH=CH2), 4.16 (dd, Jgem = 12.8, Jvic = 5.6 Hz, 1 H, 
OCHHCH=CH2), 3.95 (dd, J3,4 = 9.4, J3,2 = 3.2 Hz, 1 H, 3A-H), 3.79–3.67 (m, 3 H, 2A-H, 
5A-H, 5B-H), 3.54 (t, J4,3 = J4,5 = 9.4 Hz, 1 H, 4A-H), 2.13, 2.08, 2.04, 2.00 (4 s, 12 H, 4 
CH3CO), 1.31 (d, J6,5 = 6.2 Hz, 3 H, 6A-H), 1.07 (d, J6,5 = 6.2 Hz, 3 H, 6B-H) ppm. 
13C 
NMR (CDCl3, 75 MHz): δ = 169.8–169.7 (4 CO), 137.5 (Cipso-Bn), 134.4 
(OCH2CH=CH2) , 128.5–127.7 (C-Ar) , 117.2 (OCH2CH=CH2), 99.5 (C-1B), 91.2 (C-
1A), 79.7, 78.4, 77.2, 74.4, 72.3, 71.0, 70.9, 69.9, 69.0, 66.9 (C-2A, C-2B, C-3A, C-3B, C-4A, 
C-4B, C-5A, C-5B, OCH2Ph, OCH2CH=CH2), 20.8–20.7 (4 CH3CO), 18.0, 17.5 (C-6A, C-
6B) ppm. MS (MALDI-TOF): calcd. For C30H40O13 [M]
+ 608.25; found 631.11 [M + 
Na]+. C30H40O13 (608.63): calcd. C 59.20, H 6.62; found C 59.02, H 6.54. 
 
2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-1,4,5-tri-O-acetyl-2-O-benzyl-1-
O-methyl-D-rhamnose Acetal (35): 1H NMR (500 MHz, CDCl3): δ = 7.41–7.33 (m, 5 
H’ + 5H’’, Ar-H), 6.00 (d, J1,2 = 5.0 Hz, 1 H’’, 1A’’-H), 5.98 (d, J1,2 = 6.0 Hz, 1 H’, 1A’-H), 
5.45 (m, 1 H’ + 1 H’’, 4A’-H, 4A’’-H), 5.25 (m, 1 H’ + 1 H’, 3B’-H, 3B’’-H), 5.15 (dd, J2,3 = 
3.0, J2,1 = 1.8 Hz, 1 H’’, 2B’’-H), 5.13 (dd, J2,3 = 3.0, J2,1 = 1.8 Hz, 1 H’, 2B’-H), 5.06 (t, J4,3 = 
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J4,5 = 10.0 Hz, 1 H’ + 1 H’’, 4B’-H, 4B’’-H), 4.96 (m, 1 H’ + 1 H’’, 5A’- H, 5A’’-H), 4.91 (d, 
J1,2 = 1.8 Hz, 1 H’, 1B’-H), 4.86 (d, J1,2 = 1.8 Hz, 1 H’’, 1B’’-H), 4.78 (d, Jgem = 12.0 Hz, 1 
H’, OCHHPh’), 4.69–4.61 (m, 2 H’ + 1H’’, OCHHPh’, OCHHPh’’), 4.08 (dq, J5,4 = 
10.0, J5,6 = 6.2 Hz, 1 H’ + 1 H’’, 5B’-H, 5B’’-H), 3.93 (dd, J3,4 = 8.0, J3,2 = 1.8 Hz, 1 H’, 3A’-
H), 3.89 (dd, J3,4 = 8.0, J3,2 = 3.0 Hz, 1 H’’, 3A’’-H), 3.66 (dd, J2,1 = 5.0, J2,3 = 3.0 Hz, 1 H’’, 
2A’’-H), 3.57 (dd, J2,1 = 6.0, J2,3 = 1.8 Hz, 1 H’, 2A’-H), 3.53 (s, 3 H’, OCH3’), 3.52 (s, 3 H’’, 
OCH3’’), 2.17 (s, 3 H’’, CH3CO’’), 2.14 (s, 3 H’, CH3CO’), 2.13 (s, 3 H’’, CH3CO’’), 2.11 
(s, 3 H’, CH3CO’), 2.07 (s, 3 H’, CH3CO’), 2.06 (s, 3 H’ + 3 H’’, CH3CO’, CH3CO’’), 
2.05 (s, 3 H’’, 3 CH3CO’’), 1.97 (s, 6 H’ + 6 H’’, 2 CH3CO’, 2 CH3CO’’), 1.11 (d, J6,5 = 
6.2 Hz, 3 H’’, 6B’’-H), 1.05 (d, J6,5 = 6.2 Hz, 3 H’, 6B’-H), 1.03 (d, J6,5 = 6.6 Hz, 3 H’’, 6A’’-
H), 1.00 (d, J6,5 = 6.6 Hz, 3 H’, 6A’-H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 170.4–
169.7 (5 CO’, 5 CO’’), 137.6 (Cipso-Bn’, Cipso-Bn’’), 128.5–127.8 (C-Ar), 98.8, 97.1 (C-1A’’, 
C-1B’’), 98.5, 97.7 (C-1A’, C-1B’), 79.1, 76.8, 73.6, 73.1, 71.0, 70.1, 68.9, 68.8, 67.2 (C-2A’, 
C-2B’, C-3A’, C-3B’, C-4A’, C-4B’, C-5A’, C-5B’, OCH2Ph’), 79.1, 77.2, 73.9, 72.9, 71.1, 70.0, 
68.9, 68.8, 67.2 (C-2A’’, C-2B’’, C-3A’’, C-3B’’, C-4A’’, C-4B’’, C-5A’’, C-5B’’, OCH2Ph’’), 57.9 
(OCH3’), 53.4 (OCH3’’), 21.2–20.7 (5 CH3CO’, 5 CH3CO’’), 19.2, 14.5 (C-6A’’, C-6B’’), 
17.3, 14.4 (C-6A’, C-6B’) ppm. MS (MALDI-TOF): calcd. for C32H44O16 [M]
+ 684.26; 
found 706.80 [M + Na]+. C32H44O16 (684.68): calcd. C 56.13, H 6.48; found C 56.00, H 
6.32. 
 
Acetyl 3-O-Allyl-2-O-acetyl-4-O-benzyl-α-D-rhamnopyranosyl-(1→3)-5-O-acetyl-
2-O-benzyl-D-rhamnofuranoside (36): 1H NMR (400 MHz, CDCl3) (α anomer): δ 
7.34 (m, 10 H, Ar-H), 6.20 (d, J1,2 = 2.7 Hz, 1 H, 1A-H), 5.92 (m, 1 H, OCH2CH=CH2), 
5.30 (dd, Jvic = 18.0, Jgem = 1.8 Hz, 1 H, trans OCH2CH=CHH), 5.19–5.05 (m, 3 H, 2B-H, 
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5A-H, cis OCH2CH=CHH), 4.90 (d, Jgem = 11.1 Hz, 1 H, OCHHPh), 4.78 (d, J1,2 = 1.5 
Hz, 1 H, 1B-H), 4.66–4.56 (m, 3 H, 3 OCHHPh), 4.39 (t, J3,4 = J3,2 = 4.8 Hz, 1 H, 3A-H), 
4.22–4.01 (m, 4 H, 4A-H, 5B-H, OCH2CH=CH2), 3.94 (dd, J2,3 = 4.8, J2,3 = 2.7Hz, 1 H, 
2A-H), 3.84 (dd, J3,4 = 9.2, J3,2 = 3.0 Hz, 1 H, 3B-H), 3.38 (t, J4,3 = J4,5 = 4.8Hz, 1 H, 4B-H), 
2.14, 2.06, 2.05 (3s, 9 H, 3 CH3CO), 1.29 (d, J6,5 = 6.3Hz, 3 H, 6A-H), 1.18 (d, J6,5 = 
6.3Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 75MHz) (α anomer): δ = 170.0, 169.8, 169.6 
(3 CO), 138.7, 137.1 (2 Cipso-Bn), 134.5 (OCH2CH=CH2), 128.5–127.4 (C-Ar), 117.3 
(OCH2CH=CH2), 99.6, 98.4 (C-1A, C-1B), 81.4, 80.8, 79.8, 77.3, 76.7, 75.0, 72.6, 70.8, 
69.4, 68.6, 68.5 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 2OCH2Ph, 
OCH2CH=CH2), 21.3, 21.1, 21.0 (3 CH3CO), 18.0, 16.4 (C-6A, C-6B) ppm. MS 
(MALDI-TOF): calcd. for C35H44O12 [M]
+ 656.28; found 679.21 [M + Na]+.C35H44O12 
(656.72): calcd. C 64.01, H 6.75; found C 64.23, H 6.66. 
 
Acetyl 2-O-Acetyl-3-O-allyl-4-O-benzyl-α-D-rhamnopyranosyl-(1→3)-2,4-di-O-
benzyl-α-D-rhamnopyranoside (37): [α]D = +69.6 (c = 1.0, CH2Cl2). 
1H NMR (400 
MHz, CDCl3): δ = 7.38–7.26 (m, 15 H, Ar-H), 6.13 (d, J1,2 = 2.0 Hz, 1 H, 1A-H), 5.86 (m, 
1 H, OCH2CH=CH2), 5.43 (dd, J2,1 = 1.8, J2,3 = 3.4 Hz, 1 H, 2B-H), 5.25 (dd, Jvic = 17.0, 
Jgem = 1.6 Hz, 1 H, trans OCH2CH=CHH), 5.12 (dd, Jvic = 10.0, Jgem = 1.6 Hz, 1 H, cis 
OCH2CH=CHH), 5.08 (d, J1,2 = 1.6 Hz, 1 H, 1B-H), 4.93 (d, Jgem = 11.0 Hz, 1 H, 
OCHHPh), 4.84 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.76 (d, Jgem = 11.8 Hz, 1 H, 
OCHHPh), 4.67 (d, Jgem = 11.8 Hz, 1 H, OCHHPh), 4.63 (d, Jgem = 10.8 Hz, 1 H, 
OCHHPh), 4.61 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.09 (dd, Jgem = 12.8, Jvic = 5.5 Hz, 1 
H, OCHHCH=CH2), 4.07 (dd, J3,2 = 3.2, J3,4 = 9.4 Hz, 1 H, 3A H), 4.03 (dd, Jgem = 12.8, 
Jvic = 5.5 Hz, 1 H, OCHHCH=CH2), 3.85 (dd, J3,2 = 3.4, J3,4 = 9.3 Hz, 1 H, 3B-H), 3.78 
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(m, 2 H, 5A-H, 5B-H), 3.72 (dd, J2,1 = 1.6, J2,3 = 2.2Hz, 1 H, 2A-H), 3.70 (t, J4,5 = J4,3 = 
9.4Hz, 1 H, 4B-H), 3.39 (t, J4,5 = J4,3 = 9.4 Hz, 1 H, 4AH), 2.11 (s, 3 H, CH3CO), 2.07 (s, 3 
H, CH3CO), 1.32 (d, J6,5 = 6.1Hz, 3 H, 6A-H), 1.24 (d, J6,5 = 6.2Hz, 3 H, 6B-H) ppm. 
13C 
NMR (CDCl3, 100 MHz): δ = 170.0, 169.1 (2 CO), 138.6, 137.8, 137.5 (3 Cipso-Bn), 134.6 
(OCH2CH=CH2), 129.0–127.6 (C-Ar), 117.1 (OCH2CH=CH2), 99.4 (C-1B), 91.2 (C-1A), 
80.1, 79.8, 77.4, 77.3, 76.7, 75.4, 75.1, 72.6, 70.7, 70.6, 69.2, 69.1 (C-2A, C-2B, C-3A, C-3B, 
C-4A, C-4B, C-5A, C-5B, 3 OCH2Ph, OCH2CH=CH2), 21.0, 20.9 (2 CH3CO), 18.0, 17.9 
(C-6A, C-6B) ppm. MS (MALDITOF): calcd. for C40H48O11 [M]
+ 704.32; found 727.39 
[M + Na]+. C40H48O11 (704.80): calcd. C 68.16, H 6.86; found C 68.23, H 6.97. 
 
Acetyl 3-O-Allyl-2-O-benzoyl-4-O-benzyl-α-D-rhamnopyranosyl-(1→3)-5-O-
acetyl-2-O-benzyl-α-D-rhamnofuranoside (38α): [α]D = +5.9 (c = 0.8, CH2Cl2). 
1H 
NMR (500 MHz, CDCl3): δ = 8.07–7.26 (m, 15 H, Ar-H), 6.22 (d, J1,2 = 3.0Hz, 1 H, 1A-
H), 5.87 (m, 1 H, OCH2CH=CH2), 5.38 (dd, J2,3 = 3.4, J2,1 = 2.0 Hz, 1 H, 2 B-H), 5.28 
(dd, Jvic = 18.0, Jgem = 1.5 Hz, 1 H, trans OCH2CH=CHH), 5.18 (q, J5,6 = J5,4 = 6.0Hz, 1 H, 
5A-H), 5.12 (dd, Jvic = 10.0, Jgem = 1.5 Hz, 1 H, cis OCH2CH=CHH), 4.94 (d, Jgem = 11.0 
Hz, 1 H, OCHHPh), 4.91 (d, J1,2 = 2.0Hz, 1 H, 1 B-H), 4.64 (m, 3 H, 3 OCHHPh), 4.43 
(t, J3,4 = J3,2 = 5.4 Hz, 1 H, 3A-H), 4.20 (m, 2 H, 4A-H, OCHHCH=CH2), 4.09 (m, 2 H, 
5B-H, OCHHCH=CH2), 3.96 (m, 2 H, 2A-H, 3B-H), 3.49 (t, J4,5 = J4,3 = 9.0 Hz, 1 H, 4B-
H), 2.08 (s, 3 H, CH3CO), 2.06 (s, 3 H, CH3CO), 1.31 (d, J6,5 = 6.0 Hz, 3 H, 6A-H), 1.21 
(d, J6,5 = 6.0 Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 50 MHz): δ = 169.9, 169.8, 165.5 (3 
CO), 138.6, 137.1 (2 Cipso-Bn), 134.6 (OCH2CH=CH2), 133.1 (Cipso-Bz), 129.9–127.6 (C-
Ar), 117.3 (OCH2CH=CH2), 99.5, 98.3 (C-1A, C-1B), 81.4, 80.8, 79.7, 77.4, 76.6, 75.0, 
72.5, 70.6, 69.7, 68.6, 68.5 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 2 OCH2Ph, 
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OCH2CH=CH2), 21.4, 21.2 (2 CH3CO), 18.2, 16.4 (C-6A, C-6B) ppm. MS (MALDI-
TOF): calcd. for C40H46O12 [M]
+ 718.30; found 741.03 [M + Na]+. C40H46O12 (718.79): 
calcd. C 66.84, H 6.45; found C 66.68, H 6.32. 
 
Acetyl 3-O-Allyl-2-O-benzoyl-4-O-benzyl-α-D-rhamnopyranosyl-(1→3)-5-O-
acetyl-2-O-benzyl-α-D-rhamnofuranoside (38β): [α]D = –6 (c = 0.3, CH2Cl2). 
1H 
NMR (500 MHz, CDCl3): δ = 8.07–7.28 (m, 15 H, Ar-H), 6.25 (d, J1,2 = 4.5 Hz, 1 H, 1A-
H), 5.88 (m, 1 H, OCH2CH=CH2), 5.36 (dd, Jvic = 18.0, Jgem = 1.6 Hz, 1 H, trans 
OCH2CH=CHH), 5.30 (dd, J2,3 = 3.4, J2,1 = 2.0 Hz, 1 H, 2B-H), 5.13 (m, 2 H, 5A-H, cis 
OCH2CH=CHH), 4.95 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.85 (d, J1,2 = 1.8 Hz, 1 H, 
1B-H), 4.69 (d, Jgem = 13.0 Hz, 1 H, OCHHPh), 4.63 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 
4.61 (d, Jgem = 13.0 Hz, 1 H, OCHHPh), 4.32 (dq, J5,4 = 10.0, J5,6 = 6.0 Hz, 1 H, 5B-H), 
4.23 (m, 2 H, 3A-H, OCHHCH=CH2), 4.10 (dd, Jgem = 13.0, Jvic = 6.0 Hz, 1 H, 
OCHHCH=CH2), 4.00 (dd, J3,4 = 10.0, J3,2 = 3.4Hz, 1 H, 3B-H), 3.94 (dd, J4,5 = 8.5, J4,3 
= 4.0 Hz, 1 H, 4A-H), 3.85 (t, J2,3 = J2,1 = 4.5 Hz, 1 H, 2A-H), 3.50 (t, J4,5 = J4,3 = 10.0 Hz, 
1 H, 4B-H), 2.11 (s, 3 H, CH3CO), 2.09 (s, 3 H, CH3CO), 1.36 (d, J6,5 = 6.0 Hz, 3 H, 6A-
H), 1.15 (d, J6,5 = 6.0Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 125 MHz): δ = 170.5, 
170.3, 165.6 (3 CO), 138.9, 137.1 (2 Cipso-Bn), 135.2, 134.8 (OCH2CH=CH2, Cipso-Bz), 
129.9–127.4 (C-Ar), 117.3 (OCH2CH=CH2), 99.8, 93.2 (C-1A, C-1B), 82.7, 80.1, 77.7, 
77.2, 76.6, 75.0, 72.6, 70.1, 69.8, 68.6, 68.3 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-
5B, 2 OCH2Ph, OCH2CH=CH2), 21.4, 21.3 (2 CH3CO), 18.1, 16.9 (C-6A, C-6B) ppm. MS 
(MALDI-TOF): calcd. for C40H46O12 [M]
+ 718.30; found 740.56 [M + Na]+. C40H46O12 
(718.79): calcd. C 66.84, H 6.45; found C 66.55, H 6.25. 
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Acetyl 3-O-Allyl-2-O-benzoyl-4-O-benzyl-α-D-rhamnopyranosyl-(1→3)-2,4-di-O-
benzyl-α-D-rhamnopyranoside (39): [α]D = –2.5 (c = 1.2, CH2Cl2). 
1H NMR (200 
MHz, CDCl3): δ = 8.07–7.16 (m, 20 H, Ar-H), 6.14 (d, J1,2 = 2.0 Hz, 1 H, 1A-H), 5.84 (m, 
1 H, OCH2CH=CH2), 5.68 (dd, J2,1 = 1.6, J2,3 = 3.4 Hz, 1 H, 2B-H), 5.25–5.21 (m, 2 H, 
1B-H, trans OCH2CH=CHH), 5.08 (dd, Jvic = 10.2, Jgem = 1.8 Hz, 1 H, cis 
OCH2CH=CHH), 4.95 (d, Jgem = 11.0 Hz, 1 H, OCHHPh), 4.90 (d, Jgem = 11.0 Hz, 1 H, 
OCHHPh), 4.79 (d, Jgem = 12.0 Hz, 1 H, OCHHPh), 4.72–4.62 (m, 3 H, 3 OCHHPh), 
4.19 (dd, Jgem = 12.0, Jvic = 5.0 Hz, 1 H, OCHHCH=CH2), 4.12–4.05 (m, 2 H, 3A-H, 
OCHHCH=CH2), 3.98 (dd, J3,2 = 3.2, J3,4 = 9.2 Hz, 1 H, 3B-H), 3.91–3.65 (m, 4 H, 2A-H, 
4A-H, 5A-H, 5B-H), 3.51 (t, J4,5 = J4,3 = 9.6 Hz, 1 H, 4B-H), 2.06 (s, 3 H, CH3CO), 1.32 (d, 
J6,5 = 6.2 Hz, 3 H, 6B-H), 1.29 (d, J6,5 = 6.2Hz, 3 H, 6A-H) ppm. 
13C NMR (CDCl3, 50 
MHz): δ = 169.2, 165.5 (2 CO), 138.6, 137.8, 137.5 (3 Cipso-Bn), 134.6 (OCH2CH=CH2), 
133.1 (Cipso-Bz), 129.8–125.3 (C-Ar), 117.1 (OCH2CH=CH2), 99.5 (C-1B), 91.2 (C-1A), 
80.1, 79.9, 77.6, 77.4, 76.7, 75.5, 75.2, 72.6, 72.5, 70.6, 69.6, 68.4 (C-2A, C-2B, C-3A, C-3B, 
C-4A, C-4B, C-5A, C-5B, 3 OCH2Ph, OCH2CH=CH2), 21.0 (CH3CO), 18.2, 18.1 (C-6A, C-
6B) ppm. MS (MALDI-TOF): calcd. for C45H50O11 [M]
+ 766.34; found 789.42 [M + 
Na]+. C45H50O11 (766.87): calcd. C 70.48, H 6.57; found C 70.28, H 6.34. 
 
Acetyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2,4-di-O-benzyl- L-fucopy-
ranoside (41): 1H NMR (300 MHz, CDCl3) (α-anomer): δ = 7.42–7.32 (m, 10 H, Ar-H), 
6.44 (d, J1,2 = 2.7 Hz, 1 H, 1A-H), 5.41 (dd, J5,4 = 9.9, J5,6 = 3.6 Hz, 1 H, 3B-H), 5.20 (dd, 
J2,3 = 3.6, J2,1 = 1.8Hz, 1 H, 2B-H), 5.06 (t, J4,3 = J4,5 = 9.9 Hz, 1 H, 4B-H), 5.00 (s, 1 H, 
1B-H), 4.93 (d, Jgem = 11.1 Hz, 1 H, OCHHPh), 4.71 (d, Jgem = 11.4 Hz, 1 H, OCHHPh), 
4.62 (d, Jgem = 11.4 Hz, 1 H, OCHHPh), 4.60 (d, Jgem = 11.1 Hz, 1 H, OCHHPh), 4.18 
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(dq, J5,4 = 9.9, J5,6 = 6.3 Hz, 1 H, 5B-H), 4.12 (d, J4,3 = 2.4 Hz, 1 H, 4A-H), 3.99 (q, J5,6 = 
6.6 Hz, 1 H, 5A-H), 3.69–3.61 (m, 2 H, 2A-H, 3A-H), 2.16, 2.11, 2.03, 2.00 (4 s, 12 H, 4 
CH3CO), 1.18 (d, J6,5 = 6.6 Hz, 3 H, 6A-H), 0.98 (d, J6,5 = 6.3 Hz, 3 H, 6B-H) ppm. 
13C 
NMR (CDCl3, 75 MHz) (α anomer): δ = 170.3, 169.9, 169.7, 169.3 (4 CO), 137.9, 137.7 
(2 Cipso-Bn), 128.9–127.7 (C-Ar), 94.1 (C-1B), 90.6 (C-1A), 76.1, 75.6, 74.3, 73.4, 73.0, 
70.9, 70.3, 69.0, 68.9, 66.5 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 2 OCH2Ph), 
21.0–20.7 (4 CH3CO), 17.0, 16.8 (C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. for 
C34H42O13 [M]
+ 658.26; found 680.88 [M + Na]+. C34H42O13 (658.69): calcd. C 62.00, H 
6.43; found C 62.18, H 6.61. 
 
4,5-di-O-acetyl-2,3-di-O-benzyl-D-quinovose (42): [α]D +10 (c 0.4; CH2Cl2); 
1H 
NMR (400 MHz, CDCl3): δ 9.73 (s, 1H, CHO), 7.36-7.23 (m, 10H, H-Ar), 5.35 (dd, 1H, 
J4,5 6.4 Hz, J4,3 3.0 Hz, H-4), 5.10 (quintet, 1H, J5,4=J5,6 6.4 Hz, H-5), 4.77 (d, 1H, Jgem 12.0 
Hz, OCHHPh), 4.57 (s, 2H, OCH2Ph), 4.52 (d, 1H, Jgem 12.0 Hz, OCHHPh), 3.92 (m, 
2H, H-2, H-3), 2.02 (s, 3H, CH3CO), 1.97 (s, 3H, CH3CO), 1.19 (d, 3H, J6,5 6.4 Hz, H-
6); 13C NMR (100 MHz, CDCl3): δ 201.1 (CHO), 169.9, 169.7 (2 CO), 136.9, 136.8 (2 
Cipso-Bn), 128.6-128.0 (C-Ar), 80.6, 77.5, 74.1, 73.2, 72.1, 68.6 (C-2, C-3, C-4, C-5, 2 
OCH2Ph), 21.2, 20.8 (2 CH3CO), 15.8 (C-6). MALDI TOF-MS: calcd for C24H28O7 
(m/z), 428.18; found, 451.01 [M+Na]+. Anal Calcd for C24H28O7: C, 67.28; H, 6.59. 
Found: C, 67.09; H, 6.49. 
 
1,1,4,5-tetra-O-acetyl-2,3-di-O-benzyl-D-quinovose acetal (43): [α]D +19 (c 0.5; 
CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.34-7.28 (m, 10H, H-Ar), 6.97 (d, 1H, J1,2 3.2 
Hz, H-1), 5.24 (d, 1H, J4,5 5.9 Hz, J4,3 3.2 Hz, H-4), 5.16 (quintet, 1H, J5,4=J5,6 6.2 Hz, H-
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5), 4.78 (d, 1H, Jgem 10.9 Hz, OCHHPh), 4.74 (d, 1H, Jgem 11.6 Hz, OCHHPh), 4.71 (d, 
1H, Jgem 11.6 Hz, OCHHPh, 4.52 (d, 1H, Jgem 10.9 Hz, OCHHPh), 3.81 (m, 2H, H-2, H-
3), 2.09 (s, 3H, CH3CO), 2.08 (s, 3H, CH3CO), 2.03 (s, 3H, CH3CO), 1.97 (s, 3H, 
CH3CO), 1.21 (d, 3H, J6,5 6.2 Hz, H-6); 
13C NMR (100 MHz, CDCl3): δ 170.2, 170.0, 
168.7, 168.5 (4 CO), 137.7, 137.5 (2 Cipso-Bn), 128.6-127.8 (C-Ar), 88.1 (C-1), 78.0, 76.1, 
74.7, 74.1, 73.3, 69.2 (C-2, C-3, C-4, C-5, 2 OCH2Ph), 21.1, 20.9, 20.8, 20.7  (4 CH3CO), 
15.8 (C-6). MALDI TOF-MS: calcd for C28H34O10 (m/z), 530.22, found, 552.89 
[M+Na]+. Anal Calcd for C28H34O10: C, 63.39; H, 6.46. Found: C, 63.11; H, 6.24. 
 
1.11 1,5-di-O-acetyl-2,3-di-O-benzyl-D-quinovofuranose (44): 1H NMR (400 MHz, 
CDCl3): δ 7.36-7.24 (m, 10Hα + 10Hβ, H-Ar), 6.35 (d, 1Hα, J1,2 4.2 Hz, H-1α), 6.16 (bs, 
1Hβ, H-1β), 5.24 (dq, 1Hβ, J5,6 7.4 Hz, J5,6 6.3 Hz, H-5β), 5.18 (dq, 1Hα, J5,6 6.2 Hz, J5,4 4.5 
Hz, H-5α), 4.64 (m, 2Hα+ 1Hβ, 2 OCHHPhα + OCHHPhβ), 4.58 (d, 1Hα, Jgem 12.0 Hz, 
OCHHPhα), 4.55 (d, 1Hβ, Jgem 12.0 Hz, OCHHPhβ), 4.50 (d, 1Hα, Jgem 11.5 OCHHPhα), 
4.48 (d, 1Hβ, Jgem 12.0 Hz, OCHHPh ), 4.41 (d, 1Hβ, Jgem 12.0 Hz, OCHHPhβ), 4.36 (dd, 
1Hα, J4,3 5.8 Hz, J4,5 4.5 Hz, H-4α), 4.29 (dd, 1Hβ, J4,5 7.4 Hz, J4,3 5.0 Hz, H-4β), 4.12 (m, 
2Hα, H-2α, H-3α), 4.04 (bs, 1Hβ, H-2β), 4.03 (dd, 1Hβ, J3,4 5.0 Hz, J3,2 1.3 Hz, H-3β), 2.09 
(s, 3Hα, CH3COα), 2.04 (s, 3Hβ, CH3COβ), 1.97 (s, 3Hα, CH3COα), 1.91 (s, 3Hβ, 
CH3COβ), 1.34 (d, 3Hα, J6,5 6.2 Hz, H-6α), 1.30 (d, 3Hα, J6,5 6.2 Hz, H-6α);  
13C NMR (100 
MHz, CDCl3): δ 170.1, 169.9 (2 COα), 170.1, 169.8 (2 COβ), 137.6, 137.2 (2 Cipso-Bnα), 
137.4, 137.1 (2 Cipso-Bnβ), 128.5-127.5 (C-Ar), 100.2 (C-1β), 94.4 (C-1α), 84.5, 84.2, 80.5, 
72.1, 72.0, 68.6 (C-2β, C-3β, C-4β, C-5β, 2 OCH2Phβ), 83.2, 80.0, 77.0, 73.3, 72.6, 69.0 (C-
2α, C-3α, C-4α, C-5α, 2 OCH2Phα), 21.2-21.1 (2 CH3COα + 2 CH3COβ), 17.2 (C-6β), 15.8 
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(C-6α). MALDI TOF-MS: calcd for C24H28O7 (m/z), 428.18; found, 451.39 [M+Na]
+. 
Anal Calcd for C24H28O7: C, 67.28; H, 6.59. Found: C, 66.99; H, 6.38. 
 
2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-1,1,4,5-tetra-O-acetyl-2-O-benzyl-
D-quinovose Acetal (46): [α]D = –15 (c = 0.1, CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ 
= 7.36 (m, 5 H, Ar-H), 6.95 (d, J1,2 = 3.2 Hz, 1 H, 1A-H), 5.33 (s, J4,3 = 2.3 Hz, 1 H, 4A-
H), 5.28 (dd, J3,4 = 10.0, J3,2 = 4.8Hz, 1 H, 3B-H), 5.19 (dd, J2,3 = 4.8, J2,1 = 3.2 Hz, 1 H, 
2B-H), 5.11 (q, J5,6 = 6.3 Hz, 1 H, 5A-H), 5.06 (t, J4,3 = J4,5 = 10.0 Hz, 1 H, 4B-H), 5.03 
(br. s, 1 H, 1B-H), 4.75 (d, Jgem = 11.6 Hz, 1 H, OCHHPh), 4.70 (d, Jgem = 11.5 Hz, 1 H, 
OCHHPh), 4.06 (dd, J3,2 = 6.8, J3,4 = 2.3Hz, 1 H, 3A-H), 4.00 (dq, J5,4 = 10.0, J5,6 = 6.4 
Hz, 1 H, 5B-H), 3.80 (dd, J2,3 = 6.8, J2,1 = 3.2 Hz, 1 H, 2A-H), 2.10, 2.07, 2.06, 2.05, 2.04, 
2.03, 1.97 (7 s, 21 H, 7 CH3CO), 1.24 (d, J6,5 = 6.3 Hz, 3 H, 6A-H), 1.21 (d, J6,5 = 6.4 Hz, 
3 H, 6B-H) ppm. 
13C NMR (CDCl3, 100 MHz): δ = 170.1, 170.0, 169.9, 169.7, 168.6, 
168.5, 168.4 (7 CO), 134.7 (Cipso-Bn), 128.4–127.9 (C-Ar), 100.8, 98.9 (C-1A, C-1B), 87.7, 
74.5, 74.1, 72.9, 70.9, 69.6, 69.0, 68.8, 67.5 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-
5B, OCH2Ph), 21.1–20.7 (7 CH3CO), 17.3, 15.8 (C-6A, C-6B) ppm. MS (MALDI-TOF): 
calcd. for C33H44O17 [M]
+ 712.29; found 734.61 [M + Na]+. C33H44O17 (712.69): calcd. C 
55.61, H 6.22; found C 55.42, H 6.10. 
 
Acetyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-5-O-acetyl-2-O-benzyl-D-
quinovofuranoside (47): 1H NMR (300 MHz, CDCl3) (β-anomer): δ = 7.31 (m, 5 H, 
Ar-H), 6.21 (s, 1 H, 1A-H), 5.25–5.00 (m, 4 H, 2B-H, 3B-H, 4B-H, 5A-H), 4.76 (s, 1 H, 1B-
H), 4.69 (d, Jgem = 11.7 Hz, 1 H, OCHHPh), 4.60 (d, Jgem = 11.7 Hz, 1 H, OCHHPh), 
4.36 (dd, J4,5 = 7.2, J4,3 = 4.5 Hz, 1 H, 4A-H), 4.29 (d, J3,4 = 4.5 Hz, 1 H, 3A-H), 4.08 (s, 1 
Chapter 2:Acetolysis of 6-deoxysugar 
 
89 
 
H, 2A-H), 3.79 (dq, J5,4 = 9.3, J5,6 = 6.3 Hz, 1 H, 5B-H), 2.15, 2.09, 2.06, 2.04, 1.98 (5 s, 15 
H, 5 CH3CO), 1.38 (d, J6,5 = 6.3 Hz, 3 H, 6A-H), 1.24 (d, J6,5 = 6.3 Hz, 3 H, 6B-H) ppm. 
13C NMR (CDCl3, 75 MHz) (β-anomer): δ = 170.1–169.6 (5 CO), 136.8 (Cipso-Bn), 
128.5–127.7 (C-Ar), 99.2 (C-1B), 95.8 (C-1A), 84.2, 83.6, 76.9, 72.4, 70.6, 69.8, 68.9, 68.5, 
67.5 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, OCH2Ph), 21.3–20.7 (5 CH3CO), 
17.6, 17.2 (C-6A, C-6B) ppm. MS (MALDI-TOF): calcd. for C29H38O14 [M]
+ 610.23; 
found 632.97 [M + Na]+. C29H38O14 (610.60): calcd. C 57.04, H 6.27; found C 57.00, H  
6.24. 
 
Acetyl 2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl-(1→3)-2,4-di-O-benzyl-D-
quinovopyranoside (48): 1H NMR (400 MHz, CDCl3) (α-anomer): δ = 7.34–7.24 (m, 
10 H, Ar-H), 6.25 (d, J1,2 = 3.6 Hz, 1 H, 1A-H), 5.39–5.28 (m, 3 H, 1B-H, 2B-H, 3B-H), 
4.99 (t, J4,3 = J4,5 = 9.9 Hz, 1 H, 4B-H), 4.86 (d, Jgem = 11.1 Hz, 1 H, OCHHPh), 4.72 (d, 
Jgem = 11.1 Hz, 1 H, OCHHPh), 4.63 (d, Jgem = 11.1 Hz, 1 H, OCHHPh), 4.50 (d, Jgem = 
11.1 Hz, 1 H, OCHHPh), 4.10 (t, J3,4 = J3,2 = 9.6Hz, 1 H, 3A-H), 4.05 (dq, J5,4 = 9.9, J5,6 
= 6.3 Hz, 1 H, 5B-H), 3.91 (dq, J5,4 = 9.6, J5,6 = 6.3 Hz, 1 H, 5A-H), 3.66 (dd, J2,3 = 9.6, 
J2,1 = 3.3 Hz, 1 H, 2A-H), 3.17 (t, J4,3 = J4,5 = 9.6 Hz, 1 H, 4A-H), 2.13, 2.07, 2.01, 1.94 (4 
s, 12 H, 4 CH3CO), 1.32 (d, J6,5 = 6.3 Hz, 3 H, 6A-H), 0.91 (d, J6,5 = 6.3 Hz, 3 H, 6B-H) 
ppm. 13C NMR (CDCl3, 75 MHz) (α-anomer): δ = 170.0, 169.8, 169.7, 169.4 (4 CO), 
137.6, 136.9 (2 Cipso-Bn), 128.9–127.3 (C-Ar), 97.6 (C-1B), 89.0 (C-1A), 81.9, 79.8, 75.4, 
75.0, 72.8, 71.0, 69.6, 69.5, 69.2, 66.4 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, 2 
OCH2Ph), 21.0–20.8 (4 CH3CO), 18.0, 17.1 (C-6A, C-6B) ppm. MS (MALDI-TOF): 
calcd. for C34H42O13 [M]
+ 658.26; found 681.15 [M + Na]+. C34H42O13 (658.69): calcd. C 
62.00, H 6.43; found C 62.20, H 6.56. 
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3.1 The prokaryotic cell-wall 
 
The cell wall is the layer, usually fairly rigid, that lies just outside the plasma membrane. 
It is one of the most important part of a prokaryotic cell for several reasons. Most 
bacteria have strong walls that give them shape and protect them from the osmotic lysis 
and its components can contribute to the pathogenicity of the bacteria. Moreover, the 
wall can protect the cell from toxic substances and is the site of action of several 
antibodies. 
Bacteria can be divided into two major groups based on their response to the Gram-
stain procedure: Gram-positive and Gram-negative bacteria. The advent of the 
transmission electron spectroscopy made clear the structural differences between these 
two types of bacteria.  The Gram-positive bacterial cell wall consists of a single 20 to 80 
nm thick homogeneous peptidoglycan or murein layer lying outside the plasma membrane. 
In contrast, Gram-negative cell wall is quite complex: it has in fact a 2 to 7 nm 
FIG. 3.1: Gram-Positive And Gram-Negative Cell Walls. The Gram-positive envelope is from Bacillus lichteniformis 
(left), and the Gram-negative micrograph is of Aquaspirillum serpens (right). 
Chapter 3: Synthesis of biologically relevant peptidoglycan fragments 
 
91 
 
173 peptidoglycan layer surrounded by a 7 to 8 nm outer membrane. 
 
3.1.1 Gram-positive Cell Walls 
 
The thick homogeneous cell wall of Gram-positive bacteria is composed primarily of 
peptidoglycan. Usually Gram-positive cell walls contain large amounts of teichoic acids, 
polymers of glycerol or ribitol joined 
by phosphate groups. Amino acids 
such as D-alanine or sugars like 
glucose are attached to the glycitol 
or ribitol groups (FIG. 3.2). The 
teichoic acids are connected to 
either the peptidoglycan itself by a 
covalent bond with hydroxyl of N-
acetylmuramic acid or to plasma membrane lipids: in the latter case they are called 
lipoteichoic acids. Teichoic acids appear to extend to the surface of peptidoglycan, and, 
because they are negatively charged, give the Gram-positive cell wall its negative charge. 
The functions of these molecules are still unclear, but they may be important in 
maintaining the structure of the wall. Teichoic acids are not present in Gram-negative 
bacteria. 
 
 
 
                                                 
173 (a) Matias, V.R.; Al-Amoudi, A.; Dubochet, J.; Beveridge, T.J. J Bacteriol. 2003, 185, 6112; (b) Vollmer, 
W.; Höltje, J.V. J. Bacteriol. 1990, 186, 5978. 
FIG.3.2: The Gram-positive envelope. 
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3.1.2 Gram-negative Cell Walls 
The Gram-negative cell wall (FIG.3.3) is much more complex than Gram-positive cell 
wall. The thin peptidoglycan layer next to the plasma membrane may constitute not 
more than 5 to 10% of the cell wall. 
The outer membrane lies outside 
the thin peptidoglycan layer. The 
most abundant protein present in 
Gram-negative cell wall is the 
Brown’s protein, a small lipoprotein 
covalently joined to the underlying 
peptidoglycan and embedded in the outer membrane by its hydrophobic end. The outer 
membrane and peptidoglycan are so firmly linked by this lipoprotein that they can be 
isolated as one unit. The most particular component of the Gram-negative cell wall are 
the lipopolysaccharides (LPS). These large macromolecules contain both lipid and 
carbohydrate moieties and 
consist of three parts: (1) lipid A; 
(2) the core oligosaccharide and 
(3) the O-side chain. The lipid A 
is formed by two units of 
glucosamine linked together by a 
β-(1→6) glycosidic bond. Each 
glucosamine residue has three 
fatty acids and phosphate or pyrophosphate groups attached. It is bound to the outer 
membrane and the remainder of LPS molecule projects from the surface. The core 
FIG. 3.3: The Gram-negative envelope. 
FIG. 3.4: A chemical model of the Gram-negative outer 
membrane 
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oligosaccharide is joined both to lipid A and to the O-antigen. It is constructed of a 
limited number of sugars some of which are peculiar for this region such as KDO (3-
deoxy-D-manno-2-octulu-sonic acid). The core oligosaccharides possess a more 
conservative structure when compared with those of the O-specific polysaccharides. 174 
The O-side chain or O-antigen is a polysaccharide chain extending outward from the 
core. It is constituted of several sugars and varies even in the same bacterial strain. 
Although O-side chains are readily recognized by host antibodies, Gram-negative 
bacteria may thwart host defenses by changing the nature of their O-side chains to avoid 
detection. LPS is important for several reasons other than the avoidance of host 
defenses. Since the core polysaccharides contain charged sugars and phosphates, LPSs 
help stabilize membrane structure. Furthermore, lipid A is often toxic; as a result LPS 
can act as endotoxin and causes some of the symptoms that arise in Gram-negative 
bacterial infections. 
 
3.1.3 Peptidoglycan: a closer look 
 
As anticipated before peptidoglycan (PGN) is one of the most important component of 
the bacterial cell-wall. Its main function is to preserve cell integrity by withstanding the 
turgor; it also contributes to the maintenance of a well defined shape and serves as a 
scaffold for anchoring other cell wall components such as proteins 175 and teichoic acids 
176 and is involved in the division processes. 177 
                                                 
174 Holst, O. In Endotoxin in Health and Disease, Brade, H.; Opal, S.M.; Vogel, S.N.; Morrison, C.D. Ed., 
Marcel Dekker Inc, New York, 1999. 
175 Dramsi, S.; Davison, S.; Magnet, S.; Arthur, M. FEMS Microbiol Rev. 2008, 32, 307. 
176 Neuhaus, F.C.; Baddiley, J. Microbiol. Mol. Biol. Rev. 2003, 67, 686. 
177 Nanninga, N. Microbiol. Mol. Biol. Rev. 1998, 62, 110. 
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The main structural features of peptidoglycan are linear glycan strands cross-linked by 
short peptides. The glycan strands are made up of alternating β-1→4 linked N-acetyl-D-
glucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) residues cross-linked by 
peptide chains. Four to five amino acids are linked to the lactyl group of each MurNAc 
residue. The amino acids occur in alternating L and D isomers (whose presence protects 
against the attack of most peptidase) and include γ-
bonded-D-glutamic acid, non-protein  amino acids like 
diaminopimelic acid (DAP), ornithine or lanthionine, 
in combinations typical for the bacterial species. These 
amino acids cross-link the glycan backbones, usually 
via the free amino group of a basic amino acid, such as 
L-lysine (Lys) or meso-DAP, for Lys-type or DAP-type 
PGN, and a terminal free carboxyl group, frequently 
D-alanine. 178 The peptide structure of a Gram-negative 
bacterium is commonly L-Ala-γ-D-Glu-meso-DAP-D-Ala-D-Ala, where the dibasic meso-
                                                 
178 Schleifer, K.H.; Kandler, O. Bacteriol. Rev. 1972, 36, 407. 
FIG. 3.5: Schematic representation of Gram-positive and Gram-negative peptidoglycan. 
FIG. 3.6 Peptidoglycan Cross-Links: (a) 
E. coli peptidoglycan with direct cross-
linking, typical of many Gram-negative 
bacteria. (b) Staphylococcus aureus 
peptidoglycan. S. aureus is a Gram-positive 
bacterium.  
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DAP is the cross-linking peptide. The typical structure of PGN of Gram-positive 
bacteria is L-Ala-γ-D-Glu-L-Lys-D-Ala-D-Ala, with an interpeptide bridge often made up 
of a chain of five Gly between the Lys side chain and the Ala of neighboring chain (FIG. 
3.6). 179 
Peptidoglycan is not only an essential structural component of the bacterial cell wall, but 
is also involved in diverse biological processes, such as microbial pathogenesis, 
symbiotic associations and a range of interactions between bacteria and other organisms. 
In particular the importance of 
peptidoglycan detection in the host 
immune response has acquired great 
relevance nowadays. It has been 
demonstrated in fact that peptidoglycan 
fragments generated during bacterial 
division and growth can be detected in 
mammals, 180 insects 181 and plants, by 
PGRP proteins (―PG Recognition Protein‖) 
and can stimulate innate immunity that is the first line of defense against infections by 
microbes: 182 PGN fragments are in fact considered PAMPs (―Pathogen Associated 
Molecular Patterns‖) and are therefore recognized by PRRs (―Pattern Recognition Receptors‖). 
These recognition process lead, through activation of transcription factors such as NF-
KB and IRF3, to the production of pro- and anti-inflammatory cytokines, chemokines 
                                                 
179 Navarre, W.W.; Schneewind, O. Microbiol. Mol. Biol. Rev. 1999, 63, 174. 
180 Le Bourhis, L.; Wertz, C. Microbes and Infection 2007, 9, 629. 
181 (a) Gobert, V.; Gottar, M.; Matskevich, A.A.; Rutschmann, S.; Royet, J.; Belvin, M.; Hoffmann, J.A.; 
Ferrandon, D. Science 2003, 302, 2126; (b) Chang, C.I.; Pili-Floury, S.; Herve, M.; Parquet, C.; Chelliah, Y.; 
Lemaitre, B.; Mengin-Lecreulx, D.; Deisenhofer, J. PLoS Biol. 2004, 2, E277. 
182 Hoffmann, J.A., Kafatos, F.C., Janeway, C.A., Ezekowitz, R.A.B. Science 1999, 284, 1313. 
FIG. 3.7: Recognition of peptidoglycans (PGNs) by 
immune-competent cells in Drosophila and 
mammals. A major distinction exists between PGN 
accessibility of Gram-positive and Gram-negative bacteria. 
While Gram-positive bacteria have their PGN exposed for 
direct recognition by small PGRPs, Gram-negative bacteria 
have their PGN between the cytoplasmatic membrane and 
outer membrane . Hence, their detection by PGRPs occurs 
most likely via recognition of PGN fragments release 
during PG turmover. 
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and to to the expression of co-stimulatory molecules on antigen presenting cells. the 
PRRs involved in the recognition mechanism are different for different species. In FIG. 
3.7, it is schematically reported the way of interaction of PGN fragments in flies (such 
as Drosophila melanogaster) and in mammals and it is clearly showed that the way of 
interaction and the receptors involved are completely different. In the case of plants it 
has been also demonstrated that peptidoglycan can be recognized but  the mechanism 
of interaction and the species involved are still unclear. 183 In order to impair the 
detection by host innate immune receptors and to enhance the resistance to antibiotics 
and host degradative enzymes that target the bacterial cell wall, 184 PGN structures can 
be modified in both the peptide stem FIG. 3.8) and bridge regions and in the glycan 
strands. 185 
 
FIG. 3.8: Most common variation in peptide stem (a) and in the cross-linking (b and c). Amino acids with a 
star (*) are formed by a secondary modification during peptidoglycan biosynthesis. 
The most common modifications of the glycan strands are reported in FIG. 3.9: these 
include N-deacetylation (at GlcN, MurN or both), N-glycolylation (at MurN), O-
acetylation (at MurNAc), the formation of a muramic-δ-lactam (in all Gram-negative  
 
                                                 
183 (a) Gust, A.A.; Biswas, R.; Lenz, H.D.; Rauhut, T.; Ranf, S.; Kemmerling, B.; Götz, F.; Glawischnig, E.; 
Lee, G.; Felix, G.; Nürnberger, T. J. Biol. Chem. 2007, 282, 32338; (b) Silipo, A.; Erbs, G.; Shinya, T.; Dow, 
J.M.; Parrilli, M.; Lanzetta, R.; Shibuya, N.; Newman, M.A.; Molinaro, A. Glycobiology 2010, 20, 406. 
184 Humann, J.; Lenz, L.L. J. Innate Immun. 2009, 1, 88. 
185 For a detailed review on structural variation of peptidoglycan structures see: Vollmer, W.; Blanot, D.; 
de Pedro, M.A. FEMS Microbiol Rev. 2008, 32, 149. 
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FIG. 3.9: Modification in the glycan strands. The name of some species containing the modifications in their peptidoglycan are indicated.  
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bacteria), the attachment of surface polymers (e.g. teichoic acids or capsular 
polysaccharides via phosphodiester bonds to their GlcNAc or MurNAc residues). 
Among these modifications N-deacetylation has acquired great relevance because of its 
influence on recognition processes. The presence of deaceylated sugars in peptidoglycan 
strands strongly reduces the activity of the muramidase lysozyme, the enzyme that is 
involved in the hydrolysis of the glycan strands. The absence of acetyl groups indeed 
destabilizes the interaction between a hexasaccharide glycan strand and amino acids in 
the long groove of the lysozyme reducing its activity. 186 It is worth noting that the 
activity of the lysozyme can be restored by chemical acetylation of the substrate. 187 
Moreover, it is likely that the effect of peptidoglycan deacetylation on the interaction 
with host might be multifactorial and not restricted to the effect on lysozyme activity. 
Deacetylation introduces additional positive charges into the cell wall, potentially 
affecting the binding of specific cell-wall proteins and other compounds such as 
capsular polysaccharides. In addition, increasing the positive charge of the cell wall is 
likely to increase the resistance of the bacterium to cationic antimicrobial peptides, 
which are important elements of the innate immune system. 188 The role of 
peptidoglycan in virulence has been largely investigated for the human-pathogen Gram-
positive Lysteria monocytogenes 189 where it has been demonstrated that the N-deacetylation 
enhances the resistance of the bacterium to the lysozyme. Recently, partially N-
deacetylated PGN fragments have been also isolated from the phythopathogenic Gram-
                                                 
186 (a) Blake, C.C.; Koenig, D.F.; Mair, G.A.; North, AC.; Phillips, D.C.; Sarma, V.R. Nature 1965, 206, 
757; (b) Vocadlo, D.J.; Davies, G.J.; Laine, R.; Withers, S.G. Nature 2001, 412, 835. 
187 (a) Westmacott, D.; Perkins, H.R. J. Gen. Microbiol. 1979, 115, 1; (b) Vollmer, W.; Tomasz, A. J. Biol. 
Chem. 2000, 275, 20496. 
188 Peschel, A. Trends Microbiol. 2002, 10, 179. 
189
 Boneca, I.G.; Dussurget, O.; Cabanes, D.; Nahori, M.A.; Sousa, S.; Lecuit, M.; Psylinakis, E.; Bouriotis, 
V.; Hugot, J.P.; Giovannini, M.; Coyle, A.; Bertin, J.; Namane, A.; Rousselle, J.C.; Cayet, N.; Prévost, 
M.C.; Balloy, V.; Chignard, M.; Philpott, D.J.; Cossart, P.; Girardin, S.E. Proc. Nat. Acad. Sci. U.S.A. 2007, 
104, 997. 
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negative bacterium Xanthomonas campestris pv campestris but in this case it seems that the 
N-deacetylation at GlcN site seems to enhance the immune response of the plant model 
Arabidopsis thaliana. 190 A fully comprehension of the influence of N-deacetylation is 
therefore not well defined and further studies are going on to clarify exactly how this 
modification affects the response of the immune system. 
 
3.1.3.1 Peptidoglycan hydrolysis and bacterial resuscitation 
 
The interest toward peptidoglycan structures has increased recently because it has been 
found that peptidoglycan can exert a controlling influence on non-growth states and is 
involved in reactivation process of several bacteria from dormancy. 191 In particular 
several human pathogen bacteria such as Escherichia coli, Helicobacter pylori, Legionella 
pneumophila, Listeria monocytogenes, Salmonella tiphymurium, Vibrio cholera and the most 
important medically Mycobacterium tuberculosis 192 can enter in a dormant state in which, 
crucially, they are insensitive to antibiotics.193 Peptidoglycan seems to be involved in 
such processes because in the dormant states cells have an altered peptidoglycan 
structure (similar modifications are found also in bacterial spores). 194 For example, 
Escherichia coli in the dormant state has a substantial increase in the degree of 
peptidoglycan cross-linking, an increase in lipoprotein-bearing muropeptides and a 
                                                 
190
 Erbs, G.; Silipo, A.; Aslam, S.; De Castro, C.; Liparoti, V.; Flagiello, V.; Pucci, P.; Lanzetta, R.; Parrilli, 
M.; Molinaro, A.; Newmann, M.A.; Cooper, R.M. Chem.Biol. 2008, 15, 438. 
191 (a) Dworkin, J.; Shah, I.M. Nature Microb. 2010, 8, 890; (b) Keep, N.H.; Ward, J.M.; Cohen-Gonsaud, 
M.; Henderson, B. T. TRENDS in Microbiology 2006, 14, 271. 
192 Oliver, J.D. J. Microbiol. 2005, 43, 93. 
193 Hu, Y.; Coates, A.R.M. In Dormancy and Low-Growth States in Microbial Deseases, Coates A.R.M. Ed., 
Cambridge University Press, 2003, 1. 
194 Atrih, A.; Foster, S.J. Antonie Van Leeuwenhoek 1999, 75, 299. 
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shortening of the chain length of glycan strands. 195 Also Enterococcus feacalis exhibits 
qualitatively similar modifications in peptidoglycan 196 and, recently, it has been shown 
that also O-acetylation is increased. 197  
The most important discovery in the analysis of the resuscitation process has been the 
understanding of non-growth states for the high G+C Gram-positive 198 Actinobacter 
Micrococcus luteus (lysodeiktikus), whose cells could be resuscitated by exposure to non-
dormant Micrococcus luteus, this suggesting that cell-cell interaction are required to exit 
from dormancy. 199 It was established that resuscitation was caused by a protein which 
was therefore called Rpf (resuscitation promoting factor). The Rpf protein was found to 
be extremely potent and exhibited activity at low picomolar concentrations. 200 
Inactivation of the Micrococcus luteus rpf gene was not possible, which indicated the 
essential nature of Rpf for cell survival. 201 In the case of Mycobacterium tuberculosis, five 
resuscitation promoting factors have been found (RpfA-E), which are responsible for 
the revival of the bacterium from dormancy. 202 A key enzyme for M. tuberculosis cell 
division is resuscitation promoting factor interacting protein (RipA), which is believed 
to cleave peptidoglycan cross-links 203 but its mechanism of action is still unknown and 
                                                 
195 Signoretto, C.; Lleò; M.M.; Canepari, P. Curr Microbiol. 2002, 44, 125. 
196 Signoretto, C.; Lleò, M.M.; Tafi, M.C.; Canepari, P. Appl. Environ. Microbiol. 2000, 66, 1953. 
197 Pfeffer, J.M.; Strating, H.; Weadge, J.T.; Clarke, A.J. J. Bacteriol. 2006, 188, 902. 
198 The H+G bacteria are a family of bacteria that are phylogenetically related for a high content of guanine 
and cytosine in the sequence of 16SrRNAs isolated from 30S subunits of prokaryotic ribosomes. The 
vantages of this phylogenetic classification are due to the low variations of their structure with time, 
presumably because of their constant and critical role: rRNAs are almost ideal for studies of microbial 
evolution and relatedness since they are essential to a critical organelle found in all microorganisms. 
199 Votyakova, T.V.; Kaprelyants, A.S.; Kell, D.B. Appl. Env. Microbiol. 1994, 60, 3284. 
200 Mukamolova, G.V.; Kaprelyants, A.S.; Young, D.I.; Young, M.; Bell, D.B. Proc. Nat. Acad. Sci. U.S.A.  
1998, 95, 8916. 
201 Mukamolova, G.V.; Turapov, O.A.; Kazarian, K.; Telkov, M.; Kaprelyants, A.S.; Kell, D.B.; Young, M. 
Mol. Microbiol. 2002, 46, 611. 
202 (a) Downing, K.J.; Mischenko, V.V.; Shleeva, M.O.; Young, D.I.; Kaprelyants, A.S.; Apt, A.S.; Mizrahi, 
V. Infect. Immunol. 2005, 73, 3038; (b) Kana, B.D.; Gordhan, B.G.; Downing, K.J.; Sung, N.; 
Vostroktunova, G.; Machowski, E.E.; Tsenova, L.; Young, M.; Kaprelyants, A.; Kaplan, G.; Mizrahi, V. 
Mol. Microbiol. 2008, 67, 672. 
203 Hett, E,C.; Rubin, E.J. Microbiol. Mol. Biol. Rev. 2008, 72, 126. 
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is object of several studies. 204 It is in fact still unclear how peptidoglycan hydrolysis is 
linked to the reactivation growth. One of the most accredited possibility is that cleavage 
of the cell walls of the dormant bacteria is required, perhaps in a specific region such as 
the septum, and that the resuscitation factor overcomes a physical requirement for cell 
expansion or division. 205 This activity could be provided by Rpfs during normal growth 
but these enzymes are downregulated during stationary phase and become limiting for 
further growth. In this case, cell-cell signaling is carried out by diffusion of Rpfs 
themselves. In confirmation of this, two of the five M. tuberculosis RPFs (RpfC and 
RpfB) are secreted to the medium, whereas the others are likely to be attached to the 
peptidoglycan of the producing cell. 28 Moreover, it seems in some cases that the exit 
from dormancy can be favored also by a change of the external conditions or simply by 
the presence of muropeptides released by other growing microorganism. 30a 
 
FIG. 3.10: Exit from dormancy triggered by growing cells. a)  Dormant cells (beige) may sense some aspect of 
the environment before exiting dormancy and initiating growth (green cells). b) the presence of secreted signaling 
molecules such as cell wall muropeptides from growing cells (pale green) could serve as an indication that growth-
permissive conditions are present and could thereby stimulate exit from dormancy. 
                                                 
204 Ruggiero, A.; Marasco, D.; Squeglia, F.; Soldini, S.; Pedone, E.; Pedone, C.; Berisio, R. Structure 2010, 
18, 1184. 
205 (a) Ravagnani, A.; Finan, C.L.; Young, M. BMC Genomics 2005, 6, 39; (b) Mukamolova, G.V.; Murzin, 
A.G.; Salina, E.G.; Demina, G.R.; Kell, D.B.; Kapprelyants, A.; Young, M. Mol. Microbiol. 2006, 58, 84; (c) 
Cohen-Gonsaud, M.; Barthe, P.; Bagnèris, C.; Henderson, B.; Ward, J.; Roumestand, C.; Keep, N.H. Nat. 
Struct. Mol. Biol. 2005, 12, 270. 
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3.2 Results and Discussion 
 
In order to investigate the function of N-deacetylation in peptidoglycans and to obtain 
suitably substrates for the analysis of Rpf action in the resuscitation process, it has been 
developed a new strategy for the synthesis of a disaccharide moiety that could lead to 
the obtainment of both partially N-deacetylated peptidoglycan fragments at GlcN site 
and of a muramyl fragment in which two disaccharide units were linked by a peptide 
chain repeating the peptide bridge of the Gram-positive bacterium Micrococcus 
lysodeiktikus. Although in literature are present several chemical syntheses of 
peptidoglycan fragments, 206 there was no report on the synthesis of N-dacetylated-
GlcN-containing structures. The known syntheses of peptidoglycan fragments could not 
be applied to the synthesis of peptidoglycan fragments with a N-deacetylated GlcN unit 
because all necessitated to cleave the GlcN nitrogen atom protecting group and to 
acetylate it before coupling with the peptide chain. Therefore, GlcN and MurN nitrogen 
atoms had to be protected with orthogonal protecting groups, the GlcN one being able 
to liberate the amine at the final stage of the synthesis. Moreover, in order to open an 
access not only to peptidodisaccharide fragments but also to higher oligomers, the 
anomeric position of MurNAc unit and the position 4 of GlcN had to be protected with 
orthogonal protecting groups too. Finally, the eventuality of side-reactions involving the 
                                                 
206 (a) Inamura, S.; Fukase, K.; Kusumoto, S. Tetrahedron Lett. 2001, 42, 7613;(b) Kubasch, N.; Schmidt, R. 
R. Eur. J. Org. Chem. 2002, 2710; (c) Roy Chowdhury, A.; Siriwardena, A.; Boons, G.-J. Tetrahedron Lett. 
2002, 43, 7805; (d) Hesek, D.; Suvorov, M.; Morio, K.; Lee, M.; Brown, S.; Vakulenko, S. B.; Mobashery, 
S. J. Org. Chem. 2004, 69, 778; (e) Hesek, D.; Lee, M.; Morio, K.;Mobashery, S. J. Org. Chem. 2004, 69, 
2137; (f) Roy Chowdury, A.; Boons,G.-J. Tetrahedron Lett. 2005, 46, 1675; (g) Roy Chowdhury, A.; Wolfert, 
M.A.; Boons, G.-J. ChemBioChem 2005, 6, 2088; (h) Inamura, S.; Fujimoto, Y.;Kawasaki, A.; Shiokawa, Z.; 
Woelk, E.; Heine, H.; Lindner, B.; Inohara, N.; Kusumoto, S.; Fukase, K. Org. Biomol. Chem. 2006, 4, 232; 
(i) Narayan, R. S.;Van Nieuwenhze, M. S. Eur. J. Org. Chem. 2007, 1399; (j) Kawasaki, A.; Karasudani, Y.; 
Otsuka, Y.; Hasegawa, M.; Inohara, N.; Fujimoto, Y.; Fukase, K. Chem. Eur. J. 2008, 14, 10318; (k) Hesek, 
D.; Lee, M.; Zhang, M.; Noll, B.C.; Mobashery, S. J. Am. Chem. Soc. 2009, 131, 5187. 
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(R)-lactyl moiety during the manipulation of MurNAc building blocks (racemization, 
intramolecular lactonization at 4-hydroxy position), 207 suggested to introduce the lactyl 
ether at a late stage in the synthesis. All these constrains designed A as a proper 
disaccharide building block (FIG. 3.11). It could be obtained by a stereoselective 
coupling between suitably protected GlcN donor B and acceptor C. 
The glycosylation of a 4-hydroxy group in glucosamine acceptors presents some well-
known difficulties related to its low 
nucleophilicity. 208 Some methods were reported 
to address this problem; 209 among these 
protocols, we firstly focused our attention on the 
use of a N-acetyl-2,3-oxazolidinone protection 
210 on the glycosyl acceptor. Several building 
blocks were developed as glycosyl donors for the 
stereoselective synthesis of β-2-amino-2-
deoxyglucosides. 211 They generally present a N-2 protecting group capable of efficient 
participation via acyloxonium ion that guarantees 1,2-trans stereoselectivity These are 
very usually amido-, carbamato- or imido protecting groups. Unfortunately they could 
present some problems here in surviving as stable protecting groups — that is, during 
the cleavage of oxazolidinone — and/or in their final deprotection to free amine in the 
                                                 
207 Saha, S. L.; Van Nieuwenhze, M. S.; Hornback, W. J.; Aikins, J. A.; Blaszczak, L. C. Org. Lett. 2001, 3, 
3575. 
208 (a) Paulsen, H. Angew. Chem., Int. Ed. Engl. 1982, 21, 155; (b) Crich, D.; Dudkin, V. J. Am. Chem. Soc. 
2001, 123, 6819; (c) Liao, L.; Auzanneau, F.-I. Org. Lett. 2003, 5, 2607; (d) Lucas, R.; Hamza, D.; 
Lubineau, A.; Bonnaffé, D. Eur. J. Org. Chem. 2004, 2107. 
209 Crich, D.; Vinod, A. U. J. Org. Chem. 2005, 70, 1291 and references cited therein. 
210 Crich, D.; Vinod, A. U. Org. Lett. 2003, 5, 1297. 
211 A comprehensive review: Bongat, A. F. G.; Demchenko, A. V. Carbohydr. Res. 2007, 342, 374. 
FIG. 3.11: Protecting group pattern on 
glycosyl donor, acceptor and disaccaride. 
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FIG.3.12: Reagents and conditions: a) ref. 13; b) triphosgene, 2:1 v/v CH3CN/sat. aq. NaHCO3, rt, 60%; c) AcCl, DIPEA, CH2Cl2, rt, 92%; d) Et3SiH, TFA, AW-300 
4Å MS, CH2Cl2, 5°C, 57% for 4, 74% for 8, 77% for 13; e) i. TfN3, CuSO4, Et3N, py, 0°C; ii. BnBr, NaH, DMF, rt, 71% over two steps; f) PdCl2, 1:1 v/v 
CH2Cl2/MeOH, rt, 58% for 6, 80% for 10; g) Cl3CCN, DBU, CH2Cl2, rt, 78% for 7, 70% for 11; h) PMBCl, NaH, DMF, 0°C, 92%; i) i. TrocCl, NaHCO3, 2:1 
H2O/CH3CN, rt; ii. CbzCl, DMAP, CH2Cl2, rt, 70% over two steps. 
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presence of the peptide chain. To avoid any protecting group interconversion at a 
disaccharide level, an azide was selected as amino-masking group. Even if azide is 
incapable of neighboring group participation, it can be easily transformed into a free 
amine during final hydrogenolysis deprotection step. The known compound 1 212 was 
prepared in three steps from N-acetyl-glucosamine and served as key building block for 
the synthesis of both acceptor 4 and donor 7 (FIG. 3.12). An aliquot of 1 was treated 
with triphosgene 213 to give oxazolidinone 2 in 60% yield. Subsequent N-acetylation 
(92%) and regioselective benzylidene ring opening under reductive conditions 
(Et3SiH/TFA in CH2Cl2; 57%) 
214 afforded acceptor 4. Conversely, the treatment of 1 
with triflyl azide in pyridine 215 and subsequent benzylation of the 3-hydroxy group gave 
5 (71% over two steps), which was de-O-allylated with PdCl2 (58%) and then converted 
into the α-trichloroacetimidate donor 7. Unfortunately the coupling between 4 and 7 in 
a β-directing nitrile solvent gave no disaccharide (Table 3.1, entries 1 and 2). Given the 
torsional and electronic disarming effect of a 4,6-benzylidene protection on glycosyl 
donors, 216 a more reactive 2-azido-2-deoxyglucosyl donor was synthesized, having a 
benzyl at position 6 and a selectively cleavable p-methoxybenzyl group at position 4. It 
was obtained in four steps from 5 (FIG. 3.12). Regioselective reductive opening of the 
benzylidene ring gave 8 (74%), that was then treated with PMBCl and NaH to afford 9 
in 92% yield. De-O-allylation (80%) and subsequent treatment with Cl3CCN and DBU 
afforded the desired α-trichloroacetimidate 11 in 70% yield. 
                                                 
212 Gavard, O.; Hersant, Y.; Alais, J.; Duverger, V.; Dilhas, A.; Bascou, A.; Bonnaffé, D. Eur. J. Org. Chem. 
2003, 3603. 
213 Boysen, M.; Gemma, E.; Lahmann, M.; Oscarson, S. Chem. Commun. 2005, 3044. 
214
 de Ninno, M.P.; Etienne, J.B.; Duplantier, K.C. Tetrahedron Lett. 1995, 36, 669. 
215 Yan, R. B.; Yang, F.; Wu, Y.; Zhang, L.-H.; Ye, X.-S. Tetrahedron Lett. 2005, 46, 8993. 
216 (a) Jensen, H. H.; Nordstrøm, L. U.; Bols, M. J. Am. Chem. Soc. 2004, 126, 9205.  
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Again, the reaction of 4 and 11 in nitrile solvent gave no coupling (entry 3). Some 
scattered examples in the literature report the β-glycosylation of 2-azido-2- 
 
 
Table 3.1: Glycosylation Reactions (A Donor/acceptor molar ratio=1.6 unless otherwise stated; B Promoter 
equivalents calculated with respect to the donor; C Isolated yield unless otherwise stated; D detected by TLC and 
MALDI analysis; E Anomeric ratio measured by the isolation of two anomers; F Donor/acceptor molar ratio =2.3). 
Entry Acceptor  DonorA PromoterB Solvent T Disaccharide productC 
1 4 7 TMSOTf (0.02 eq.) CH3CN -20°C No reaction 
2 4 7 TMSOTf (0.2 eq.) CH3CN rt 14 (traces)D 
3 4 11 TMSOTf (0.02 eq.) Pivalonitrile Rt 15 (traces)D 
4 4 11 BF3∙OEt2 (0.6 eq.) 3:2 v/v CH2Cl2/hexane -30°C 15 (68%; β/α 1:1)E 
5F 4 11 BF3∙OEt2 (0.15 eq.) 3:2 v/v CH2Cl2/hexane -60°C 15 (68%; β/α 1.3:1)E 
6 14 7 BF3∙OEt2 (0.2 eq.) 3:2 v/v CH2Cl2/hexane -80°C 16 (traces)D 
7 14 11 BF3∙OEt2 (0.2 eq.) 3:2 v/v CH2Cl2/hexane -80°C 17 (81%; only β)E 
8 14 11 BF3∙OEt2 (0.2 eq.) 3:2 v/v CH2Cl2/hexane -30°C 17 (40%; only β)E 
9 14 11 BF3∙OEt2 (0.2 eq.) 3:2 v/v CH2Cl2/ CH3CN -30°C 17 (43%; only β)E 
10 14 11 TMSOTf (0.02 eq.) 3:2 v/v CH2Cl2/hexane -80°C 17 (71%; β/α 1:4)E 
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deoxyglycosyl-α-trichloroacetimidates under SN2 conditions. 
217 Therefore, the coupling 
between 4 and 11 was attempted at low temperature in a CH2Cl2–hexane solvent mixture 
with BF3∙OEt2 as catalyst (entry 4). Disaccharide 15 was obtained in 68% yield, but 
without any stereoselectivity. Higher donor/acceptor molar ratio and even milder 
activation conditions gave the same yield with an only slight excess of β-anomer (entry 
5). The low β/α stereoselectivity is not really surprising for glycosylations involving 2,3-
oxazolidinone GlcN acceptors. 37 Therefore, a new glycosyl acceptor (13) was designed, 
with the amino group protected as a trichloroethoxycarbamate (Troc), which affords 
greater GlcN-4-hydroxy reactivity than other carbamato- or imido-protecting groups. 218 
Compound 13 was synthesized from key building block 1 by N-
trichloroethoxycarbonylation and protection of the 3-hydroxy as benzyloxycarbonyl 
group (12, 70% over two steps), which were then subjected to Et3SiH/TFA benzylidene 
ring opening (77% for 13) (FIG. 3.12). The coupling between 13 and 7 was unsatisfying 
(entry 6), whereas glycosylation between 13 and 11 under BF3∙OEt2 catalysis in a CH2Cl2-
hexane solvent system at -78°C (typical SN2 reaction conditions) afforded disaccharide 
product 17 with a good yield and (entry 7). A higher temperature, a more polar solvent 
system or a stronger activator considerably reduced the yield of 17 (entries 8–10). 
Disaccharide 17 is a highly versatile building block. Exploiting the orthogonality of the 
allyl and PMB protecting group, it has been possible to obtain from 17 the disaccharide 
glycosyl acceptor 18 and the hemiacetals 19 from which a disaccharide glycosyl donor 
can be easily obtained installing a leaving group on the hemiacetal anomeric oxygen. 
These two molecules will be used for the synthesis of tetra- and octasaccharide muramyl 
fragments (FIG. 3.13). 
                                                 
217 Schmidt, R.R.; Behrendt, M.; Toepfer, A. Synlett 1990, 694. 
218 Xue, J.; Khaja, S. D.; Locke, R. D.; Matta, K. L. Synlett 2004, 861. 
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FIG. 3.13: Reagents and conditions: (a) DDQ, 18:1 v/v CH2Cl2/H2O, T=-20°C, 58%; (b) PdCl2, 1:1 v/v 
CH2Cl2/MeOH, rt, 43%(c) 5:1 v/v THF/2M aq. KOH, 50°C; ii. 10:10:1 v/v/v CH2Cl2/MeOH/Ac2O, rt, 67% over 
two steps; 
Disaccharide 17 was readily transformed also into alcohol 20 by cleavage of Troc- and 
Cbz-protecting groups with 2 M KOH and subsequent N-acetylation (67% over two 
steps) (FIG. 3.13). For the insertion of the lactoyl moiety several conditions were tested 
using both a (S)-2-chloropropionic acid (entries 1 and 2, Table 3.2) and the triflate of 
ethyl (S)-lactate (entries 3 and 4, Table 3.2). 34j As it is possible to see from Table 3.2, the 
best results were obtained using 3 equivalents of NaH and only 2 equivalents of ethyl 
(S)-lactate. Using the conditions reported in entry 3, it was obtained instead the 
unexpected product 22, whose mechanism of formation is still unclear and needs 
further investigations.  
Table 3.2: Screening of the conditions for the lactoyl moiety insertion. 
 
Entry Reaction conditions Products (isolated yield %) 
1 (S)-2-chloropropionic acid (5eq.), NaH (11.2 eq), THF, 40°C, on. No product 
2 (S)-2-chloropropionic acid (5eq.), NaH (15.6 eq), 1:1 v/v DMF/dioxane, 
95°C, on. 207k 
21 R=OH, R1=Ac (14%) 
3 Triflyl-(S)-2-propionic acid ethyl ester (3 eq.), NaH (9 eq.), CH2Cl2, rt, on. 22 R=Et, R1=H (50%) 
4 Triflyl-(S)-2-propionic acid ethyl ester (2 eq.), NaH (3 eq.), CH2Cl2, rt, 90 min. 23 R=Et, R1=H (63%) 
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GlcN–MurNAc deprotected disaccharide was then obtained as ethyl ester by 
hydrogenolysis of 23 (65%). It is worth noting that this deprotected disaccharide unit 24 
and its N-diacetylated derivative 25 seem to be recognized from the innate immune 
system of the plant model Arabidopsis thaliana by preliminary phytopathological tests 
conducted in the laboratory of prof. M.A. Newmann of the Department of Plant 
Biology & Biotechnology of the University of Copenhagen. Further studies are in 
course to analyze which mechanisms are involved in these recognition processes. 
 
FIG.3.14: Reagents and conditions: (a) Pd(OH)2, 9:1 v/v MeOH/AcOH, H2, rt, 65%; (b) 9:1 v/v MeOH/Ac2O, 96%. 
The disaccharide 23 has also been used for the synthesis of a muramyl fragments from 
the bacterium Micrococcus luteus (lysodeiktikus). The ester group has been hydrolyzed to 
give the free carboxylic acid 21 and then coupled with a pentadecapetide which 
represents the peptide stem of Micrococcus luteus (lysodeiktikus). The synthesis of the 
pentadecapetide unit 26 and the coupling reaction have been performed in the 
laboratory of the Prof. R. Berisio of the Institute of Biostructures and Bioimaging of the 
CNR of Naples. The unoptimized yield (≈20%) for the coupling reaction was detected 
using HPLC. The formation of the muramyl fragment (27) has been detected using 
MALDI and further experiments are now in progress in order to have the complete 
spectroscopic characterization. Because the muramyl fragments of the bacterium 
Micrococcus luteus (lysodeiktikus) are good substrate also for RipA, 205 the Rpf involved in 
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the resuscitation of Mycobacterium tuberculosis from dormancy, glycopeptide 27 will be 
completely deprotected and its interaction with RipA will be evaluated in the laboratory 
of Dr. Daniela Marasco of Institute of Biostructures and Bioimaging of the CNR of 
Naples. 
 
FIG. 3.15: Reagents and conditions: (a) LiOH, 2:1:0.5 v/v/v THF/dioxane/H20, rt, 82%; (b) PyBOP, DIPEA, 
CH2Cl2, rt, on. 
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3.3 Conclusions 
The synthesis of a highly versatile GlcN-MurNAc building block was reported. Since 
glycosylation presented several difficulties and constrains (low reactivity at position 4 of 
GlcN acceptors; necessity of gain 1,2-trans stereoselectivity without the use of amido-, 
imido- or carbamato neighboring protecting group; a protecting group pattern suitable 
for disaccharide oligomerization) a careful study of optimal glycosyl donor and acceptor 
and coupling conditions was carried out. The disaccharide was finally obtained in high 
yield and complete β-stereoselectivity. It is suitable for further manipulations towards 
the first synthesis of N-deacetylated-GlcN–containing peptidoglycan fragments, that are 
interesting molecules for the study of host innate immune system evasion mechanism in 
bacteria. From the fully protected disaccharide moiety a muramyl fragment from the 
bacterium Micrococcus luteus (lysodeiktikus) has been also synthesized for the inecstigation 
of the mechanisms involved in the resuscitation of bacteria from dotmancy. 
 
3.4 Experimental Section 
 
General methods: 1H and 13C NMR spectra were recorded with Varian XL-200 (1H: 
200 MHz; 12C: 50 MHz), Varian Gemini-300 (1H: 300 MHz; 13C:75 MHz), Bruker DRX-
400 (1H: 400 MHz; 13C:100 MHz), Varian INOVA 500 (1H: 500 MHz; 13C:125 MHz), 
CryoProbe Bruker 600 (1H: 600 MHz; 13C:150 MHz) instruments in CDCl3 (CHCl3 as 
internal standard: 1H: CHCl3 at δ=7.26 ppm; 
13C: CDCl3 at δ=77.0 ppm). Assignment of 
the proton chemical shifts was based on 1D HOHAHA experiments. Positive MALDI-
TOF MS spectra were recorded with an Applied Biosystem Voyager DE-PRO MALDI-
TOF mass spectrometer in the positive mode: compounds were dissolved in CH3CN at 
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concentration of 1 mg/mL and one microliter of these solutions were mixed with one 
microliter of a 20 mg/mL solution of 2,5-dihydroxybenzoic acid in 7:3 CH3CN/water. 
Optical rotations were measured with a JASCO P-1010 polarimeter. Analytical thin-layer 
chromatography (TLC) was performed on aluminum plates precoated with Merck Silica 
Gel 60 F254 as the adsorbent. The plates were developed with a 10% H2SO4 ethanolic 
solution and by heating to 130°C. Column chromatography was performed on Merck 
Kiesegel 60 (63-200 mesh). 
 
Allyl 4,6-O-benzylidene-2,3-N,O-carbonyl-2-deoxy-α-D-glucopyranoside (2): 
Amino alcohol 1 (325.2 mg, 1.05 mmol) was dissolved in 2:1 v/v CH3CN/sat. NaHCO3 
(14.6 mL) and treated at T=0°C with triphosgene (430.5 mg, 1.45 mmol). The solution 
was stirred at room temperature for 30 min and then a solution of ethylendiamine in 
ethyl acetate (195 μL of ethylendiamine in 15 mL of ethyl acetate) was added. The 
mixture was then diluted with AcOEt (15 mL) and washed with 1 M NaHCO3. The 
organic layer was collected, dried with Na2SO4, filtered and purified by chromatography 
(1% methanol in dichloromethane) to give 2 as a white powder (209.6 mg, 60%). [α]D 
+33 (c 0.3; CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.51-7.36 (m, 5H, H-Ar), 5.91 (m, 
1H, OCH2CH=CH2), 5.62 (s, 1H, CHPh), 5.35 (ddd, 1H, Jvic 17.2 Hz, 
4JH,H 3.0 Hz, Jgem 
1.5 Hz, trans OCH2CH=CHH), 5.28 (dd, 1H, Jvic 10.4 Hz, Jgem 1.5 Hz, cis 
OCH2CH=CHH), 5.15 (d, 1H, J1,2 2.9 Hz, H-1), 5.07 (bs, 1H, NH), 4.84 (dd, 1H, 
J3,2=11.3 Hz, J3,4=10.2 Hz, H-3), 4.29 (m, 2H, H-6a, OCHHCH=CH2), 4.09 (m, 2H, H-
4, OCHHCH=CH2), 3.90 (m, 2H, H-5, H-6b), 3.74 (dd, 1H, J2,3 11.3 Hz, J2,1 2.9 Hz, H-
2); 13C NMR (125 MHz, CDCl3): δ 159.1 (NCOO), 136.5 (Cipso), 132.8 
(OCH2CH=CH2), 129.2, 128.3, 126.2 (C-Ar), 118.5 (OCH2CH=CH2), 101.4 (CHPh), 
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95.5 (C-1), 80.1, 75.6, 69.1, 68.5, 65.5, 59.5 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). 
MALDI TOF-MS: calcd for C17H19NO6 (m/z), 333.12; found, 334.16 [M+H]
+. Anal 
Calcd for C17H19NO6: C, 61.26; H, 5.75; N, 4.20. Found: C, 61.06; H, 5.58; N 4.11. 
 
Allyl 2-acetamido-4,6-O-benzylidene-2-N,3-O-carbonyl-2-deoxy-α-D-
glucopyranoside (3): Compound 2 (207.4 mg, 0.623 mmol) was dissolved in CH2Cl2 
(5.1 mL) and treated with DIPEA (542 μL, 3.11 mmol) and then with AcCl (221 μL, 
3.11 mmol). The solution was stirred for 60 min at room temperature and then diluted 
with CH2Cl2 and washed with 1 M NaHCO3. The organic layer was collected, dried with 
Na2SO4, filtered and purified by chromatography (16% ethyl acetate in petroleum ether) 
to give 3 as a amorphous solid (206.5 mg, 83.1%):1H NMR (600 MHz, CDCl3): δ 7.50-
7.34 (m, 5H, H-Ar), 5.85 (m, 1H, OCH2CH=CH2), 5.80 (d, 1H, J1,2=2.7 Hz, H-1), 5.58 
(s, 1H, CHΦ), 5.31 (d, 1H, Jvic=17.6 Hz, trans OCH2CH=CHH), 5.27 (d, 1H, Jvic 10.3 
Hz, cis OCH2CH=CHH), 4.75 (t, 1H, J3, 2 = J3, 4= 11.7 Hz, H-3), 4.32 (dd, 1H, Jvic=16.2 
Hz, J5,6=10.2 Hz, H-6a,), 4.27 (dd, 1H, Jvic= 12.6 Hz, Jgem=5.2 Hz, OCHHCH=CH2), 
4.23 (dd, 1H, Jvic= 12.6 Hz, Jgem=6.24 Hz, OCHHCH=CH2), 4.7 (t, 1H, J4, 5 = J3, 4= 11.7 
Hz, H-4); 3.95-3.91 (m, 2H, H-5, H6b), 3.88 (dd, 1H, J2,1 =2.7 Hz, J2,3=11.7 Hz, H-2). 
13C NMR (50 MHz, CDCl3): δ 171.11 (COCH3), 152.8 (NCOO), 136.3 (Cipso), 132.9 
(OCH2CH=CH2), 129.1, 128.1, 125.2 (C-Ar), 118.2 (OCH2CH=CH2), 101.0 (CHPh), 
95.8 (C-1), 79.4, 73.4, 69.4, 68.3, 65.0, 60.6 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2), 
23.6 (COCH3). MALDI TOF-MS: calcd for C17H19NO6 (m/z), 357.13; found, 358.16 
[M+H]+. Anal Calcd for C19H21NO7: C, 60.79; H, 5.64; N, 3.73. Found: C, 60.82; H, 
5.67; N 3.53. 
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Allyl 2-acetamido-6-O-benzyl-2-N,3-O-carbonyl-2-deoxy-α-D-glucopyranoside 
(4): compound 3 (184.6 mg, 0.492 mmol) was co-evaporated three times with toluene (4 
mL). The residue was dried, mixed with freshly activated AW-300 molecular sieves (4Å) 
under Ar, cooled to 0°C and dissolved in CH2Cl2(6.0 mL). Et3SiH (393 μL, 2.46 mmol) 
and a 2.4 M solution of TFA in CH2Cl2 were then added and the mixture was stirred at 
5°C over night. The mixture was then filtered, diluted in CH2Cl2 (10 mL) and washed 
with a 1 M NaHCO3. The organic layer was collected, dried with Na2SO4, filtered and 
purified by chromatography (20% ethyl acetate in petroleum ether) to give 4 as a yellow 
oil (98.6 mg, 53.1%):1H NMR (400 MHz, CDCl3): δ 7.35-7.38 (m, 5H, H-Ar), 5.85 (m, 
1H, OCH2CH=CH2), 5.68 (d, 1H, J1,2=2.7 Hz, H-1), 5.24 (dd, 1H, Jvic=17.2 Hz, trans 
OCH2CH=CHH), 5.19 (dd, 1H, Jvic=10.3 Hz, cis OCH2CH=CHH), 4.64-4.59 (m, 3H, 
H-3, OCHHPh), 4.54 (d, 1H, Jgem=12.1 Hz, OCHHPh), 4.18 (dd, 1H, Jvic= 12.7 Hz, 
Jgem=5.5 Hz, OCHHCH=CH2), 4.10-4.03 (m, 2H, H-4, OCHHCH=CH2), 3.80 (dd, 1H, 
Jgem=9.5 Hz, J5-6=3.7 Hz, H-6a), 3.75-3.66 (m, 3H, H-2, H-5, H-6b), 2.48 (s, 3H, 
NCOCH3). 
13C NMR (50 MHz, CDCl3): δ 171.3 (COCH3), 152.3 (NCOO), 136.3 (Cipso), 
133.2 (OCH2CH=CH2), 128.5, 127.9, 127.7 (C-Ar), 118.1 (OCH2CH=CH2), 95.1 (C-1), 
76.6, 73.7, 72.1, 70.1, 69.2, 59.6 (C-2, C-3, C-4, C-5, C-6, CH2Ph OCH2CH=CH2), 23.7 
(COCH3). MALDI TOF-MS: calcd for C19H23NO7 (m/z), 377.15; found, 378.23 
[M+H]+. Anal Calcd for C19H23NO7: C, 60.47; H, 6.14; N, 3.71. Found: C, 60.7; H, 6.27; 
N 3.75. 
 
Allyl 2-azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy- α-D-glucopyranoside (5): 
Compound 2 (1.0071 gr, 3.28 mmol) were disolved in pyridine (5.0 mL) and treated with 
Et3N (930 μL, 6.67 mmol) and CuSO4 (54.8 mg, 0.343 mmol). A 0°C a 0.71 M solution 
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of triflyl azide (5.6 mL, 3.97 mmol) was added and the mixture was stirred for 2h at 
room temperature. The pyridine was co-evapored with toluen and a yellow oil was 
obtained. The residue was then dissolved in DMF (8 mL) and to the solution BnBr 
(1.640 mL, 13.78 mmol) and NaH (60% in oil, 555.1 mg, 13.80 mmol) were added. The 
mixture was stirred over night, then cooled to 0 °C and treated dropwise with a little 
water until production of gas ceased. The mixture was diluted with CH2Cl2 (20 mL) and 
washed with water. The organic layer was collected, dried with Na2SO4, filtered and 
purified by chromatography (4 to 6% ethyl acetate in petroleum ether) to give 5 as a 
yellow oil (984.6 mg, 71.1%):1H NMR (500 MHz, CDCl3): δ 7.56-7.36 (m, 10H, H-Ar), 
6.0 (m, 1H, OCH2CH=CH2), 5.63 (s, 1H, CHΦ), 5.41 (d, 1H, Jvic=17.0 Hz, trans 
OCH2CH=CHH), 5.3 (d, 1H, Jvic=8.4 Hz, trans OCH2CH=CHH), 5.01 (d, 1H, Jgem= 11 
Hz, OCHHPh), 4.98 (d, 1H, J1,2=3.0 Hz, H-1), 4.86 (d, 1H, Jgem= 11 Hz, OCHHPh), 
4.33 (dd, Jgem= 10 Hz, J5,6=5.5 Hz, H-6a), 4.26 (dd, 1H, Jvic= 12.7 Hz, Jgem=4.5 Hz, 
OCHHCH=CH2), 4.17 (t, 1H, H-3), 4.10 (dd, 1H, Jvic= 12.7 Hz, Jgem=6 Hz, 
OCHHCH=CH2), 3.97 (m, 1H, H-5), 3.82-3.74 (m, 2H, H-4, H-6b), 3.46 (dd, 1H, J1-2= 
3 Hz, J2-3= 10 Hz, H-2). 
13C NMR (125 MHz, CDCl3): δ 137.8, 137.1 (Cipso), 133.0 
(OCH2CH=CH2), 128.9, 128.4, 128.3, 128.2, 128.1, 128.0, 128.7, 126.0, 125.9 (C-Ar), 
118.1 (OCH2CH=CH2), 101.3 (CHPh), 97.4 (C-1), 82.7, 76.1, 74.9, 68.8, 68.6, 62.9, 62.7 
(C-2, C-3, C-4, C-5, C-6, CH2Ph OCH2CH=CH2). MALDI TOF-MS: calcd for 
C23H25N3O5 (m/z), 423.18; found, 423.8 [M+H]
+. Anal Calcd for C23H25N3O5: C, 65.24; 
H, 5.95; N, 9.92. Found: C, 65.5; H, 5.89; N 9.95. 
 
2-Azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy-α-D-glucopyranose (6): A 
solution of 5 (99.1 mg, 0.234 mmol) in 9:1 v/v MeOH/CH2Cl2 (1.46 mL) was treated 
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with PdCl2 (17.52 mg, 95.6 μmol). The mixture was vigorously stirred at room 
temperature for 1 h and then filtered over a Celite pad, diluted with CH2Cl2 (8 mL) and 
washed with water (8 mL). The organic layer was collected, dried over anhydrous 
Na2SO4, filtered and concentrated. The residue was subjected to column 
chromatography (17 to 25% ethyl acetate in petroleum ether) to give 6 (51.5 mg, 58% 
6α/6β≈1:1) as a colourless oil: 1H NMR (400 MHz, CDCl3): δ 7.50-7.32 (m, 20H, H-
Ar), 5.60 (s, 1H, CHΦ),, 5.58 (s, 1H, CHΦ), 5.25 (d, 1H, J1,2=3.5 Hz, H-1α), 4.98 (d, 
1H, , Jgem= 11.1 Hz, OCHHPh), 4.94 (d, 1H, , Jgem= 11.2 Hz, OCHHPh), 4.82 (d, 1H, , 
Jgem= 11.2 Hz, OCHHPh), 4.81 (d, 1H, , Jgem= 11.1 Hz, OCHHPh), 4.59 (d, 1H, J1,2=4.6 
Hz, H-1β), 4.35-4.27 (m, 2H, H-3α, H-3β), 4.14-4.09 (m, 2H, H-6α’, H-6β’), 3.81-3.70 
(m, 4H, H-6α’, H-4α, H-4β, H-5β), 3.60 (t, 1H, H-6β’’), 3.49 (dd, 1H, J1-2= 3.6 Hz, J2-3= 
9.8 Hz, H-2). MALDI TOF-MS: calcd for C20H21N3O5 (m/z), 384.15; found, 384.8 
[M+H]+. Anal Calcd for C20H21N3O5: C, 62.65; H, 5.52; N, 10.96. Found: C, 62.5; H, 
5.89; N 9.95. 
 
2-Azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy-α-D-glucopyranosyl 
trichloroacetimidate (7): to a solution of compound 6 (51.5 mg, 0.134 mmol) in 
CH2Cl2 (900 μL) Cl3CCN (200 μL, 2.01 mmol) and a 0.40 M solution of DBU in CH2Cl2 
(100 μL, 40.2 μmol)  wew added. After 2 h the mixture is concentred and subjected to 
column cromatography (12.5 to 20% ethyl acetate in n-hexane) to give 7 (63.5 mg, 94%) 
as a yellow oil: 1H NMR (400 MHz, CDCl3): δ 8.74 (s, 1H, NH), 7.51-7.32 (m, 5H, H-
Ar), 6.39 (d, 1H, J1,2=3.7 Hz, H-1), 5.63 (s, 1H, CHΦ), 5.03 (d, 1H, Jgem= 10.8Hz, 
OCHHPh), 4.85 (d, 1H, Jgem= 10.8Hz, OCHHPh), 4.34 (dd, 1H, J6,5=4.9 Hz, Jgem=7.4 
Hz, H-6a), 4.18 (t, 1H, , J3, 2 = J3, 4= 9.4 Hz, H-3), 4.08 (m, 1H, H-5), 3.84 (t, 1H, Jgem= J6, 
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6=10.8Hz, H-6b), 3.80 (t, 1H, H-4), 3.73 (dd, 1H, 1H, J1-2= 3.7 Hz, J2-3= 9.9 Hz, H-2). 
MALDI TOF-MS: unstable. Anal Calcd for C22H21Cl3N4O5: C, 50.06; H, 4.01; Cl 20.15; 
N, 10.62. Found: C, 50.13; H, 4.21; Cl 20.00; N, 10.81. 
 
Allyl 2-azido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside (8): Compound 5 
(225.4 mg, 0.532 mmol) was co-evaporated three times with toluene (5 mL). The residue 
was dried, mixed with freshly activated AW-300 molecular sieves (4Å) under Ar, cooled 
to 0°C and dissolved in CH2Cl2(6.5 mL). Et3SiH (425 μL, 2.66 mmol) and a 2.4 M 
solution of TFA in CH2Cl2 (1 mL, 2.66 mmol) were then added and the mixture was 
stirred at 5°C over night. The mixture was then filtered, diluted in CH2Cl2 (5 mL) and 
washed with a 1 M NaHCO3. The organic layer was collected, dried with Na2SO4, 
filtered and purified by chromatography (11% ethyl acetate in petroleum ether) to give 8 
as a yellow oil (155.3 mg, 69%):1H NMR (500 MHz, CDCl3): δ 7.43-7.32 (m, 10H, H-
Ar), 5.93 (m, 1H, OCH2CH=CH2), 5.36 (dd, 1H, Jvic=17.5 Hz, Jgem=1.5 Hz, trans 
OCH2CH=CHH), 5.27 (dd, 1H, Jvic=12.6 Hz, Jgem=1 Hz, cis OCH2CH=CHH), 4.97 (d, 
1H, J1,2=3.5 Hz, H-1), 4.94 (d, 1H, Jvic=11.5 Hz, OCHHPh), 4.82 (d, 1H, Jvic=11 Hz, 
OCHHPh), 4.62 (d, 1H, Jvic=12 Hz, OCHHPh), 4.55 (d, 1H, Jvic=12 Hz, OCHHPh), 
4.22 (dd, 1H, Jvic= 12.6 Hz, Jgem=5.0 Hz, OCHHCH=CH2), 4.06 (dd, 1H, Jvic= 12.6 Hz, 
Jgem=6.5 Hz, OCHHCH=CH2), 3.87 (t, 1H, H-6a), 3.80 (m, 1H, H-5), 3.73 (m, 3H, H-3, 
H-4, H-6b), 3.35 (dd, 1H, J1-2= 3.5 Hz, J2-3= 10 Hz, H-2). MALDI TOF-MS: calcd for 
C23H27N3O5 (m/z), 425.20; found, 448.2 [M+Na]
+. Anal Calcd for C23H27N3O5 : C, 
64.93; H, 6.40; N, 9.88. Found: C, 64.72; H, 6.22; N, 9.74. 
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Allyl 2-azido-3,6-di-O-benzyl-4-p-methoxybenzyl-2-deoxy-α-D-glucopyranoside 
(9): Compound 8 (155.3 mg, 0.366mmol) was dissolved in DMF (1 mL) and to the 
solution p-methoxybenzy bromide (100 μL, 0.732 mmol) and NaH (60% in oil, 28.1 mg, 
0.702 mmol) were added. The mixture was stirred for 3 h, then cooled to 0 °C and 
treated dropwise with a little water until production of gas ceased. The mixture was 
diluted with CH2Cl2 (6 mL) and washed with water. The organic layer was collected, 
dried with Na2SO4, filtered and purified by chromatography (16 to 7% ethyl acetate in 
petroleum ether) to give 5 as a yellow oil (181.1 mg, 92%): 1H NMR (300 MHz, CDCl3): 
δ 7.60-7.50 (m, 10H, H-Ar), 7.25 (d, 2H, Jvic= 14 Hz, H-Ar), 7.02 (d, 2H, Jvic= 13.5 Hz, 
H-Ar), 6.12 (m, 1H, OCH2CH=CH2), 5.54 (dd, 1H, Jvic=17.1 Hz, Jgem=0.9 Hz, trans 
OCH2CH=CHH), (dd, 1H, Jvic=10.5Hz, cis OCH2CH=CHH), 5.19 (d, 1H, , J1,2=3.3 Hz, 
H-1), 5.10 (s, 2H, CH2PhOMe), 4.95 (d, 1H, Jvic=10.5 Hz, OCHHPh), 4.86 (d, 1H, 
Jgem=12.3 Hz, OCHHPh), 4.71 (d, 1H, Jgem=12.3 Hz, OCHHPh), 4.66 (d, 1H, Jgem=10.2 
Hz, OCHHPh), 4.41 (dd, 1H, Jvic= 12.9 Hz, Jgem=4.8 Hz, OCHHCH=CH2), 4.28-4.19 
(m, 2H, H-3, OCHHCH=CH2), 4.06-3.84 (m, 7H, H-6a, H-6b, H-4, H-5, OCH3), 3.62 
(dd, J1-2= 3.6 Hz, J2-3= 10.2 Hz, H-2). MALDI TOF-MS: calcd for C31H35N3O6 (m/z), 
524.25; found, 547.77 [M+Na]+. Anal Calcd for C31H35N3O6: C, 68.24; H, 6.47; N, 7.70. 
Found: C, 68.36; H, 6.44; N, 7.22. 
 
2-Azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy-α-D-glucopyranose trichloro-
acetimidate (10α) and 2-Azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy-β-D-
glucopyranose (10β): A solution of 9 (101.1 mg, 0.185 mmol) in 1:1 v/v 
MeOH/CH2Cl2 (1.8 mL) was treated with PdCl2 (16.6 mg, 93 μmol). The mixture was 
vigorously stirred at room temperature for 2 h, diluted with CH2Cl2 (20 mL) and  then 
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filtered over a Celite pad and concentrated. The residue was subjected to column 
chromatography (20% ethyl acetate in petroleum ether) to give 10α and 10β in a 1:1 ratio 
(74.9 mg, 80%) as a colourless oil:1H NMR (400 MHz, CDCl3): 7.40-7.34 (28H, H-Ar), 
7.06 (t, 4H, H-Ar PMB), 6.82 (d, 4H, H-Ar PMB), 5.30 (bs, 1H, H-1α), 4.90-4.88 (m, 
3H, OCHHPh, OCH2pOMePh), 4.82 (d, 1H, Jgem=10.8 Hz, OCHHPh), 4.73 (t, 2H, 
OCH2pOMePh), 4.61-4.41 (m, 7H, 6 OCHHPh, H-1β), 4.05-3.97 (m, 2H), 3.81 (s, 6H, 
2 OCH2pOMePh), 3.65-3.37 (m, 10H). 
13C NMR (100 MHz, CDCl3): δ 159.3 (C-OMe), 
159.2 (C-OMe), 137.8, 137.5, 137.4 (Cipso), 129.8-127.7 (C-Ar), 113.8 (C-Ar PMB), 95.8 
(C-1β), 91.84 (C-1α), 83.0, 80.0, 78.2, 77.3, 75.3, 74.6, 73.3, 70.3, 68.5, 67.2, 63.8, 55.2, 
(C-2α, C-3α, C-4α, C-5α, C-6α, C-2β, C-3β, C-4β, C-5β, C-6β, 4 CH2Bn, 2CH2PhOCH3, 
2CH2PhOCH3). MALDI TOF-MS: calcd for C28H31N3O6 (m/z), 505.56; found, 548.77 
[M+Na]+. Anal Calcd for C28H31N3O6: C, 66.52; H, 6.18; N, 8.31. Found: C, 66.36; H, 
6.44; N, 8.22. 
 
2-Azido-3,6-di-O-benzyl-4-O-pmethoxy benzyl-2-deoxy-α -D-glucopyranose 
trichloroacetimidate (11): to a solution of compound 10α and 10β (74.9 mg, 0.15 
mmol) in CH2Cl2 (1 mL) Cl3CCN (220 μL, 2.19 mmol) and a 0.40 M solution of DBU in 
CH2Cl2 (110.4 μL, 44 μmol) were added. After 2 h the mixture is concentred and 
subjected to column cromatography (12.5 to 20% ethyl acetate in n-hexane) to give 11 
(67.7 mg, 70.2%) as a yellow oil: 1H NMR (400 MHz, CDCl3): δ 8.70 (NH), 7.40-7.36 
(10H, H-Ar), 7.07 (d, 2H, Jo-m=8.6 Hz, HmPMB), 6.82 (d, 2H, Jo-m=8.6 Hz, HmPMB), 
6.44 (1H, J1,2=3.5 Hz, H-1), 4.96 (d, 1H, Jgem=10.8 Hz, OCHHPh), 4.90 (d, 1H, 
Jgem=10.7 Hz, OCHHPh), 4.75 (d, 1H, Jgem=10.3 Hz, OCHHPhOMe), 4.64 (d, 1H, 
Jgem=12Hz, OCHHPh), 4.50 (d, 1H, Jgem=10.3 Hz, OCHHPhOMe), 4.49 (1H, Jgem=12 
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Hz, OCHHPh), 4.05-3.97 (m, 2H, H-6a, H-3), 3.89-3.79 (m, 5H, H-6b, H-5, OCH3), 
3.71-3.65 (m, 2H, H-2, H-4). 13C NMR (100 MHz, CDCl3): δ 160.6 (C=NH), 159.4 (C-
OMe), 137.7 (Cipso), 129.7-127.7 (C-Ar), 113.8 (CmPMB), 94.8 (C-1), 79.9, 77.3, 75.3, 
74.8, 73.5, 73.4, 67.7, 62.9, 55.1 (C-2, C-3, C-4, C-5, C-6, 2 CH2Bn, CH2PhOCH3, 
CH2PhOCH3). MALDI TOF-MS: unstable. Anal Calcd for C30H31Cl3N4O6 (649.95): C, 
55.44; H, 4.81; Cl 16.36; N, 8.62. Found: C, 55.13; H, 4.21; Cl 16.00; N, 8.81. 
 
Allyl 4,6-O-benzylidene-3-O-benzyloxycarbonyl-2-N-trichloroethoxycarbonyl-
amino-2-deoxy-α-D-glucopyranoside (12): Compound 2 (265.1 mg , 0.865 mmol) 
was dissolved in 2:1 v/v H20/CH3CN (5.7 mL) and treated with NaHCO3 (214.9 mg, 
2.55 mmol) and TrocCl (300 μL, 2.2 mmol). The mixture was vigorously stirred at room 
temperature for 1 h and then with AcOEt (10 mL) and washed with water (8 mL). The 
organic layer was collected, dried over anhydrous Na2SO4, filtered and concentrated. 
The residue was dissolved in CH2Cl2 and treated with DMAP (212,1 mg, 1.74 mmol) 
and CbzCl (245 μL, 1.72 mmol). The mixture was stirred for 90 min and concentrated. 
The residue was subjected to column chromatography (14% ethyl acetate in n-hexane) 
to give 12 (361.3 mg, 70%) as a colourless oil: [α]D +30.2 (c 1.05 in CH2Cl2); 
1H NMR 
(200 MHz, CDCl3): δ 7.46-7.31 (10 H, m, H-Ar), 5.90 (, m, 1 H, OCH2CH=CH2), 5.52 
(s, 1H, CHΦ), 5.44-5.06 (m, 6H, H-3, NH, trans OCH2CH=CHH, cis OCH2CH=CHH, 
COCH2CCl3), 4.94 (d, 1-H, H-1, J1,2=3.6 Hz), 4.66 (s, 2H, COCH2Φ), 4.34-3.91 (m, 6-
H, H-2, H-6a, H-5, OCHHCH=CH2), 3.83-3.71 (m, 2H, H-4, H-6b). 
13C NMR (100 
MHz, CDCl3): 155.13 (C=O), 154.23 (C=O), 136.84 (Cipso), 132.94 (Cipso, 
OCH2CH=CH2), 129.07-126.16 (C-Ar), 118.65 (OCH2CH=CH2), 101.54 (C-Φ), 97.05 
(C-1), 79.02, 74.51, 74.16, 69.99, 68.82, 68.73, 62.98, 54.55 (C-2, C-3, C-4, C-5, C-6, 
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CH2-Φ, CH2CCl3, OCH2CH=CH2). MALDI TOF-MS: calcd for C27H28Cl3NO9 (m/z), 
615.08; found, 538.69 [M+Na]+. Anal Calcd for C27H28Cl3NO9: C, 52.57; H, 4.58; Cl, 
17.24; N, 2.27. Found: C, 52.36; H, 4.44; Cl, 17.39, N, 2.22. 
 
Allyl 4-O-benzyl-3-O-benzyloxycarbonyl-2-N-trichloroethoxycarbonylamino-2-
deoxy-α-D-glucopyranoside 13: Compound 12 (345.6 mg, 0.560 mmol) was co-
evaporated three times with toluene (5 mL). The residue was dried, mixed with freshly 
activated AW-300 molecular sieves (4Å) under Ar, cooled to 0°C and dissolved in 
CH2Cl2(7.5 mL). Et3SiH (465 μL, 3.01 mmol) and a 5.1 M solution of TFA in CH2Cl2 
(545 μL, 2.8 mmol) were then added and the mixture was stirred at 5°C over night. The 
mixture was then filtered, diluted in CH2Cl2 (10 mL) and washed with a 1 M NaHCO3. 
The organic layer was collected, dried with Na2SO4, filtered and purified by column 
chromatography (17% ethyl acetate in petroleum ether) to give 12 as a yellow oil (266.0 
mg, 77%): [α]D +56.3 (c 0.88 in CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.37-7.26 (m, 
10H, H-Ar), 5.87 (m, 1H, OCH2CH=CH2), 5.35 (d, 1H, JNH-H2=9.8 Hz), 5.29 (dd, 1H, 
Jvic=17.2 Hz, Jgem 1.4 Hz, trans OCH2CH=CHH), 5.22 (dd, 1H, Jvic=10.3 Hz, Jgem 1.2 Hz, 
cis OCH2CH=CHH), 5.15 (s, 2H, COCH2Φ), 4.99 (m, 1H, H-3), 4.91 (d, 1H, J1,2=3.6 
Hz, H-1), 4.69-4.61 (m, 3H, CHHΦ, CH2Cl3), 4.55 (d, 1H, CHHΦ, Jgem=12.0 Hz), 4.19 
(dd, 1H, Jvic= 5.27 Hz, Jgem= 12.8 Hz, OCH2CH=CH2), 4.04-3.97 (m, 2H, H-2, 
OCH2CH=CH2), 3.84-3.83 (bs, 2H, H-4, H-5), 3.78 (dd, 1H, Jgem= 10.7 Hz, J6a-5= 2.8 
Hz, H-6a), 3.71 (dd, 1H, Jgem= 10.4 Hz, J6b-5= 2.6 Hz, H-6b). 
13C NMR (100 MHz, 
CDCl3): 155.74 (C=O), 154.15 (C=O), 137.60 (Cipso), 134.77 (Cipso), 133.12 
(OCH2CH=CH2), 128.55-127.61 (C-Ar), 118.24 (OCH2CH=CH2), 96.34 (C-1), 77.86, 
74.40, 73.61, 70.26, 70.09, 69.86, 69.39, 68.48, 53.77 (C-2, C-3, C-4, C-5, C-6, CH2-Φ, 
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CH2CCl3, OCH2CH=CH2). MALDI TOF-MS: calcd for C27H30Cl3NO9 (m/z), 617.10; 
found, 540.53 [M+Na]+. Anal Calcd for C27H30Cl3NO9: C, 52.40; H, 4.89; Cl, 17.19; N, 
2.26. Found: C, 52.38; H, 4.92; Cl, 17.33; N, 2.18. 
 
Allyl 2-azido-3,6-di-O-benzyl-4-O-p-methoxybenzyl-2-deoxy-α -D-
glucopyranosyl-(1→4)-2-acetamido-6-O-benzyl-2-N,3-O-carbonyl-2-deoxy-α-D-
glucopyranoside (15α) and allyl 2-azido-3,6-di-O-benzyl-4-O-p-methoxybenzyl-2-
deoxy-β -D-glucopyranosyl-(1→4)-2-acetamido-6-O-benzyl-2-N,3-O-carbonyl-2-
deoxy-α-D-glucopyranoside (15β): a mixture of acceptor 4 (8.96 mg, 24 μmol) and of 
donor 11 (27.8 mg, 42.8 μmol) was co-evaporated three times with toluene. The residue 
was dried, mixed with freshly activated AW-300 molecular sieves (4Å) under Ar, cooled 
to -30°C and dissolved in 2:1.3 v/v CH2Cl2/n-Hex (441 μL). A 1.4 M solution of 
BF3∙OEt2 in CH2Cl2 (18.5 μL, 26.7 μmol) was the added and the mixture was stirred at -
30°C for 1 h. Et3H (10 μL) was added and the mixture was filtered on a Celite pad. The 
mixture was purified by column cromatography (10 to 15% ethyl acetate in n-hexane) to 
give 15α (7.3 mg, 35%) and 15β (6.9 mg, 33%) both as a white crystalline compounds: 
15β [α]D +29.1 (c 0.54 in CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.37-7.21 (m, 15H, H-
Ar), 7.10 (d, 2H, Jortho 8.6 Hz, H-Ar PMB), 6.82 (d, 2H, Jortho 8.6 Hz, H-Ar PMB), 5.85 
(m, 1H, OCH2CH=CH2), 5.72 (d, 1H, J1,2=2.7 Hz, H-1 A), 5.26 (dd, 1H, Jvic=18.7 Hz, 
Jgem 1.4 Hz, trans OCH2CH=CHH), 5.21 (dd, 1H, Jvic=10.4 Hz, Jgem 1.3 Hz, cis 
OCH2CH=CHH), 4.83 (s, 2H, OCH2PhOMe), 4.26-4.65 (m, 5H, H-3A, CH2Ph), 4.57 
(d, 1H, Jgem=13.4 Hz, CHHΦ), 4.51 (d, 1H, CHHΦ, Jvic=10.8 Hz), 4.20-4.14 (m, 3H, H-
1B, H-3B, OCH2CH=CH2); 4.07 (dd, 1H, Jvic= 5.27 Hz, Jgem= 12.8 Hz, OCH2CH=CH2), 
3.90 (dd, 1H, Jgem= 10.4 Hz, J6Ba-5B=2.6 Hz, H-6Ba), 3.81-3.59 (m, 10H, H-2A, H-4A, H-
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5A, H-6Aa, H-6Bb, H-4B, H-6Bb, OCH3), 2.45 (s, 3H, COCH3). 
13C NMR (75 MHz, 
CDCl3): δ  171.2 (C=O), 159.4 (Cipso PMB), 152.9 (C=O), 138.6, 137.8, 135.1 (3 Cipso 
Bn), 133.2 (OCH2CH=CH2), 130.8 (Cipso PMB), 130.1-125.1 (C-Ar), 118.4 
(OCH2CH=CH2), 113.8 (C-Ar), 101.2 (C-1B), 95.0 (C-1A), 83.2 (C-3B), 75.6, 75.5, 75.2, 
74.5, 73.7, 73.7, 72.4, 69.5, 68.5, 67.6, 66.4, 59.9 (C-4B, C-3A, C-5B, OCH2pOMePh, C-4A, 
3 OCH2Ph, C-5A, C-6B, OCH2CH=CH2, C-6A, C-2B, C-2A) 55.3 (OMe), 29.7 (CH3CO). 
MALDI TOF-MS: calcd for C47H52N4O12 (m/z), 864.36; found, 898.60 [M+Na]
+. Anal 
Calcd for C47H52N4O12: C, 65.27; H, 6.06; N, 6.48. Found: C, 65.79; H, 5.99; N, 6.99. 
Compound 15α: [α]D +29.6 (c 0.47 in CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.38-
7.21 (m, 15H, H-Ar), 7.03 (d, 2H, Jortho 8.4 Hz, H-Ar PMB), 6.81 (2 H, d, Jortho 8.6 Hz, 
H-Ar PMB), 5.84 (m, 1H, OCH2CH=CH2), 5.73 (d, 1H, J1,2=2.8 Hz, H-1A), 5.41 (d, 1H, 
J1,2=2.8 Hz, H-1B), 5.25 (dd, 1H, Jvic=17.2 Hz, Jgem 1.5 Hz, trans OCH2CH=CHH), 5.20 
(dd, 1H, Jvic=10.4 Hz, Jgem=1.2 Hz, cis OCH2CH=CHH), 4.85 (s, 2H, OCH2PhOMe), 
4.76 (t, 1H, J3,4=J3,2= 9.9 Hz, H-3A), 4.68 (d, 1H, Jgem=12 Hz, CHHΦ), 4.56 (d, 1H, 
Jgem=12.0 Hz, CHHΦ), 4.52 (d, 1H, Jgem=12.0 Hz, CHHΦ), 4.46 (d, 1H, Jgem=12.0 Hz, 
CHHΦ), 4.40 (d, 1H, Jgem=12.0 Hz, CHHΦ), 4.35 (t, 1H, J4,3 =J4,5= 10 Hz, H-4A), 4.30 
(d, 1H, Jgem=12.0 Hz, CHHΦ), 4.20 (dd, 1H, Jvic= 5.27 Hz, Jgem= 12.8 Hz, 
OCH2CH=CH2), 4.07 (dd, 1H, Jvic= 5.33 Hz, Jgem= 12.6 Hz, OCH2CH=CH2), 3.82-376 
(m, 6H, H-3B, H-5A, H-2A, OCH3). 3.71-3.55 (m, 4H, H-4B, H-5B, H-6Aa, H-6Ab), 3.45 
(dd, 1H, Jgem= 10.6 Hz, J6Ba-5B=2.8 Hz, H-6Ba), 3.45 (dd, 1H, , J1,2=2.8 Hz, J3,2= 9.5 Hz, 
H-2B), 3.35 (d, 1H, Jgem= 10.6 Hz, H-6Bb), 2.5 (s, 3H, COCH3). 
13C NMR (75 MHz, 
CDCl3): δ  171.2 (C=O), 160.0 (Cipso PMB), 152.9 (C=O), 137.9, 135.2, 133.2 (3 Cipso 
Bn), 130.9 (OCH2CH=CH2), 130.2, 129.6, 128.8, 128.5, 128.3, 127.9, 127.9, 127.7, 127.4  
(C-Ar), 118.1 (OCH2CH=CH2), 113.8 (C-Ar), 96.3 (C-1B), 95.0 (C-1A), 80.2 (C-3B), 77.6, 
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75.4, 74.7, 73.6, 73.5, 71.9, 71.8, 71.7, 70.7, 69.5, 68.2, 67.8, 63.3, 59.9 (C-4B, C-3A, C-5B, 
OCH2pOMePh, C-4A, 3 OCH2Ph, C-5A, C-6B, OCH2CH=CH2, C-6A, C-2B, C-2A) 55.3 
(OMe), 29.7 (CH3CO). MALDI TOF-MS: calcd for C47H52N4O12 (m/z), 864.36; found, 
898.88 [M+Na]+. Anal Calcd for C47H52N4O12: C, 65.27; H, 6.06; N, 6.48. Found: C, 
65.82; H, 6.00; N, 6.23. 
 
Allyl 2-azido-3,6-di-O-benzyl-4-O-p-methoxybenzyl-2-deoxy-β -D-gluco-
pyranosyl-(1→4)-6-O-benzyl-3-O-benzyloxycarbonyl-2-N-trichloroethoxy-
carbonylamino-2-deoxy-α-D-glucopyranoside (17): a mixture of acceptor 13 (13.5 
mg, 21.8 μmol) and of donor 11 (22.8 mg, 35.0 μmol) was co-evaporated three times 
with toluene. The residue was dried, mixed with freshly activated AW-300 molecular 
sieves (4Å) under Ar, cooled to -30°C and dissolved in 2:1.3 v/v CH2Cl2/n-Hex (370 
μL). A 31.1 mM solution of BF3∙OEt2 in CH2Cl2 (230 μL, 7.45 μmol) was the added and 
the mixture was stirred at -80°C for 30 min. Et3H (5 μL) was then added and the 
mixture was filtered on a Celite pad. The mixture was purified by column 
cromatography (10 to 15% ethyl acetate in n-hexane) to give 17 (7.3 mg, 35%) as a white 
crystalline compound: [α]D +7 (c 0.6 in CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.37-
7.25 (20 H, m, H-Ar), 7.08 (2 H, d, Jortho 8.4 Hz, H-Ar PMB), 6.80 (2 H, d, Jortho 8.4 Hz, 
H-Ar PMB), 5.86 (1 H, m, OCH2CH=CH2), 5.28 (2 H, m, NH, trans OCH2CH=CHH), 
5.22 (1 H, br d, Jvic 10.4 Hz, cis OCH2CH=CHH), 5.08 (1 H, t, J3,2=J3,4 10.1 Hz, H-3A), 
5.06 (1 H, d, Jgem 12.5 Hz, OCHHCCl3), 4.97 (1 H, d, Jgem 12.5 Hz, OCHHCCl3), 4.93 (1 
H, dd, J1,2 3.5 Hz, H-1A), 4.81 (2 H, s, OCH2pOMePh), 4.69-4.60 (4 H, m, 4 OCHHPh), 
4.51 (1 H, d, Jgem 12.1 Hz, OCHHPh), 4.47 (2 H, s, OCH2Ph), 4.45 (1 H, d, Jgem 10.5 Hz, 
OCHHPh), 4.21 (1 H, dd, Jgem 12.5 Hz, Jvic 5.2 Hz, OCHHCH=CH2), 4.13 (1 H, d, J1,2 
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7.2 Hz, H-1B), 4.07-3.91 (5 H, m, H-2A, H-4A, H-5A, H-6aA, OCHHCH=CH2), 3.79 (3 
H, s, OMe), 3.72 (1 H, dd, Jgem =9.8 Hz, J6b,5 1.7 Hz, H-6bA), 3.61 (1 H, d, Jgem 10.8 Hz, 
J6a,5 1.7 Hz, H-6aB), 3.47 (2 H, m, H-4B, H-6Bb), 3.23 (3 H, m, H-2B, H-3B, H-5B); 
13C 
NMR (100 MHz, CDCl3): δ 159.3 (Cipso PMB), 155.3, 154.1 (OCOOCH2Ph, 
NCOOCH2CCl3), 138.4, 138.0, 137.7, 135.2 (4 Cipso Bn), 133.1 (OCH2CH=CH2), 130.1 
(Cipso PMB), 129.4-125.0 (C-Ar), 118.4 (OCH2CH=CH2), 113.8 (C-Ar), 100.8 (C-1B), 
96.3 (C-1A), 83.3 (C-3B), 77.6 (C-4B), 75.7 (C-3A), 75.4 (C-5B, OCH2pOMePh), 74.7 
(OCH2Ph), 74.5 (C-4A, OCH2Ph), 73.5 (2 OCH2Ph), 70.3 (C-5A), 69.5 (OCH2CCl3), 68.7 
(C-6B), 68.6 (OCH2CH=CH2), 67.7 (C-6A), 66.4 (C-2B), 55.3 (OMe), 54.1 (C-2A). 
MALDI TOF-MS: calcd for C55H59Cl3N4O14 (m/z), 1104.31; found, 1127.07 [M+Na]
+. 
Anal Calcd for C55H59Cl3N4O14: C, 59.70; H, 5.37; N, 5.06. Found: C, 59.55; H, 5.34; N, 
4.99. 
 
Allyl 2-azido-3,6-di-O-benzyl-2-deoxy-β -D-gluco-pyranosyl-(1→4)-6-O-benzyl-3-
O-benzyloxycarbonyl-2-N-trichloroethoxy-carbonylamino-2-deoxy-α-D-gluco-
pyranoside (18): Compound 17 (46 mg, 0.041 mmol) was dissolved in 18:1 v/v CH2Cl2 
/MeOH (5.2 mL) and the solution was treated with DDQ (12.8 mg, 0.056 mmol). After 
stirring for 3 h at room temperature, the mixture was diluted with CH2Cl2 and washed 
with water. The mixture was diluted with CH2Cl2 and then washed with water. The 
organic layer was collected and treated with Na2SO4, filtered and the solvent was 
evaporated. The residue was purified by column cromatography (30% ethyl acetate in n-
hexane) to give 18 as a white oil (23.5 mg, 58%).  1H NMR (400 MHz, CDCl3): δ 7.40-
7.23 (m, 20H, H-Ar), 5.86 (m, 1H, OCH2CH=CH2), 5.31-5.21 (m, 3H, H-3A, 
OCH2CH=CH2), 5.05 (d, 1H, Jgem= 8.5 Hz, COOCHHPh), 5.00 (d, 1H, Jgem= 8.6 Hz, 
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COOCHHPh), 4.92 (d, 1H, J1,2=3.6 Hz, H-1A), 4.87 (d, 1H, (d, 1 H, Jgem=11.1 Hz, 
OCHHPh), 4.79 (d, 1 H, Jgem=11.1 Hz, OCHHPh), 4.70 (d, 1 H, Jgem=11.9 Hz, 
OCHHPh), 4.69 (d, 1 H, Jgem=11.9 Hz, OCHHPh), 4.61 (d, 1 H, Jgem=11.9 Hz, 
OCHHPh), 4.48 (d, 1 H, Jgem=11.9 Hz, OCHHPh), 4.29 (s, 2H, OCH2Cl3), 4.17 (dd, 1H, 
, Jvic= 5.2 Hz, Jgem= 12.6 Hz, OCHHCH=CH2), 4.11-4.39 (m, 5H, OCHHCH=CH2, H-
2A, H-1B, H-4A, H-6Aa), 3.86 (dd, 1H, J4-5= 10 Hz, H-5A), 3.72 (d, 1H, Jgem= 9.6 Hz, H-
6Ab), 3.62 (dd, 1H, Jgem= 9.7 Hz, J6Ba-5= 4.5 Hz, H-6Ba), 3.48 (t, 1H, J4-3= J4-5= 8.8 Hz, H-
4B), 3.34 (dd, 1H, J6gem= 9.7 Hz, J6Bb-5= 7.2 Hz, H-6Bb), 3.17-3.11 (m, 3H, H-3B, H-2B, H-
5B); 
13C NMR (50 MHz, CDCl3): δ 155.2 (OCOOCH2Ph), 154.1 (NCOOCH2CCl3), 
138.1, 137.7, 137.3 (3 Cipso), 137.3-127.6 (C-Ar), 118.5 (OCH2CH=CH2), 100.8 (C-1B), 
96.3 (C-1A), 95.4, 82.5, 75.7, 74.9, 74.4, 74, 2, 73.7, 73.5, 72.4, 71.5, 70.2, 69.5, 68.6, 67.5, 
65.3 (C-3B, C-4B C-3A, C-5B, OCH2Ph, C-4A, OCH2Ph, 2 OCH2Ph, C-5A, OCH2CCl3, 
OCH2CH=CH2 C-6A, C-2B), 53.9 (C-2A). MALDI TOF-MS: calcd for C47H51Cl3N4O13 
(m/z), 984.25; found, 1008.33 [M+Na]+. Anal Calcd for C47H51Cl3N4O13: C, 57.24; H, 
5.21; N, 10.75; Cl, 5.68. Found: C, 57.65; H, 5.44; N, 10.12; Cl, 5.76. 
 
2-Azido-3,6-di-O-benzyl-4-O-p-methoxybenzyl-2-deoxy-β -D-gluco-pyranosyl-
(1→4)-2-acetamido-6-O-benzyl-3-O-benzyloxycarbonyl-2-deoxy-α-D-gluco-
pyranose (19): Compound 17 (46.9 mg, 42.3 μmol) was dissolved in 1:1 v/v 
CH2Cl2/MeOH(500 μL) and the solution was treated with PdCl2 (3.5 mg, 19 μmol) and 
stirred for 2 h. The mixture was then diluted with CH2Cl2 (4,5 mL) and filtered on a 
Celite pad. The solvent was evaporated and the produc was isolated by column 
cromatography (10 to 12.5/ toluene in ethyl acetate) to give 19 as a yellow oil (19.4 mg, 
43%, α/β 9:1). 1H NMR (400 MHz, CDCl3): δ 7.42-7.18 (m, 15H, H-Ar), 7.06 (2 H, d, 
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Jortho 8.5 Hz, H-Ar PMB), 6.81 (2 H, d, Jortho 8.5 Hz, H-Ar PMB), 5.47 (d, 1H, JNH-H2a=7.6 
Hz, NH), 5.29 (d, 1H, J1-2= 3.0 Hz, H-1A), 5.17 (t, 1H, J2-3= J3-4= 10 Hz, H-3A), 5.11 (d, 
1H, Jgem=13 Hz, OCHHΦ), 5.03-5.00 (m, 4H, COOCH2Φ, 2 OCHHΦ), 4.84 (s, 2H, 
CH2PhOMe), 4.70-4.65 (m, 3H, 1 OCHHΦ, COOCH2Cl3), 4.54 (d, 1H, Jgem=12 Hz, 
OCHHΦ), 4.50-4.47 (m, 2H, 2 OCHHΦ), 4.18-4.16 (bm, 1H, H-5A), 4.06 (dd, 1H, J2-3= 
10 Hz, J1-2= 3.0 Hz, H-2A), 4.00 (t, 1H, J4-5= J3-4= 9.6 Hz, H-4A), 3.90 (dd, 1H, J5-6= 3.5 
Hz, Jgem=10.5 Hz, H-6A), 3.81 (s, 3H, OCH3), 3.76 ( d, 1H, , Jgem=10.5 Hz, H-6B), 3.64 
(d, 1H, , Jgem=11Hz, H-6B), 3.51-3.46 (m, 2H, H-4B, H-6B), 3.28-3.24 (m, H-2B, H-3B, H-
5B). 
13C NMR (125 MHz, CDCl3): 
13C NMR (125 MHz, CDCl3): δ 159.3 (Cipso PMB), 
155.3, 154.1 (OCOOCH2Ph, NCOOCH2CCl3), 138.3, 137.9, 137.8, 135.7 (4 Cipso Bn), 
130.1 (Cipso PMB), 129.4-125.0 (C-Ar), 113.8 (C-Ar), 100.8 (C-1B), 91.7 (C-1A), 83.3 (C-
3B), 79.2 77.5, 77.3, 75.3, 75.0, 74.4, 73.5, 70.0, 69.6, 68.6, 68.0, 66.4 (C-4A, C-5A, C-4B, 
C-5B, C-6B, C-6A, C-3A, C-2B, OCH2pOMePh, OCH2CCl3, OCH2Ph, 3 OCH2Ph), 55.2 
(OMe), 54.3 (C-2A). MALDI TOF-MS: calcd for C52H55Cl3N4O14 (m/z), 1064.28; found, 
1628.28 [M+Na]+. Anal Calcd for C52H55Cl3N4O14: C, 58.57; H, 5.20; Cl 9.97; N, 5.25. 
Found: C, 58.42; H, 5.33; Cl 10.0; N, 5.43. 
 
Allyl 2-azido-3,6-di-O-benzyl-4-O-p-methoxybenzyl-2-deoxy-β -D-gluco-
pyranosyl-(1→4)- 2- acetamido-6-O-benzyl-2-deoxy-α-D-glucopyranoside (20): 
Compoun 17 (33.5 mg, 30 μmol) is dissolved in 10:1 v/v THF/KOH 2M (3.3 mL) and 
the mixture was stirred for 6 h at 50°C. The solvent was then evaporated, the residue 
was dissolved in 1:1 v/v CH2Cl2/MeOH and Ac2O (300 μL, 3.17 mmol) was added. 
After 4 h the mixture was concentrated and the produc was purified by column 
cromatography (20% of n-hexane in ethyl acetate) to give 21 as a white powder (17 mg, 
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67%). [α]D=+34.0 (c 1.2 in CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.37-7.31 (m, 15H, 
H-Ar), 7.06 (2 H, d, Jortho= 8.6 Hz, H-Ar PMB), 6.81 (2 H, d, Jortho= 8.6 Hz, H-Ar PMB), 
5.83 (m, 1H, OCH2CH=CH2), 5.62 (d, 1H, JNH-H2A=8.6 Hz, NH), 5.28 (dd, 1H, Jvic=17.2 
Hz, Jgem 1.5 Hz, trans OCH2CH=CHH), 5.20 (dd, 1H, Jvic=10.4 Hz, Jgem=1.4 Hz, cis 
OCH2CH=CHH), 4.96 (1 H, d, J1,2=3.6 Hz, H-1A), 4.84 (s, 2H, OCH2PhOMe), 4.69 (d, 
1 H, Jgem=10.1 Hz, OCHHPh), 4.67 (d, 1 H, Jgem=12.0 Hz, OCHHPh), 4.55 (d, 1 H, 
Jgem=11.9 Hz, OCHHPh), 4.53 (d, 1 H, Jgem=11.9 Hz, OCHHPh), 4.45 (d, 1 H, Jgem=11.9 
Hz, OCHHPh), 4.44 (d, 1 H, Jgem=11.9 Hz, OCHHPh), 4.12 (m, 4H, OCHHCH=CH2, 
H-3A, H-1B, H-2A), 4.95 (dd, 1H, , Jvic= 5.33 Hz, Jgem= 12.6 Hz, OCHHCH=CH2), 3.86-
3.75 (m, 6H, OCH3, H-6Aa, H-6Ab, H-5A), 3.70-3.59 (m, 3H, H-4B, H-6Ba, H-6Bb), 3.35-
3.33 (m, 3H, H-3b, H-5B, H-2B), 2.00 (COCH3). 
13C NMR (75 MHz, CDCl3): δ  170.9 
(C=O), 159.5 (Cipso PMB), 138.2, 137.7, 133.7 (3 Cipso Bn), 129.8 (OCH2CH=CH2), 
129.6, 128.5, 128.4, 127.9, 127.8 (C-Ar), 117.5 (OCH2CH=CH2), 113.9 (C-Ar), 101.7 (C-
1B), 96.5 (C-1A), 83.1, 81.1, 75.6, 74.7, 73.3, 70.7, 69.7, 68.5, 68.4, 68.2, 66.5, 55.3 (C-3B, 
C-4B, C-3A, C-5B, OCH2pOMePh, C-4A, 3 OCH2Ph, C-5A, C-6B, OCH2CH=CH2, C-6A, 
C-2B, C-2A), 53.3 (OMe), 23.5 (CH3CO). MALDI TOF-MS: calcd for C46H54N4O11 
(m/z), 838.38; found, 862.38 [M+Na]+. Anal Calcd for C46H54N4O11: C, 65.86; H, 6.49; 
N, 6.68. Found: C, 65.82; H, 6.00; N, 6.21. 
 
Allyl 2-azido-3,6-di-O-benzyl-4-O-p-methoxybenzyl-2-deoxy-β -D-gluco-
pyranosyl-(1→4)- 2-acetamido-6-O-benzyl-3-O-((R)-1’-carboxyethyl)-2-deoxy-α-
D-glucopyranoside (21): Compound 20 (231.1 mg, 0.27 mmol) was co-evaporated 
three times with toluene and then under Ar dissolved in 1:1 v/v DMF/dioxane (2 mL). 
To the solution NaH (60% in oil, 167.1 mg, 4.17 mmol) was added and stirred for 30 
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min at 95°C. The mixture was treated with (S)-2-chloropropionic acid ( 1.35 mmol) and 
stirred for 3 h, then cooled to 0 °C and treated dropwise with a little water until 
production of gas ceased. The mixture was diluted with CH2Cl2 and then washed with 
water. The organic layer was collected and treated with Na2SO4, filtered and the solvent 
was evaporated. The residue was purified by column cromatography (2% methanol in 
dichloroethane) to give 21 as a white oil (42.4 mg, 14%). [α]D +13 (c 0.3 in CH2Cl2); 
1H 
NMR (400 MHz, CDCl3): δ 7.36-7.26 (15H, m, H-Ar), 7.06 (2 H, d, Jortho 8.5 Hz, H-Ar 
PMB), 6.81 (2 H, d, Jortho 8.5 Hz, H-Ar PMB), 5.86 (1 H, m, OCH2CH=CH2), 5.26 (1 H, 
br d, Jvic 17.0 Hz, trans OCH2CH=CHH), 5.21 (1 H, d, J1,2 3.0 Hz, H-1A), 5.18 (1 H, br d, 
Jvic 11.0 Hz, cis OCH2CH=CHH), 4.81 (2 H, s, OCH2pOMePh), 4.71 (1 H, d, Jgem 12.1 
Hz, OCHHPh), 4.68 (1 H, d, Jgem 10.5 Hz, OCHHPh), 4.63 (1 H, q, Jvic 6.5 Hz, 
CH3CHO), 4.54-4.45 (4 H, m, 4 OCHHPh), 4.25 (1 H, d, J1,2 7.5 Hz, H-1B), 4.12 (1 H, 
dd, Jgem 13.5 Hz, Jvic 5.5 Hz, OCHHCH=CH2), 4.06 (1 H, t, J4,3= J4,5 10.0 Hz, H-4A), 
4.00-3.92 (3 H, m, H-2A, H-6aA, OCHHCH=CH2), 3.79 (3 H, s, OMe), 3.76-3.64 (6 H, 
m, H-3A, H-4B, H-5A, H-6bA, H-6aB, H-6bB), 3.28 (1 H, dd, J2,3 9.5 Hz, J2,1 7.5 Hz, H-2B), 
3.23 (1 H, t, J3,4=J3,2 9.5 Hz, H-3B), 3.16 (1H, br d, J5,4 9.6 Hz, H-5B), 2.02 (3H, s, 
CH3CO), 1.41 (3H, d, Jvic 6.5 Hz, CH3CHO); 
13C NMR (100 MHz, CDCl3): δ 177.0 
(COOH), 171.1 (NHCOCH3), 159.5 (Cipso PMB), 137.9, 137.8, 137.6 (3 Cipso Bn), 133.8 
(OCH2CH=CH2), 130.2 (Cipso PMB), 129.4-127.7 (C-Ar), 117.5 (OCH2CH=CH2), 113.8 
(C-Ar), 100.7 (C-1B), 96.0 (C-1A), 83.3 (C-3B), 77.5 (C-3A), 76.9 (C-4A), 76.1 (C-4B), 75.4 
(OCH2pOMePh), 75.2 (CH3CH), 74.7 (C-5B), 74.5 (OCH2Ph), 73.5 (OCH2Ph), 73.3 
(OCH2Ph), 70.6 (C-5A), 70.5 (C-6B), 68.6 (OCH2CH=CH2), 67.8 (C-6A), 66.6 (C-2B), 55.3 
(OMe), 54.0 (C-2A), 23.1 (CH3CO), 18.3 (CH3CH). MALDI TOF-MS: calcd for 
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C49H58Cl3N4O13 (m/z), 910.40; found, 933.29 [M+Na]. Anal Calcd for C49H58N4O13: C, 
64.60; H, 6.42; N, 6.15. Found: C, 64.44; H, 6.34; N, 6.06. 
Compound 21 could be obtained also through a basic hydrolysis of the ethyl ester 23: 
Compound 23 (41.2 mg, 44.0 μmol) was dissolved in 2:1:0.5 v/v/v 
THF/dioxane/water. LiOH (1.39 mg, 58 μmol) was then added and the mixture was 
stirred 2 h. Dowex-H+ resin was added until a pH=7. The mixture was filtered, the 
solvent was evaporated and the product was purified by column cromatography (98% to 
96% dicloromethane in methanol) to give 21 as a white oil (32.8 mg, 82%). 
 
Allyl 2-azido-3,6-di-O-benzyl-4-O-p-methoxybenzyl-2-deoxy-β -D-gluco-
pyranosyl-(1→4)-2-amino-6-O-benzyl-3-O-((R)-1’-(ethoxycarbonyl)ethyl)-2-
deoxy -α-D-glucopyranoside (22): Compound 20 (342 mg, 0.407 mmol) was co-
evaporated three times with toluene and then under Ar dissolved in CH2Cl2 (6.8 mL). 
To the solution NaH (60% in oil, 154 mg, 3.9 mmol) was added and stirred for 15 min 
at room temperature. The mixture was treated with triflyl (S)-2-propionic acid methyl 
ester (989.1 mg, 3.95 mmol) and stirred on at room temperature, then cooled to 0 °C 
and treated dropwise with a little water until production of gas ceased. The mixture was 
diluted with CH2Cl2 and then washed with water. The organic layer was collected and 
treated with Na2SO4, filtered and the solvent was evaporated. The residue was purified 
by column cromatography (70% ethyl acetate in n-hexane) to give 22 as a white oil 
(209.4 mg, 50%). 1H NMR (500 MHz, CDCl3): δ 7.37-7.32 (15H, m, H-Ar), 7.09 (2 H, 
d, Jortho= 8.5 Hz, H-Ar PMB), 6.84 (2 H, d, Jortho= 8.5 Hz, H-Ar PMB), 5.88 (1 H, m, 
OCH2CH=CH2), 5.29 (1 H, d, Jvic=17.0 Hz, trans OCH2CH=CHH), 5.22 (d, 1 H, Jvic= 
11.0 Hz, cis OCH2CH=CHH), 5.18 (d, 1H, J1,2=3.5 Hz, H-1A), 4.84-4.82 (s, 2H, 
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OCH2pOMePh), 4.74-4.70 (m, 3H), 4.63-4.44 (m, 7H), 4.23-3.95 (m, 4H), 3.80-3.74 (m, 
8H), 3.30-3.18 (m, 4H), 1.18 (3 H, t, Jvic=7.5 Hz, OCH2CH3).
 13C NMR (125 MHz, 
CDCl3): δ 175.3 (COOEt), 159.3 (Cipso PMB), 137.9-137.5 (3 Cipso Bn), 133.4 
(OCH2CH=CH2), 130.0 (Cipso PMB), 129.3-127.6 (C-Ar), 118.2 (OCH2CH=CH2), 113.8 
(C-Ar), 100.4 (C-1B), 95.1 (C-1A), 83.3, 78.3, 77.0, 76.4, 75.5, 75.3, 75.1, 74.5, 74.4, 73.4, 
73.3, 70.4, 69.0, 68.2, 67.5, 66.5 (C-2A, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, C-6A, C-6B, 
OCHCH3, 3 OCH2Ph, OCH2PhOMe, OCH2CH=CH2), 61.2 (OCH2CH3), 55.2, 54.6 (C-
2A, OCH3), 18.4 (CH3CH), 14.0 (OCH2CH3). MALDI TOF-MS: calcd for C49H60N4O13 
(m/z), 868.39; found, 891.21 [M+Na]. Anal Calcd for C49H60N4O13: C, 65.61; H, 6.74; 
N, 6.25. Found: C, 65.48; H, 6.30; N, 6.27. 
 
Allyl 2-azido-3,6-di-O-benzyl-4-O-pmethoxy benzyl-2-deoxy-β -D-gluco-
pyranosyl-(1→4)- 2-acetamido-6-O-benzyl-3-O-((R)-1’-(ethoxtcarbonyl)ethyl)-2-
deoxy-α-D-glucopyranoside (23): Compound 20 (83.5 mg, 0.099 mmol) was co-
evaporated three times with toluene and then under Ar dissolved in CH2Cl2 (1 mL). To 
the solution NaH (60% in oil, 11.8 mg, 2.9 mmol) was added and stirred for 15 min at 
room temperature. The mixture was treated with triflyl (S)-2-propionic acid methyl ester 
(48.5 mg, 0.194 mmol) and stirred for 1 h, then cooled to 0 °C and treated dropwise 
with a little water until production of gas ceased. The mixture was diluted with CH2Cl2 
and then washed with water. The organic layer was collected and treated with Na2SO4, 
filtered and the solvent was evaporated. The residue was purified by column 
cromatography (50% ethyl acetate in n-hexane) to give 23 as a white oil (53.9 mg, 60%). 
[α]D +25.0 (c 2.0 in CH2Cl2); 
1H NMR (500 MHz, CDCl3): δ 7.37-7.30 (15H, m, H-Ar), 
7.07 (2 H, d, Jortho= 8.5 Hz, H-Ar PMB), 6.81 (2 H, d, Jortho= 8.5 Hz, H-Ar PMB), 5.86 (1 
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H, m, OCH2CH=CH2), 5.37 (d, 1H, J1,2 3.5 Hz, H-1A), 5.25 (1 H, br d, Jvic 17.0 Hz, trans 
OCH2CH=CHH), 5.15 (1 H, br d, Jvic 11.0 Hz, cis OCH2CH=CHH), 4.83 (2 H, s, 
OCH2pOMePh), 4.73 (1 H, d, Jgem 12.0 Hz, OCHHPh), 4.69 (1 H, d, Jgem 10.5 Hz, 
OCHHPh), 4.66 (1 H, q, Jvic 7.5 Hz, CH3CHO), 4.54 (1 H, d, Jgem 11.5 Hz, OCHHPh), 
4.50 (1 H, d, Jgem 10.5 Hz, OCHHPh), 4.46 (1 H, d, Jgem 12.0 Hz, OCHHPh), 4.43 (1 H, 
d, Jgem 11.5 Hz, OCHHPh), 4.25 (1 H, d, J1,2 8.0 Hz, H-1B), 4.22 (2 H, m, OCH2CH3),  
4.11 (1 H, dd, Jgem 13.5 Hz, Jvic 5.5 Hz, OCHHCH=CH2), 4.06 (1 H, t, J4,3= J4,5 10.0 Hz, 
H-4A), 3.99 (1 H, dd, Jgem 13.5 Hz, Jvic 5.5 Hz, OCHHCH=CH2), 3.95 (dd, 1H, J2,3 9.0 
Hz, J2,1 3.5 Hz, H-2A), 3.80-3.64 (m, 10H, H-3A, H-4B, H-5A, H-6aA, H-6bA, H-6aB, H-
6bB, OCH3), 3.30 (1 H, t, J2,3=J2,1 8.0 Hz, H-2B), 3.25 (1 H, t, J3,4=J3,2 9.5 Hz, H-3B), 3.16 
(1 H, br d, J5,4 9.6 Hz, H-5B), 2.04 (3H, s, CH3CO), 1.36 (3 H, d, Jvic 7.5 Hz, CH3CHO), 
1.30 (3 H, t, Jvic 7.5 Hz, OCH2CH3); 
13C NMR (125 MHz, CDCl3): δ 176.3 (COOEt), 
170.1 (NHCOCH3), 159.3 (Cipso PMB), 137.9-137.7 (3 Cipso Bn), 134.1 (OCH2CH=CH2), 
130.2 (Cipso PMB), 129.3-127.6 (C-Ar), 116.9 (OCH2CH=CH2), 113.8 (C-Ar), 100.6 (C-
1B), 95.9 (C-1A), 83.3, 77.3, 76.8, 75.4, 75.2, 75.1, 74.5, 74.4, 73.4, 73.1, 70.6, 68.7, 68.3, 
67.8, 66.7 (C-2A, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, C-6A, C-6B, OCHCH3, 3 OCH2Ph, 
OCH2PhOMe, OCH2CH=CH2), 61.2 (OCH2CH3), 55.2, 54.4 (C-2A, OCH3), 23.1 
(CH3CO), 18.5 (CH3CH), 14.1 (OCH2CH3). MALDI TOF-MS: calcd for C51H62N4O13 
(m/z), 938.43 [M+H]+; found, 961.21 [M+Na]. Anal Calcd for C51H62N4O13: C, 65.23; 
H, 6.65; N, 5.97. Found: C, 65.35; H, 6.55; N, 6.01. 
 
Propyl 2-amino-2-deoxy-β-D-glucopyranosyl-(1→4)- 2-acetamido-3-O-((R)-1’-
(ethoxtcarbonyl)ethyl)-2-deoxy-α-D-glucopyranoside (24): Compound 23 (24.8 mg, 
0.026 mmol) was dissolved in 2.2:1 v/v MeOH/CH2Cl2 (2.4 mL).Pd(OH)2 (26.1 mg) 
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and AcOH (165 μL, 2.88 mmol) were then added. The solution was stirred in H2 
atmosphere fpr 10 h. The mixture was then filtered on a Celite pad and the solvent was 
evaporated to give 24 as a white solid (8.6 mg, 65%). 1H NMR (500 MHz, D2O): δ 4.86 
(d, 1H, J1-2=3 Hz, H-1A), 4.44 (q, 1H, Jgem=7 Hz, CH(CH3)COOEt), 4.16-4.05 (m, 2H), 
3.96-3.13 (m, 11H), 3.00 (t, J2-3= J1-2=8.5 Hz, H-2B), 1.92 (s, 3H, COCH3), 1.46 (m, 2H, 
OCH2CH2CH3), 1.31 (d, 3H, Jgem=7 Hz, CH(CH3)COOEt), 1.16 (t, 3H, COOCH2CH3), 
0.77 (t, 3H, Jgem=7 Hz, OCH2CH2CH3). MALDI TOF-MS: calcd for C22H40N2O12 
(m/z), 524.56; found, 546.28 [M+Na]+. Anal Calcd for C22H40N2O12: C, 50.37; H, 7.59; 
N, 5.34. Found: C, 50.46; H, 7.73; N, 5.22. 
 
Propyl 2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→4)- 2-acetamido-3-O-((R)-
1’-(ethoxtcarbonyl)ethyl)-2-deoxy-α-D-glucopyranoside (25): Compound 24 (3.9 
mg, 7.43 μmol) was dissolved in 9:1 v/v MeOH/Ac2O and the mixture was stirred at 
room temperature for 2 h. The solvent was evaporated and 25 coul be obtained as a 
white solid (2.8 mg, 95%). 1H NMR (500 MHz, D2O): δ 4.85 (d, 1H, J1-2=3 Hz, H-1A), 
4.55 (q, 1H, Jgem=7 Hz, CH(CH3)COOEt), 4.39 (d, 1H, J1-2=8.5 Hz, H-1B), 4.11 (q, 2H, 
Jgem=7 Hz, COOCH2CH3), 3.82 (dd, 1H, J6Aa-5a= 2 Hz, Jgem= 12.5 Hz), 3.75-3.41 (m, 
10H), 3.32-3.29 (m, 3H), 1.92 (s, 3H, COCH3), 1.91 (s, 3H, COCH3), 1.44 (m, 2H, 
OCH2CH2CH3), 1.33 (d, 3H, Jgem=7 Hz, CH(CH3)COOEt), 1.16 (t, 3H, COOCH2CH3), 
0.76 (t, 3H, Jgem=7 Hz, OCH2CH2CH3). MALDI TOF-MS: calcd for C24H42N2O13 (m/z), 
567.27 [M+H]+; found, 590.32 [M+Na]+. Anal Calcd for C24H42N2O13: C, 50.88; H, 7.47; 
N, 4.94. Found: C, 50.92 H, 7.53; N, 4.88. 
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Chapter 4: Synthesis of Urea Neosaccharide 
4.1 Introduction 
Although the preparation of urea and its derivatives dates back to the early history 
of organic chemistry, the enourmous chemical and biological potential of the ureido 
linkage has been largely exploited only in the last decades: urea itself is capable of 
forming inclusion complexes with long-chain alkanes and some functionalized 
molecules. 219 In such complexes, the urea molecules self-assemble through 
intramolecular hydrogen bonds giving rise to a helical lattice into which the guest 
compounds can be oriented and accomodated. Urea moieties also act as strong 
hydrogen-bond donors and acceptors, 220 and have been frequently used as 
functional groups for the formation of supramolecular architectures. 221 Substituted 
ureas and bis-ureas have also been shown to give gels with organic liquids and water, 
222 and in some cases gels are also thermally reversible and require very low 
concentrations. 
In the last decade, growing and growing efforts were also dedicated to the 
obtainment of ureido sugar mimics (a new class of ―pseudosaccharides‖) which have the 
acid-labile glycosidic bonds substituted with ureido-linkages (in this case the 
incorporation of a pseudo-amide intersaccharide linkage has an additional feature 
because this functional groups is isosteric with phosphodiester group occurring in 
                                                 
219 (a) Brown, M.E.; Hollingsworth, M.D. Nature 1995, 376, 323; (b) Harris, K.D.M. Chem. Soc. Rev. 1997, 
26, 279. 
220 Choi, K.H.; Hamilton, A.D. Coord. Chem. Rev. 2003, 240, 101 
221 (a) Castellano, R.K.; Nuckolls, C.; Rebek Jr., J. J. Am. Chem. Soc. 1999, 121, 11156; (b) Cho, Y.L.; 
Rudkevich, D.M.; Shivanyuk, A.; Rissanen, K.; Rebek Jr., J. Chem. Eur. J. 2000, 6, 3788. 
222 (a)van Esch, J.; De Feyter; S.; Kellogg, R.M.; De Schryver, S.; .Feringa, B.L. Chem. Eur. J. 1997, 3, 1238; 
(b) Estroff, L.A.; Hamilton, A.D. Angew. Chem. 2000, 112, 3589; (d) de Loos, M.; van Esch, J.; Kellogg, 
R.M.; Feringa, B.L. Angew. Chem. 2001, 113, 633; e) Kölbel, M.; Menger, F.M. Langmuir 2001, 17, 4490; f) 
Beginn, U.; Tartsch, B. Chem. Commun. 2001, 1924–1925; g) Tamaru, S.-I.; Uchino, S.-Y.; Takeuchi, M.; 
Ikeda, M.; Hatano, T.; Shinkai, S. Tetrahedron Lett. 2002, 43, 3751; h) Wang, G.; Hamilton, A. D. Chem. 
Commun. 2003, 310; i) Babu, P.; Sangeetha, N. M.; Vijayakumar, P.; Mitra, U.; Rissanen, K.; Raju, A. R. 
Chem. Eur. J. 2003, 9, 1922; j) George, S. J.; Ajayaghosh, A. Chem. Eur. J. 2005, 11, 3217. 
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oligoglycosylphosphates and nucleotides). 223 Some carbohydrate-based ureas exhibit 
in fact relevant biological properties such as the antibiotics SF-1993, 224 CV-1, 225 and 
the family of glycocinnamoiylspermidines (FIG. 4.1, 1-4). 226
 
Fig. 4.141: Aminoglycosidic antibiotics of the glycocinnamoylspermidine family. 
In 2005, Ichikawa and co-workers described the total synthesis of the 
glycocinnasperemicin D 4, a broad spectrum antibiotic against Gram-negative 
organisms, which contains two highly functionalised aminosugars connected by an 
urea linkage. 227 While exploring the synthesis of this target molecule, this group 
established a new method for the stereoselective synthesis of novel β-urea-linked 
pseudooligosaccharides, which involves the reaction of amine-glycoside with 
Steyemark-type gluco- and galactopyranosyl oxazolidinones. 228 Another example of 
                                                 
223 Jiménez Banco, J.L.; Ortega-Caballero, F.; Ortiz Mellet, C.O.; Garcìa Fernàndez, J.M. Beilstein Journal of 
Organic Chemistry 2010, 6, 1. 
224 Omoto, S.; Shomura, T.; Suzuki, H.; Inouye, S. J. Antibiot. 1979, 32, 436. 
225 (a) Ichimura, M.; Koguchi, T.; Yasuzawa, T.; Tomita, F. J. Antibiot. 1987, 40, 723; (b) Yasuzawa, T.; 
Yoshida, M.; Ichimura, M.; Shirahata, K.; Sano, H. J. Antibiot. 1987, 40, 727. 
226 Ellestad, G.A.; Cosulich, D.B.; Broschard, R.W.; Martin, J.H.; Kunstmann, M.P.; Morton, G.O.; 
Lancaster, J.E.; Fulmor, W.; Lovell, F.M. J. Am. Chem. Soc. 1978, 100, 2515. 
227 Nishiyama, T.; Isobe, M.; Ichikawa, Y. Angew. Chem. Int. Ed. 2005, 44, 4372. 
228 (a) Ichikawa, Y.; Matsukawa, Y.; Tamura, M.; Ohara, F.; Isobe, M.; Kotsuki, H. Chem. Asian J. 2006, 1, 
717; (b) Ichikawa, Y.; Matsukawa, Y.; Isobe, M. J. Am. Chem. Soc. 2006, 128, 3934. 
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natural disaccharide analogue containing a pseudoamide linkage is trehazolin 7, 229 
which possesses a cyclic isourea functionality between the α-D-glucose and 
aminocyclopentitol rings. Trehazolin is a potent trehalase inhibitor in which an 
aminocyclopentitol ring replaces the glucopyranosyl cation postulated as an 
intermediate in the enzymatic hydrolysis of α,α-trehalose. Although several synthetic 
methodologies had been successfully applied to prepare this inhibitor, Chiara and 
co-workers have described a novel complementary appreoach in which the oxazoline 
ring is generated by SN2 nucleophilic displacement reaction from the β-hydroxyurea 
5 via the triflate intermediate 6 (FIG. 4.2). 230 
 
FIG. 4.242: Synthesis of trehazoline , via triflate, from β-hydroxyurea: Reagents and conditions: (a) Tf2O, py, CH2Cl2, 
from -20°C to rt; (b) i. H2, Pd(OH)2/C, EtOH, TFA; ii. 2N HCl, rt. 
Most part of urea-linked pseudosaccharides presents a tether involving at least one 
anomeric position; there are two general strategies to access these oligosaccharide 
                                                 
229 Ando, O.; Satake, H.; Itoi, K.; Sato, A.; Nakajima, M.; Takahashi, S.; Haruyama, H.; Ohkuma, Y.; 
Kinishita, T.; Enokita, R. J. Antibiot. 1991, 44, 1165. 
230 Storch de Gracia, I.; Bobo, S.; Martin-Ortega, M.D.; Chiara, J.L. Org. Lett. 1999, 1, 1705. 
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mimics: i) nucleophilic addition of sugar derivatives to carbohydrate isocyanate 231 
and ii) conversion of sugar azides into glycosyl carbodiimides via a tandem 
Staudinger-aza-Wittig type reaction with triphenylphosphine and an isothiocyanate, 
followed by the addition of a nucleophile (generally H2O). The experimental 
difficulties in handling isocyanates have led to the preferential use of sugar 
carbodiimides as key intermediates for the preparation of glycosylureido sugars (F IG. 
4.3). 232 
 
FIG. 4.3: Approaches to access pseudoamyde-type oligosaccaride mimics. 
A particular area of interest in glycomimetics is that of neosaccharides, that are 
oligosaccharides linked together without using the anomeric centre.233 To the best of 
our knowledge, urea-linked neosaccharides were reported only twice. 234 Herein, it is 
reported an access 235 to a novel class of neosaccharides starting from an 
unprecedented urea-linked glucosamine dimer obtained from amino-alcohol 8 
through a modification of the known 236 oxazolidinone closure reaction. 
                                                 
231
 (a) Ichikawa, Y.; Nishiyama, T.; Isobe, M. J. Org. Chem. 2001, 66, 4200; (b) Prosperi, D.; Ronchi, S.; 
Lay, L.; Rencurosi, A.; Russo, G. Eur. J. Org. Chem. 2004, 395; (c) Ichikawa, Y.; Matsukawa, Y.; Nishiyama, 
T.; Isobe, M. Eur. J. Org. Chem. 2004, 586; (d) Ichikawa, Y.; Ohara, F.; Kotsuki, H.; Nakano, K. Org. Lett. 
2006, 8, 5009; (e) Park, N.H.; Nguyen, H.M. Org. Lett. 2009, 11, 2433. 
232 (a) Jiménez Banco, J.L.; Bootello, P.; Benito, J.M.; Ortiz Mellet, C.; Garcìa Fernàndez, J.M. J. Org. 
Chem. 2006, 71, 5136; (b) Benito, J.M.; Rodriguez-Lucena, D.; Jiménez Banco, J.L.; Ortiz Mellet, C.; 
Garcìa Fernàndez, J.M. J. Iclusion Phenom. Macrocyclic Chem. 2007, 57, 147; (c) Rodriguez-Lucena, D.; Benito, 
J.M.; Álvarez, E.; Jaime, C.; Perez-Miron, J.; Garcìa Fernàndez, J.M. J. Org. Chem. 2008 73, 2967; (d) 
Rodriguez-Lucena, D.; Ortiz Mellet, C.; Jaime, C.; Burusco, K.K.; Garcìa Fernàndez, J.M.; Benito, J.M. J. 
Org. Chem. 2009, 74, 2997. 
233 Akhtar, T.; Cumpstey, I. Tetrahedron Lett. 2007, 48, 8673 and references cited therein. 
234 (a) Ávalos, M.; Babiano, R.; Cintas, P.; Hursthouse, M.B.; Jiménez, J.L.; Light, M.E.; Palacios, J.C.; 
Pérez, E.M.S. Eur. J. Org. Chem. 2006, 657; (b) García-Moreno, M.I.; Benito, J.M.; Ortiz Mellet, C.; García 
Fernandez, J.M. J. Org. Chem. 2001, 66, 7604. 
235 Cirillo, L.; Silipo, A.; Bedini, E.; Parrilli, M. Eur. J. Org. Chem. 2010, 4062. 
236 (a) Benakli, K.; Zha, C.; Kerns, R.J. J. Am. Chem. Soc. 2001, 123, 9461; (b) Crich, D.; Vinod, A.U. Org. 
Lett. 2003, 5, 1297; (c) Manabe, S.; Ishii, K.; Ito, Y. J. Am. Chem. Soc. 2006, 128, 10666; (d) Geng, Y.; 
Zhang, L.-H.; Ye, X.-S. Tetrahedron 2008, 64, 4949; (e) Olsson, J.D.M.; Eriksson, L.; Lahmann, M.; 
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4.2 Results and Discussion 
As mentioned in Chapter 3, for the synthesis of peptidoglycan fragments it was firstly 
proposed to use as glycosyl acceptor a derivative of glucosamine in which the hydroxyl 
group at position 3 and the amino group at position 2 were protected with a 2,3 
oxazolidinone protecting group. A procedure alternative to that reported in Chapter 3 
for the installation of the oxazolidinone protecting group (triphosgene, base) is based on 
the reaction between a 2,3-aminoalcohol sugar derivative with 4-nitrophenyl 
chloroformate (NPCC) at 0°C for 3 hours, producing a mixture of the desired 
oxazolidinone and uncyclised carbamate, that is converted to the fully protected material 
by an additional step with Amberlyst IR-120 Na ion exchange resin. 18b Performing the 
reaction between the amino alcohol 8 and NPCC with shorter times (30 min instead of 
180 min) an uncyclised carbamate 9 was exclusively obtained. In order to have the 
desired oxazolidinone derivative, it was thought to treat 9 with a strong base (such as 
sodium hydride) in N,N-dimethylformamide but the product obtained was unexpectedly 
 
FIG. 4.4: Reagents and Conditions: (a) pNO2PhOCOCl, NaHCO3, 3:2 v/v CH3CN/H2O, 0°C; (b) NaH, DMF. 
 
constituted by two oxazolidinone protected glucosamine derivatives held together by a 
ureido-linkage (10).This unprecedented system has been then largely studied and the 
                                                                                                                                          
Oscarson, S. J. Org. Chem. 2008, 73, 7181; (f) Nagai, Y.; Ito, N.; Sultana, I.; Sagai, T. Tetrahedron 2008, 64, 
9599. 
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methodology has been applied also for the synthesis of galactose ureido-sugars. The 
results obtained are described in the next pages of this chapter. 
 
4.2.1 Glucosamine dimerization 
It was firstly studied the behavior of the reaction of 8 – easily available from N-acetyl 
glucosamine - 237 with 4-nitrophenyl chloroformate in dependence of the temperature. 
By performing the reaction at 40°C, no uncyclised carbamate 9 was detected by 1H 
NMR analysis of the crude mixture and 2,3-oxazolidinone 11 was recovered in 80% 
isolated yield. On the contrary, at 0°C only uncyclised carbamate 9 was obtained when 
reaction was conducted for short times (FIG. 4.5 and Table 4.1). 
 Compound 9 was recovered by simple extraction and then treated with NaH in DMF 
at 30°C. No oxazolidinone 2 was recovered, whereas a new compound was isolated as 
major product (62% yield over two steps) together with N-aryloxycarbonyl-
oxazolidinone 12 (10% from 8). 1H NMR analysis of the unknown compound presented 
a single set of carbinolic signals, with H-2 and H-3 ones downfield shifted at 3.99 and 
4.94 ppm, respectively. 13C NMR spectrum was characterized by two signals at 150.4 
and 150.0 ppm, with the first one approximately double than the second. MALDI-MS 
spectrum gave a peak at 715 m/z ([M+Na+]). According to these data, two C2-
symmetric dimeric structures could be hypothesized, with two glucosamines linked by 
an ureido (structure 10) or an ureido and two carbamate bridges (13). To assign an 
unequivocal structure to the new compound, the benzylidene rings were cleaved with 
CSA in dioxane/water to afford the water-soluble tetraol 14/15 (73% yield), which was 
subjected to detailed NMR analysis and molecular mechanics and dynamics calculations  
                                                 
237 For the synthesis of the glucose derivative see: Gavard, O.; Hersant, Y.; Alais, J.; Duverger, V.; Dilhas, 
A.; Bascou, A.; Bonnaffé, D. Eur. J. Org. Chem. 2003, 3603.  
Chapter 4: Synthesis of Urea Neosaccharides 
 
140 
 
 
FIG. 4.5: Synthesis of urea-linked neodisaccharide from amino alcohol 8. Reagents and conditions: (a) p-
NO2PhOCOCl, 3:2 CH3CN/H2O, 40°C, 80%; (b) p-NO2PhOCOCl, 3:2 CH3CN/H2O, 0°C; (c) NaH, DMF, 30°C, 
72% from 8, (10/13:12=6.2:1); (d) CSA, 4:1 dioxane/ H2O, 60°C, 73%. 
Table 4.1: Oxazolidinone 11 versus uncyclized carbamate 9 formation from 8 with NPCC (5 equiv.) and 
NaHCO3 (5 euiv.) in 2:3 (v/v) H2O/CH3CN. 
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in order to discriminate between the two possible structures and, in addition, to have an 
evaluation of the conformational behavior of the novel neodisaccharide in aqueous 
solution. The molecular mechanics and dynamics calculations have been carried out by 
Dr Alba Silipo of the Department of Organic Chemistry and Biochemistry of the 
University of Naples ―Federico II‖. No specific details in the choice of parameters and 
force field used will be given here,  but it is worth noting that the experimental 3JC-H 
measured in NMR experiments were in good agreement with the calculated 3JC-H for 14. 
The formation of 15 was therefore excluded because the calculated data were in 
discordance with those measured in the NMR experiments (Table 4.2). 238 
 
Table 4.2: Experimental and theoretical values for selected 3JC,H coupling constants [Hz] of structures 14 
and 15. 
 
 
 
 
4.2.2 Mechanism Investigation 
The dimerization process of aminoalcohol 8 into 10 is strictly dependent on the 
presence of excess NPCC in the reaction mixture. Indeed, when uncyclised carbamate 9 
was recovered pure by column chromatography (87% yield from 8) and then subjected 
to NaH/DMF treatment, no dimer 10 was detected in this case. The reaction produced 
                                                 
238 For the complete treating of the molecular mechanics and dynamic calculations, see Ref. 236. 
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exclusively oxazolidinone 11 in 91% yield, accordingly with known similar 
transformations. 239 On the basis of this result a mechanism was firstly hypothesized 
(FIG. 4.6), in which, after the initial formation of 11 through reactive isocyanate 17, N-
                                                 
239 (a) Gavard, O.; Hersant, Y.; Alais, J.; Duverger, V.; Dilhas, A.; Bascou, A.; Bonnaffé, D. Eur. J. Org. 
Chem. 2003, 3603; (b) Sugawara, T.; Narisada, M. Carbohydr. Res. 1989, 194, 125; (c) Manabe, S.; Ishii, K.; 
Ito, Y. J. Am. Chem. Soc. 2006, 128, 10666; (c) Bodlenner, A.; Alix, A.; Weibel, J.-M.; Pale, P.; Ennifar, E.; 
Paillart, J.-C.; Walter, P.; Marquet, R.; Dumas, P. Org. Lett. 2007, 9, 4415; (d) Chen, G.; Pan, P.; Yao, Y.; 
Chen, Y.; Meng, X.; Li, Z. Tetrahedron 2008, 64, 9078-9087. 
FIG. 4.6: Proposed mechanism for the formation of 10. 
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aryloxycarbonyl-oxazolidinone 12 is produced and then coupled to 9 (FIG. 4.6). 
Nonetheless, by mixing pure 9 and 12 in the presence of NaH in DMF, no dimer 
species were detected. Moreover, by treating pure 11 under dimerization conditions in 
the presence of excess NPCC, only compound 12 was recovered together with starting 
oxazolidinone. These results suggested that this pathway had to be discarded. Instead, 
the formation of derivative 16 was proposed as a pathway in competition with 
oxazolidinone formation. Compound 16 could then be converted into isocyanate 18, 
which cannot give any intramolecular reaction as for 17. On the contrary, it can be 
subjected to nucleophilic addition by oxazolidinone 11 to a dimer specie, which could 
easily react further to give final product 10. Indeed when pure compound 16 240 was 
mixed with 11 in the presence of excess NaH, dimer 10 was obtained exclusively. 
However, a deeper study is in progress to confirm in details the proposed mechanism. 
 
4.2.3 Galactosamine dimerzation 
The methodology developed for the synthesis of the glucosamine neodisaccharide 10 
has been also applied for the synthesis of an analogous galactosamine neodisaccharide. 
The aminoalcohol 21 has been synthesized using a known procedure from N-acetyl 
glucosamine 241 and then the reaction with excess of NPCC was performed at 0°C for 
50 min and after a simple extractive work-up the desired uncyclised carbamate 22 (FIG. 
4.7) was obtained together with not reacted NPCC as it could be demonstrated by 1H-
NMR (the amount of the NPCC were dependent on the number of equivalents used in 
the reaction). On the crude reaction mixture several reactions (Table 4.3) were 
performed in order to have the urea-linked  galactose   neodisaccharide  25.  It  is  worth  
                                                 
240 Compound 16 was obtained by reacting 9 with DMAP and excess NPCC in DMF at 5°C. 
241 Cai, Y.; Ling, C.C.; Bundle, D.R. J. Org. Chem. 2009, 74, 580. 
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FIG. 4.7: Synthesis of galctosamine derived neosaccharide. Reagents and conditions: (a) p-NO2PhOCOCl, 3:2 CH3CN/H2O;(b) NaH, DMF. 
Table 4.3: Screening of the reaction conditions for the synthesis of 25. 
Entry Concentration of 22 pNO2PhOCOCl eq. 
a
Base (eq.) T (°C) 23 24 25
1 0.16 M 4 NaH (5) 0 33% 46% 8%
2 0.16 M 4 NaH (5) 30 43% 30%
3 0.16 M 4 NaH (5) 50 27% 43%
4 0.16 M 4 NaH (5) 70 27% 42%
5 0.05 M 4 NaH (5) 30 64% 32%
6 0.46 M 4 NaH (5) 30 13% 78%
7 0.46 M 4 NaH (5) 50 10% 32%
8 0.46 M 0 NaH (5) 30 90%
9 0.46 1.01 NaH (5) 0 85%
10 0.46 M 4 DBU (5) 30 20% 20%  
[a the equivalents of pNO2PhOCOCl have been verified by 1H-NMR integration] 
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noting that the reaction conditions that lead to the formation of the glucosamine ureido-
neodisaccharide gave 25 in only 30% yield together with 43% of 24 (entry 2). Thus, a 
large screening of the reaction conditions was mandatory by varying the temperature, 
the base, the concentration of both NPCC and of the uncyclised carbamate 31 in the 
dimerization reaction. As it is possible to see from the Table 4.3, the best results for the 
synthesis of 25 were obtained at 30°C and with a more concentrated solution of the 
substrate (entry 6, Table 4.3) with respect to glucosamine dimerization reaction (in this 
case the preferential formation of the dimeric structure is probably due to the more 
favorite intermolecular process respect to the intramolecular cyclization for the closure 
of the oxazolidinone ring); as it could be easily expected performing the reaction in a 
more diluted solution (entry 5) the N-aryloxy-oxazolidinone-derivative 24 is 
preferentially formed. In accordance with the proposed mechanism, also in the case of 
galactosamine derived neosaccharides the role of NPCC seems to be crucial for the 
formation of the galactosamine dimer: in entries 8 and 9, in which no NPCC or a small 
excess of NPCC was used, dimer product 25 could be detected in 0% or 17% yield, 
respectively. The role of temperature is also determinant for the obtainment of 25: in 
general from entries 1, 2, 3 and 4 it is clear that increasing the temperature the 
intermolecular process is slightly favoured (the yield of 25 also increases). It is worth 
noting that a simultaneous increase of both concentration of 22 and temperature (entry 
7) has an adverse effect on the yield of 25: the reasons of the mismatching behaviour of 
this two factors is not yet fully understood and will be object of further investigations. 
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4.2.4 Chemoselective Reactions on the Oxazolidinone-Urea-Oxazolidinone System 
A case study of selective reactions on the oxazolidinone-urea-oxazolidinone system of 
dimer 10 was then pursued. To the best of our knowledge, this system is unprecedented. 
Mild conditions were searched for the chemoselective cleavage of one or both 
oxazolidinone cycles with respect to the ureido bridge or vice versa. Solvolysis of 10 was 
conducted under several conditions, as indicated FIG. 4.8. Reaction conditions 
employed for the chemoselective deprotection of a N-acetyl-2,3-N,O-oxazolidinone 
derivative of glucosamine 242 gave unsatisfying results on 10 (Entries 1-3). Interestingly, 
chemoselective cleavage of one or both carbamates with respect to the ureido bridge 
 
FIG. 4.8: Chemoselective Cleavage Of The Oxazolidinone-Urea-Oxazolidinone System 10. 
was accomplished by employing mild Et3N-mediated hydrolysis or methanolysis (entries 
4-6). A very interesting compound obtained by mild solvolysis was alcohol 26a (entry 5), 
which could be used as glycosyl acceptor to access higher neooligosaccharides. For 
example, a glycosylation reaction between 26a and fucosyl donor 28 150 afforded 
neotrisaccharide 29 (76%), that was deprotected in two steps (FIG. 4.9). A first 
                                                 
242 Wei, P.; Kerns, R.J. Tetrahedron Lett. 2005, 46, 6901. 
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chemoselective cleavage of the residual oxazolidinone ring was possible under the 
 
FIG. 4.9: Synthesis of neotrisaccharide 26. Reaction and conditions: (a) TMSOTf, AW-300 4Å MS, 1:1 v/v 
CH2Cl2/THF, T=-30°C, 76%; (b) 6:2:1 v/v/v dioxane/H20/Et3N, T=80°C, 58%; (c) Pd/C, 9:1 v/v 
MeOH/HCOOH, ultrasound bath, 40°C, 72%. 
conditions developed above. Indeed, hydrolysis in 6:2:1 v/v/v dioxane/water/Et3N 
gave alcohol 30 (58%). Then, a transfer hydrogenation under Perlin conditions 243 
furnished water-soluble urea-linked neotrisaccharide 31 in 72% yield.  
Alcohol 26a was an useful building block to access also a first representative example of 
a novel class of carbamate-linked macrocycles analogues to cyclodextrins. 244 Indeed, 
when treated with DBU in DMF, 26a gave carbamate-linked macrocycle 32 (43%; 51% 
based on recovered starting material) (FIG. 4.10). The detection of oxazolidinone 2 as 
the sole byproduct in the crude reaction mixture suggested that the mechanism could 
                                                 
243 Rao, V.S.; Perlin, A.S. Carbohydr. Res. 1980, 83, 175. 
244 (a) Gattuso, G.; Nepogodiev, S.A.; Stoddart, J.F. Chem. Rev. 1998, 98, 1919; (b) Chong, P.Y.; Petillo, 
P.A. Org. Lett. 2000, 2, 1093; (c) Stichler-Bonaparte, J.; Vasella, A. Helv. Chim. Acta 2001, 84, 2355; (d) 
Locardi, E.; Stöckle, M.; Gruner, S.; Kessler, H. J. Am. Chem. Soc. 2001, 123, 8189; (e) Fan, L.; Hindsgaul, 
O. Org. Lett. 2002, 4, 4503; (f) van Well, R.M.; Marinelli, L.; Erkelens, K.; van der Marel, G.A.; Lavecchia, 
A.; Overkleeft, H.S.; van Boom, J.H.; Kessler, H.; Overhand, M. Eur. J. Org. Chem. 2003, 2303; (g) Mayes, 
B.A.; Stetz, R.J.E.; Ansell, C.W.G.; Fleet, G.W.J. Tetrahedron Lett. 2004, 45, 153; (h) Velasco-Torrijos, T.; 
Murphy, P.V. Tetrahedron Asimm. 2005, 16, 261; (i) Bodine, K.D.; Gin, D.Y.; Gin, M.S. Org. Lett. 2005, 7, 
4479; (j) Ménand, M.; Blais, J.-C.; Valéry, J.-M.; Xie, J. J. Org. Chem. 2006, 71, 3295; (k) Di Fabio, G.; 
Randazzo, A.; D’Onofrio, J.; Ausín, C.; Pedroso, E.; Grandas, A.; De Napoli, L.; Montesarchio, D. J. Org. 
Chem. 2006, 71, 3395; (l) Kim, K.S.; Lee, B.-Y.; Yoon, S.H.; Jeon, H.J.; Baek, J.Y.; Jeong, K.-S. Org. Lett. 
2008, 10, 2373; (m) Muthana, S.; Yu, H.; Chao, H.; Cheng, J.; Chen, X. J. Org. Chem. 2009, 74, 2928; (n) 
Paul, S.; Raghothama, S.; Jayaraman, N. Carbohydr. Res. 2009, 344, 177; (o) Hsieh, Y.-C.; Chir, J.-L.; Zou, 
W.; Wu, H.-H.; Wu, A.-T. Carbohydr. Res. 2009, 344, 1020; (m) Porwanski, S.; Marsura, A. Eur. J. Org. 
Chem. 2009, 2047; (p) Romero Zaliz, C.L.; Varela, O. Tetrahedron Lett. 2009, 50, 5677. 
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proceed through the attack of the alcoholate ion on the ureido carbonyl group, giving 
the macrocycle 27 after a subsequent rearrangement of the amine intermediate (path a,a) 
or directly the oxazolidinone 11 (path b). The latter compound could be obtained also 
through the amine intermediate (path a,b). Benzylidene cleavage on 32 with CSA in 4:1 
v/v dioxane/water at 60°C afforded the water-soluble macrocycle 33 (98%). 
 
Fig. 4.10: Synthesis of carbamate-linked cyclic neosaccharide 33. Reaction and conditions: (a), DBU, DMF, 50°C; 
(b) CSA, T=60°C, 98%. 
Compound 33 has been fully characterized and through molecular mechanics and 
dynamic calculation it has been shown that this cyclodextrin mimic is characterized by 
an elliptic shape in which the major axis has an average length of 4.43 Å, the minor one 
of 3.03 Å (FIG. 4.10). 
 
FIG. 4.11: View of the cyclic neodisaccharide 33. 
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4.2.5 Self-assembling properties of urea derivatives 
Urea-urea hydrogen bonding motif has already proven to be a reliable and predictable 
self-assembling motif. 245 This versatile urea-urea motif has been employed to direct the 
formation of sheets, 246 fibers, 247 polymers, 248 gels 249 and two-dimensional molecular 
solids. 250 The properties of self-assembling have been also valuated for urea-linked 
disaccharides 27a and 34 (the latter was obtained using on neodisaccharide 25 the same 
reaction conditions used for 27a, FIG. 4.12), 
 
FIG. 4.12: Synthesis of galactosamine urea-linked disaccharide 
1H-NMR experiments at different conditions have been conducted on compounds 27a 
and 34 to investigate if these compounds could self-assemble by measuring the variation 
                                                 
245 Yang, J.; Dewal, M.B.; Sobransingh, D.; Smith, M.D.; Xu, Y.; Shimizu, L.S. J. Org. Chem. 2009, 74, 102. 
246 (a) Custelcean, R. Chem. Commun. 2008, 295; (b) Davis, R.; Berger, R.; Zentel, R. Adv. Mat. 2007, 19, 
3878. 
247 Castellano, R.K.; Nuckolls, C.; Eichhorn, S.H.; Wood, M.R.; Lovinger, A.J.; Rebek, J. Angew. Chem. Int. 
Ed. 1999, 38, 2603. 
248 Castellano, R.K.; Clark, R.; Craig, S.L.; Nuckolls, C.; Rebek, J. PNAS 2000, 97, 12418. 
249 (a) van Esch, J.; De Feyter, S.; Kellog, R. M.; De Schryver, F.; Feringa, B. L. Chem. Eur. J. 1997, 3, 1238; 
(b) van Esch, J.; Kellogg, R. M.; Feringa, B. L. Tetrahedron Lett. 1997, 38, 281; (c) Carr, A. J.; Melendez, R.; 
Geib, S. J.; Hamilton, A. D. Tetrahedron Lett. 1998, 39, 7447; (d) Jeong, Y.; Hanabusa, K.; Masunaga, H.; 
Akiba, I.; Miyoshi, K.; Sakurai, S.; Sakurai, K. Langmuir 2005, 21, 586; (e) Suzuki, M.; Nakajima, Y.; 
Yumoto, M.; Kimura, M.; Shirai, H.; Hanabusa, K. Langmuir 2003, 19, 8622; (f) Estroff, L. A.; Hamilton, 
A. D. Angew. Chem., Int. Ed. 2000, 39, 3447; (g) Wang, G.; Hamilton, A. D. Chem. Eur. J. 2002, 8, 1954; (h) 
Jung, J. H.; Ono, Y.; Shinkai, S. Chem. Eur. J. 2000, 6, 4552; (i) Moreau, J. J. E.; Vellutini, L.; Wong Chi 
Man, M.; Bied, C. J. Am. Chem. Soc. 2001, 123, 1509. 
250 (a) Shao, X.; Chang, Y.-L.; Fowler, F. W.; Lauher, J. W. J. Am. Chem.Soc. 1990, 112, 6627; (b) Schauer, 
C. L.; Matwey, E.; Fowler, F. W. J. Am.Chem. Soc. 1997, 119, 10245; (c) Hollingsworth, M. D.; Brown, M. 
E.; Satarsiero, B. D.; Huffman, J. C.; Goss, C. R. Chem. Mater. 1994, 6, 1227. 
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of the chemical shift on the NH of the urea moieties in CDCl3. In the graphs below is 
reported the variation of the chemical shift on the NH in function of the logarithm of 
the concentration (the experiments have been made by successive dilutions of a 
saturated solution of 27a and 34). A it is possible to see in FIG. 4.13 with both urea-
derivatives, at low concentration there is plateau, which suggests that at these 
concentrations the molecules are unassociated monomers. Increasing the concentration 
 
FIG. 4.13: Variation of the chemical shift of the NH proton of the urea linked neodisaccharides 27a and 34 in 
function of the concentration of the solution. 
of the urea-derivatives the variation of the chemical shift is more pronounced for the 
GalN-urea derivative respect to the GlcN-urea derivative as it can be detected both 
through the trend of the blue rhombs and directly from the analysis of the 1H-NMR 
spectra (with the arrow is represented the signal of NH-urea, FIG. 4.14). The absence of 
a plateau is clearly evident for 34 also at higher concentrations, indicating that the 
association did not reach the equilibrium even in saturated solution. 28 Although the 
different behaviuor of the two urea derivatives 27a and 34 is not fully understood, it is 
probable that the difference between the value of chemical shift for 27a and 34 and the 
different increase of chemical shift of NHs in function of the concentration is due to 
the possibility of 27a to form intramolecular hydrogen bonding in the unassociated 
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monomer at low concentrations (the NH in 27a are more downfield than those of 34). 
Further experiments are in progress to clarify the different behaviour of these urea-
derivatives through NMR, IR, molecular mechanics and dynamic calculations. 
 
FIG. 4.14: Chemical shift of the NH of the urea derivative 34. Both spectra were recorded on a 500MHz 
instrument in CDCl3 at 297K. A) [34]=76.7 mM; B) [34]=2.29 mM. 
 
4.3 Conclusions 
 
In conclusion, it has been developed a new synthetic methodology for the synthesis 
of a novel urea-tethered glucosamine and galactosamine neodisaccharide building 
block by dimerization of a simple 2,3-amino-alcohol monomer of gluco and 
galactosamine through a modification of standard oxazolidinone closure reaction. 
The glucosamine dimer was fully characterized by NMR spectroscopy as well as 
molecular mechanics and dynamics calculations. The behavior of the oxazolidinone-
urea-oxazolidinone moiety of the dimer under mild solvolysis conditions was 
studied. The chemoselective cleavage of only one oxazolidinone of the glucosamine 
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neodisaccharide afforded an alcohol building block, that was used for the synthesis 
of a higher neoligosaccharide as well as a carbamate-bridged cyclic neosaccharide. 
The possibility of the urea-linked neodisaccharides to form hydrogen-bonding 
interactions has been also valuated by measuring the NMR chemical shift of the NH 
proton of the sugar moieties. 
 
4.4 Experimental Section 
1H and 13C NMR spectra were recorded on 200, 400 or 500 MHz instruments in CDCl3 
(CHCl3 as internal standard, 
1H: CHCl3 at δ =7.26; 
13C: CDCl3 at δ =77.0) Compounds 
7, 19 and 21 were analyzed in D2O (acetone as internal standard, 
1H: (CH3)2CO at δ 
2.22; 13C: (CH3)2CO  at δ 31.0). Extensive NMR analysis on compounds 7 and 21 were 
made on a 600 MHz instrument equipped with a cryo probe. Positive MALDI-MS 
spectra were recorded on a MALDI-TOF mass spectrometer in the positive mode: 
compounds were dissolved in CH3CN at a concentration of 1 mg/mL and one 
microliter of these solutions was mixed with one microliter of a 20 mg/mL solution of 
2,5-dihydroxybenzoic acid in 7:3 CH3CN/0.1 M trifluoroacetic acid. Analytical thin layer 
chromatographies (TLC) were performed on aluminium plates precoated with silica gel 
as the adsorbent. The plates were developed with 5% H2SO4 ethanolic solution and then 
heating to 130°C. Flash chromatographies were performed on silica gel (63-200 mesh).  
 
Allyl 4,6-O-benzylidene-2,3-N,O-carbonyl-2-deoxy-α-D-glucopyranoside (11). 
Compound 8 (95.4 mg, 0.310 mmol) was suspended in 2:1 v/v water/CH3CN (1.12 
mL) and then heated to 40°C. NaHCO3 (128 mg, 1.52 mmol) and then a solution of 4-
nitrophenyl chloroformate (314 mg, 1.56 mmol) in CH3CN (750 μL) were added. After 
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30 min stirring at 40°C, the mixture was diluted with ethyl acetate (50 mL) and washed 
with 1M NaHCO3. The organic layer was collected, dried over anhydrous Na2SO4 and 
concentrated. A flash-chromatography (silica gel; 5:1 to 1:1 petroleum ether-ethyl 
acetate) afforded 11 (82.3 mg, 80%) as a white powder. [α]
D
 +33 (c 0.3; CH2Cl2); 
1H 
NMR (400 MHz, CDCl3): δ 7.51-7.36 (m, 5H, H-Ar), 5.91 (m, 1H, OCH2CH=CH2), 
5.62 (s, 1H, CHPh), 5.35 (ddd, 1H, Jvic 17.2 Hz, 
4JH,H 3.0 Hz, Jgem 1.5 Hz, trans 
OCH2CH=CHH), 5.28 (dd, 1H, Jvic 10.4 Hz, Jgem 1.5 Hz, cis OCH2CH=CHH), 5.15 (d, 
1H, J1,2 2.9 Hz, H-1), 5.07 (bs, 1H, NH), 4.84 (dd, 1H, J3,2=11.3 Hz, J3,4=10.2 Hz, H-3), 
4.29 (m, 2H, H-6a, OCHHCH=CH2), 4.09 (m, 2H, H-4, OCHHCH=CH2), 3.90 (m, 
2H, H-5, H-6b), 3.74 (dd, 1H, J2,3 11.3 Hz, J2,1 2.9 Hz, H-2); 
13C NMR (125 MHz, 
CDCl3): δ 159.1 (NCOO), 136.5 (Cipso), 132.8 (OCH2CH=CH2), 129.2, 128.3, 126.2 (C-
Ar), 118.5 (OCH2CH=CH2), 101.4 (CHPh), 95.5 (C-1), 80.1, 75.6, 69.1, 68.5, 65.5, 59.5 
(C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: calcd for C17H19NO6 
(m/z), 333.12; found, 334.16 [M+H]+. Anal Calcd for C17H19NO6: C, 61.26; H, 5.75; N, 
4.20. Found: C, 61.06; H, 5.58; N 4.11. 
 
Allyl 4,6-O-benzylidene-2,3-N,O-carbonyl-2-deoxy-2-(p-nitro-
phenoxycarbonylamino)-α-D-glucopyranoside (12) and N,N’-Bis(1-O-allyl-4,6-O-
benzylidene-2,3-N,O-carbonyl-2-deoxy-α-D-glucopyranos-2-yl)urea (10). 
Compound 8 (430 mg, 1.40 mmol) was suspended in 2:1 v/v water/CH3CN (6.0 mL) 
and then cooled to 0°C. NaHCO3 (585 mg, 6.96 mmol) and then a solution of 4-
nitrophenyl chloroformate (1.83 g, 6.80 mmol) in CH3CN (4.0 mL) were added. After 
45 min stirring at 0°C, the mixture was diluted with ethyl acetate (300 mL) and washed 
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with 1M NaHCO3. The organic layer was collected, dried over anhydrous Na2SO4 and 
concentrated to give a white gummy solid. 
To obtain pure allyl 4,6-O-benzylidene-2-deoxy-2-(p-nitro-phenoxycarbonylamino)-α-D-
glucopyranoside 9 for analytical purposes, a flash-chromatography (silica gel;15:1 to 2:1 
petroleum ether-ethyl acetate) was performed: [α]
D
 +22.4 (c 1.4; CH2Cl2); 
1H NMR (400 
MHz, CDCl3): δ 8.25 (d, 2H, J3’,2’ 8.8 Hz, 2 H-3’ pNO2-Ar), 7.51-7.35 (m, 7H, H-Ar 
benzylidene, 2 H-2’ pNO2-Ar), 5.94 (m, 1H, OCH2CH=CH2), 5.58 (s, 1H, CHPh), 5.47 
(d, 1H, JH,NH 7.8 Hz, NH),  5.35 (bd, 1H, Jvic 17.2 Hz, trans OCH2CH=CHH), 5.29 (bd, 
1H, Jvic 10.4 Hz, cis OCH2CH=CHH), 5.00 (d, 1H, J1,2 3.0 Hz, H-1), 4.30 (dd, 1H, Jgem 
10.2 Hz, J6a,5  4.7 Hz, H-6a), 4.25 (dd, 1H, Jgem 12.3 Hz, Jvic 4.7 Hz, OCHHCH=CH2), 
4.06 (dd, 1H, Jgem 12.3 Hz, Jvic 4.7 Hz, OCHHCH=CH2), 4.02 (m, 2H, H-2, H-3), 3.89 
(dt, 1H, J5,4=J5,6b 10.2 Hz, J5,6a 4.7 Hz, H-5), 3.78 (t, 1H, Jgem=J6b,5 10.2 Hz, H-6b), 3.61 (t, 
1H, J4,3=J4,5 10.2 Hz, H-4), 2.58 (bs, 1H, OH); 
13C NMR (100 MHz, CDCl3): δ 155.7 
(NCOO), 153.3, 145.1, 136.9 (3 Cipso), 133.1 (OCH2CH=CH2), 129.4, 128.4, 126.2, 
125.1, 121.9 (C-Ar), 118.4 (OCH2CH=CH2), 102.0 (CHPh), 97.0 (C-1), 81.8, 70.2, 68.8, 
68.7, 62.7, 55.7 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: calcd for 
C23H24N2O9 (m/z), 472.15; found, 495.28 [M+Na]
+. Anal Calcd for C23H24N2O9: C, 
58.47; H, 5.12; N, 5.93. Found: C, 58.30; H, 5.01; N 5.85. 
The crude gummy solid was dissolved in DMF (6.4 mL) and heated to 30°C. NaH (60% 
dispersion in oil) (261 mg, 6.53 mmol) was then added portionwise to avoid a sudden 
overheating. The yellow mixture was stirred for 45 min at 30°C, then cooled to 0°C and 
treated dropwise with some mL of water until production of gas ceased. The mixture 
was diluted with CH2Cl2 (150 mL) and washed with water. The organic layer was 
collected, dried and concentrated. The residue was subjected to flash-chromatography 
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(silica gel; 6:1 to 2:3 hexane-ethyl acetate) to give, as first eluted compound, 12 (69.0 mg, 
10%) as white amorphous crystals. [α]D +64.7 (c 1.0; CH2Cl2); 
1H NMR (400 MHz, 
CDCl3): δ 8.29 (d, 2H, J3’,2’ 9.1 Hz, 2 H-3’ pNO2-Ar), 7.51-7.38 (m, 7H, benzylidene, 2 
H-2’ pNO2-Ar), 5.88 (m, 1H, OCH2CH=CH2), 5.64 (s, 1H, CHPh), 5.63 (d, 1H, J1,2 2.7 
Hz, H-1), 5.32 (bd, 1H, Jvic 17.2 Hz, trans OCH2CH=CHH), 5.22 (bd, 1H, Jvic 10.3 Hz, 
cis OCH2CH=CHH), 4.90 (t, 1H, J3,2= J3,4 11.0 Hz, H-3), 4.30 (m, 2H, H-6a, 
OCHHCH=CH2), 4.11 (m, 2H, H-4, OCHHCH=CH2), 4.05 (dd, 1H, J2,3 11.0 Hz, J2,1 
2.7 Hz, H-2), 3.92 (m, 2H, H-5, H-6b); 13C NMR (100 MHz, CDCl3): δ 154.3, 145.8 (2 
Cipso), 150.3, 148.9 (2 NCOO), 136.2 (Cipso benzylidene), 132.7 (OCH2CH=CH2), 129.3, 
128.4, 126.1, 125.4, 122.2 (C-Ar), 118.8 (OCH2CH=CH2), 101.5 (CHPh), 95.5 (C-1), 
79.5, 74.0, 69.7, 68.4, 65.4, 60.9 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI 
TOF-MS: unstable. Anal Calcd for C24H22N2O10: C, 57.83; H, 4.45; N, 5.62. Found: C, 
57.70; H, 4.40; N 5.56. 
Second eluted compound 10 (299 mg, 62%) was recovered as a white powder. [α]D +60 
(c 0.9; CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.50-7.36 (m, 5H, H-Ar), 5.85 (m, 1H, 
OCH2CH=CH2), 5.61 (s, 1H, CHPh), 5.53 (d, 1H, J1,2 2.8 Hz, H-1), 5.31 (ddd, 1H, Jvic 
17.3 Hz, 4JH,H 3.1 Hz, Jgem 1.3 Hz, trans OCH2CH=CHH), 5.22 (ddd, 1H, Jvic 10.4 Hz, 
4JH,H 2.4 Hz, Jgem 1.3 Hz, cis OCH2CH=CHH), 4.94 (dd, 1H, J3,2 11.4 Hz, J3,4 10.0 Hz, H-
3), 4.28 (m, 2H, H-6a, OCHHCH=CH2), 4.07 (m, 2H, H-4, OCHHCH=CH2), 3.99 (dd, 
1H, J2,3 11.4 Hz, J2,1 2.8 Hz, H-2), 3.92 (m, 2H, H-5, H-6b); 
13C NMR (100 MHz, 
CDCl3): δ 150.4 (OCON), 150.0 (NCON), 136.4 (Cipso), 132.3 (OCH2CH=CH2), 129.4, 
128.4, 126.2 (C-Ar), 118.0 (OCH2CH=CH2), 101.4 (CHPh), 94.6 (C-1), 79.5, 74.0, 69.3, 
68.4, 65.2, 61.0 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: calcd for 
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C35H36N2O13 (m/z), 692.22; found, 715.25 [M+Na]
+. Anal Calcd for C35H36N2O13: C, 
60.69; H, 5.24; N, 4.04. Found: C, 60.49; H, 5.09; N 3.97. 
 
N,N’-Bis(1-O-allyl-2,3-N,O-carbonyl-2-deoxy-α-D-glucopyranos-2-yl)urea (14). 
Compound 10 (44.7 mg, 64.6 μmol) was dissolved in 4:1 v/v dioxane/water (1.2 mL) 
and then treated with (±)-camphor-10-sulfonic acid (35.0 mg, 151 μmol). After 4 hours 
stirring at 60°C, silica gel (500 mg) was added and the mixture was evaporated. The 
residue was subjected to flash-chromatography (silica gel; 94:6 to 90:10 v/v 
chloroform/methanol) affording 7 (24.3 mg, 73%) as a white powder. [α]D +134 (c 0.8; 
H2O); 
1H NMR (400 MHz, D2O): δ 5.86 (m, 1H, OCH2CH=CH2), 5.54 (d, 1H, J1,2 2.9 
Hz, H-1), 5.32 (dd, 1H, Jvic 17.3 Hz, Jgem 1.1 Hz, trans OCH2CH=CHH), 5.25 (dd, 1H, 
Jvic 10.5 Hz, Jgem 0.8 Hz, cis OCH2CH=CHH), 4.81 (dd, 1H, J3,2 12.0 Hz, J3,4 10.0 Hz, H-
3), 4.30 (dd, 1H, Jgem 13.2 Hz, Jvic 5.0 Hz, OCHHCH=CH2), 4.19 (dd, 1H, J2,3 12.0 Hz, 
J2,1 2.9 Hz, H-2), 4.11 (m, 2H, H-4, OCHHCH=CH2), 3.86 (m, 2H, H-6a, H-6b), 3.73 
(m, 1H, H-5); 13C NMR (50 MHz, D2O): δ 153.4 (OCON), 149.8 (NCON), 134.0 
(OCH2CH=CH2), 118.8 (OCH2CH=CH2), 94.3 (C-1), 78.6 (C-3), 75.3 (C-5), 69.6 
(OCH2CH=CH2), 67.9 (C-4), 60.6 (C-2), 60.4 (C-6). MALDI TOF-MS: calcd for 
C21H28N2O13 (m/z), 516.16; found, 539.32 [M+Na]
+. Anal Calcd for C21H28N2O13: C, 
48.84; H, 5.46; N, 5.42. Found: C, 48.77; H, 5.28; N 5.35. 
 
Allyl 4,6-O-benzylidene-2-deoxy-3-(p-nitro-phenoxycarbonyl)-2-(p-nitro-
phenoxycarbonylamino)-α-D-glucopyranoside (16). Compound 8 (143 mg, 0.466 
mmol) was treated as described above to give crude 3, that was then dissolved in DMF 
(3.3 mL) and treated at 5°C with DMAP (28.5 mg, 0.233 mmol). After 1 hour stirring at 
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5°C, the solution was diluted with CH2Cl2 (50 mL) and washed with 0.1 M HCl and 
water. The organic layer was collected, dried and concentrated. The residue was 
subjected to column chromatography (silica gel; 12:1 to 9:1 toluene-ethyl acetate) to give 
16 (68.4 mg, 23%) as white amorphous crystals. [α]
D
=-15 (c 0.9; CH2Cl2); 
1H NMR (400 
MHz, CDCl3): δ 8.23 (d, 2H, J3’,2’ 9.1 Hz, 2 H-3’ pNO2-Ar), 8.20 (d, 2H, J3’,2’ 9.1 Hz, 2 H-
3’ pNO2-Ar), 7.49-7.39 (m, 5H, H-Ar benzylidene), 7.28 (d, 2H, J2’,3’ 9.1 Hz, 2 H-2’ 
pNO2-Ar), 7.27 (d, 2H, J2’,3’ 9.1 Hz, 2 H-2’ pNO2-Ar), 5.94 (m, 1H, OCH2CH=CH2), 
5.61 (d, 1H, JH,NH 10.0 Hz, NH), 5.59 (s, 1H, CHPh), 5.37 (bd, 1H, Jvic 17.2 Hz, trans 
OCH2CH=CHH), 5.32 (bd, 1H, Jvic 10.6 Hz, cis OCH2CH=CHH), 5.27 (t, 1H, J3,2=J3,4 
9.9 Hz, H-3), 5.05 (d, 1H, J1,2 3.8 Hz, H-1), 4.35 (dd, 1H, Jgem 10.3 Hz, J6a,5  4.8 Hz, H-6a), 
4.28 (m, 2H, H-2, OCHHCH=CH2), 4.09 (dd, 1H, Jgem 12.6 Hz, Jvic 6.5 Hz, 
OCHHCH=CH2), 4.01 (dt, 1H, J5,4=J5,6b 10.3 Hz, J5,6a 4.8 Hz, H-5), 3.88 (t, 1H, J4,3=J4,5 
10.3 Hz, H-4), 3.83 (t, 1H, Jgem=J6b,5 10.3 Hz, H-6b); 
13C NMR (100 MHz, CDCl3): δ 
155.3, 155.2, 145.5, 144.8 (4 Cipso), 152.9, 152.5 (NCOO, OCOO), 136.6 (Cipso 
benzylidene), 132.7 (OCH2CH=CH2), 129.3-121.6 (C-Ar), 118.9 (OCH2CH=CH2), 
101.8 (CHPh), 96.8 (C-1), 78.5, 76.3, 68.8, 68.6, 62.7, 54.2 (C-2, C-3, C-4, C-5, C-6, 
OCH2CH=CH2). MALDI TOF-MS: unstable. Anal Calcd for C30H27N3O13: C, 56.52; H, 
4.27; N, 6.59. Found: C, 56.38; H, 4.19; N 6.50. 
 
Allyl 4,6-O-benzylidene-2,3-N,O-carbonyl-2-deoxy-2-(p-nitro-
phenoxycarbonylamino)-α-D-galactopyranoside (24) and N,N’-Bis(1-O-allyl-4,6-
O-benzylidene-2,3-N,O-carbonyl-2-deoxy-α-D-galactopyranos-2-yl)urea (25). 
Compound 21 (235.2 mg, 0.766 mmol) was suspended in 2:1 v/v water/CH3CN (3.67 
mL) and then cooled to 40°C. NaHCO3 (317 mg, 3.77 mmol) and then a solution of 4-
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nitrophenyl chloroformate (750 mg, 3.97 mmol) in CH3CN (1.656 mL) were added. 
After 50 min stirring at 0°C, the mixture was diluted with ethyl acetate (50 mL) and 
washed with 1M NaHCO3. The organic layer was collected, dried over anhydrous 
Na2SO4 and concentrated. A portion of the crude gummy solid (168.0 mg) was 
dissolved in DMF (246 μL) and heated to 30°C. NaH (60% dispersion in oil, 28.4 mg, 
0.71 mmol) was then added portionwise to avoid a sudden overheating. The yellow 
mixture was stirred for 45 min at 30°C, then cooled to 0°C and treated dropwise with 
some mL of water until production of gas ceased. The mixture was diluted with CH2Cl2 
(30 mL) and washed with water. The organic layer was collected, dried and 
concentrated. The residue was subjected to flash-chromatography (silica gel; 5:1 to 1:5 
hexane-ethyl acetate) to give, as first eluted compound, 24 (9.9 mg, 13%) as white 
amorphous crystals. 1H NMR (400 MHz, CDCl3): δ 8.47 (d, 2H, J3’,2’ 7.2 Hz, 2 H-3’ 
pNO2-Ar), 7.51-7.38 (m, 7H, benzylidene, 2 H-2’ pNO2-Ar), 5.87 (m, 1H, 
OCH2CH=CH2), 5.73 (d, 1H, J1,2 3 Hz, H-1), 5.67 (s, 1H, CHPh), 5.30 (dd, 1H, Jvic 18.9 
Hz, Jgem 2.4 Hz trans OCH2CH=CHH), 5.23 (d, 1H, Jvic 10.2 Hz, cis OCH2CH=CHH), 
4.89 (dd, 1H, , J2,3 12 Hz, J3,4 3.2 Hz, H-3), 4.71 (m, 2H, H-2, H-4), 4.39-4.28 (m, 2H, 
OCHHCH=CH2, H-6), 4.20-4.12 (m, 2H, H-6b, OCHHCH=CH2), 3.76 (s, 1H, H-5); 
13C NMR (100 MHz, CDCl3): δ 154.1, 145.8 (2 Cipso), 150.3, 148.9 (2 NCOO), 136.8 
(Cipso benzylidene), 133.0 (OCH2CH=CH2), 129.3, 128.3, 126.1, 125.3, 122.1 (C-Ar), 
118.4 (OCH2CH=CH2), 100.3 (CHPh), 96.1 (C-1), 79.6, 73.4, 71.58, 69.8, 68.4, 63.6, 
55.4 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: unstable. Anal Calcd 
for C24H22N2O10: C, 57.83; H, 4.45; N, 5.62. Found: C, 57.68; H, 4.33; N 5.23. 
Second eluted compound 25 (41.4 mg, 78%) was recovered as a white powder. (400 
MHz, CDCl3): δ 7.56-7.18 (m, 5H, benzylidene, H-Ar), 5.87 (m, 1H, OCH2CH=CH2), 
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5.65 (s, 1H, CHPh), 5.62 (d, 1H, J1,2 2.7 Hz, H-1), 5.28 (dd, 1H, Jvic 13.7 Hz, Jgem 0.8 Hz 
trans OCH2CH=CHH), 5.18 (d, 1H, Jvic 8.4 Hz, Jgem 0.8 Hz, cis OCH2CH=CHH), 4.91 
(dd, 1H, J2,3 12.2 Hz, J3,4 2.4 Hz, H-3), 4.66-4.62 (m, 2H, H-2, H-4), 4.37 (dd, 1H, J6,5 
1.12 Hz, Jgem 12.7 Hz, H-6a), 4.24 (dd, 1H, Jvic 5.2 Hz, Jgem 11.6 Hz, OCHHCH=CH2), 
4.16 (dd, 1H, J6,5 1.73 Hz, Jgem 12.7 Hz, H-6b), 4.10 (s, 1H, Jvic 5.8 Hz, Jgem 11.7 Hz, 
OCHHCH=CH2), 3.72 (s, 1H, H-5); 
13C NMR (50 MHz, CDCl3): δ 150.4 (OCON), 
150.0 (NCON), 137.0 (Cipso), 133.1 (OCH2CH=CH2), 129.4, 128.3, 126.2 (C-Ar), 117.0 
(OCH2CH=CH2), 100.4 (CHPh), 95.2 (C-1), 74.0, 71.6, 69.8, 68.4, 69.4, 63.4, 55.5 (C-2, 
C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: calcd for C35H36N2O13 (m/z), 
692.22; found, 715.25 [M+Na]+. Anal Calcd for C35H36N2O13: C, 60.69; H, 5.24; N, 4.04. 
Found: C, 60.44; H, 5.03; N 3.34. 
According to the reaction conditions reported in Table 4.7 also compound 23 can be 
formed. Allyl 4,6-O-benzylidene-2,3-N,O-carbonyl-2-deoxy-α-D-galactoopyranoside 
(23): δ 7.52-7.36 (m, 5H, H-Ar), 5.91 (m, 1H, OCH2CH=CH2), 5.63 (s, 1H, CHPh), 
5.32 (dd, 1H, Jvic 17.1 Hz, Jgem 1.1 Hz, trans OCH2CH=CHH), 5.28 (dd, 1H, Jvic 16.9 Hz, 
cis OCH2CH=CHH), 4.82 (dd, 1H, J3,2=12.1 Hz, J3,4=2.3 Hz, H-3), 4.6 (bs, 1H, H-1) 
4.39 (dd, 1H, J3,4 2.0 Hz, J4,5 12.1 Hz, H-4) 4.23-4.25 (m, 2H, H-6a, OCHHCH=CH2), 
4.16-4.06 (m, 2H, H-2, OCHHCH=CH2), 3.90 (s, 1H, H-5). MALDI TOF-MS: calcd 
for C17H19NO6 (m/z), 333.12; found, 334.16 [M+H]
+. Anal Calcd for C17H19NO6: C, 
61.26; H, 5.75; N, 4.20. Found: C, 61.13; H, 5.47; N 4.18. 
 
N-(1-O-allyl-4,6-O-benzylidene-2,3-N,O-carbonyl-2-deoxy-α-D-glucopyranos-2-
yl)-N’-(1-O-allyl-4,6-O-benzylidene-2-deoxy-α-D-glucopyranos-2-yl)-urea (26a). 
A solution of compound 10 (45.6 mg, 65.9 μmol) in chloroform (1.5 mL) was treated 
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with water (110 μL), triethylamine (110 μL) and finally with dioxane (660 μL). After 3 
days stirring at rt, the mixture was treated at 0°C with some drops of 0.1 M HCl, then 
quickly diluted with dichloromethane (40 mL) and washed with water. The organic layer 
was collected, dried over anhydrous Na2SO4 and concentrated to give a residue, that, 
after flash-chromatography (silica gel; 6:1 to 2:1 toluene-ethyl acetate), afforded 26a 
(35.6 mg, 81%) as a white powder. [α]
D
 +81.4 (c 1.0; CH2Cl2); 
1H NMR (400 MHz, 
CDCl3): δ 7.89 (d, 1H, JH,NH 8.7 Hz, NH), 7.51-7.36 (m, 10H, H-Ar), 5.90 (m, 2H, 2 
OCH2CH=CH2), 5.76 (d, 1H, J1,2 2.8 Hz, H-1A), 5.62 (s, 1H, CHPh), 5.56 (s, 1H, 
CHPh), 5.32 (dd, 1H, Jvic 17.2 Hz, Jgem 1.5 Hz, trans OCH2CH=CHH), 5.29 (dd, 1H, Jvic 
17.2 Hz, Jgem 1.5 Hz, trans OCH2CH=CHH), 5.24 (dd, 1H, Jvic 10.3 Hz, Jgem 1.5 Hz, cis 
OCH2CH=CHH), 5.22 (dd, 1H, Jvic 10.5 Hz, Jgem 1.5 Hz, cis OCH2CH=CHH), 4.91 (d, 
1H, J1,2 3.8 Hz, H-1B), 4.83 (dd, 1H, J3,2 11.7 Hz, J3,4 10.1 Hz, H-3A), 4.26 (m, 4H, H-6aA, 
3 OCHHCH=CH2), 4.16 (m, 2H, H-2A, OCHHCH=CH2), 4.04 (m, 3H, H-5A, H-5B, H-
6aB), 3.91 (m, 4H, H-2B, H-3A, H-4A, H-4B), 3.76 (d, 1H, Jgem=J6,5 10.3 Hz, H-6bA), 3.59 
(d, 1H, Jgem=J6,5 9.9 Hz, H-6bB); 
13C NMR (100 MHz, CDCl3): δ 154.9 (OCON), 152.5 
(NCON), 137.0, 136.4 (2 Cipso), 133.2, 133.1 (2 OCH2CH=CH2), 129.3-126.1 (C-Ar), 
118.4, 118.3 (2 OCH2CH=CH2), 102.0, 101.4 (2 CHPh), 96.9, 96.5 (2 C-1), 81.9, 79.8, 
74.1, 70.5, 69.9, 68.9, 68.8, 68.5, 65.4, 62.6, 60.9 (C-2A, C-3A, C-3B, C-4A, C-4B, C-5A, C-
5B, C-6A, C-6B, 2 OCH2CH=CH2), 54.7 (C-2B). MALDI TOF-MS: calcd for C34H38N2O12 
(m/z), 666.24; found, 689.39 [M+Na]+. Anal Calcd for C34H38N2O12: C, 61.25; H, 5.75; 
N, 4.20. Found: C, 61.06; H, 5.57; N 4.11. 
 
N,N’-Bis(1-O-allyl-4,6-O-benzylidene-2-deoxy-α-D-glucopyranos-2-yl)urea (27a). 
A solution of compound 10 (172 mg, 0.25 mmol) in 3:1 v/v dioxane/water (8.0 mL) 
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was treated with triethylamine (1.0 mL). After 14 hours stirring at 80°C, silica gel (1.25 
g) was added. The mixture was immediately cooled to rt and concentrated. Flash-
chromatography (silica gel; 99:1 to 96:4 chloroform-methanol) afforded 27a (122 mg, 
76%) as a white powder. [α]D +32 (c 0.5; CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.50-
7.34 (m, 5H, H-Ar), 5.91 (m, 1H, OCH2CH=CH2), 5.55 (s, 1H, CHPh), 5.32 (bd, 1H, 
Jvic 17.2 Hz, trans OCH2CH=CHH), 5.24 (bd, 1H, Jvic 10.4 Hz, cis OCH2CH=CHH), 
4.88 (d, 1H, J1,2 3.0 Hz, H-1), 4.26 (dd, 1H, Jgem 9.9 Hz, J6a,5  4.5 Hz, H-6a), 4.20 (dd, 1H, 
Jgem 12.8 Hz, Jvic 5.2 Hz, OCHHCH=CH2), 4.01 (dd, 1H, Jgem 12.8 Hz, Jvic 5.2 Hz, 
OCHHCH=CH2), 3.93 (m, 2H, H-2, H-3), 3.83 (dt, 1H, J5,4=J5,6b 9.9 Hz, J5,6a 4.5 Hz, H-
5), 3.74 (t, 1H, Jgem=J6b,5 9.9 Hz, H-6b), 3.56 (t, 1H, J4,3=J4,5 9.9 Hz, H-4); 
13C NMR (100 
MHz, CDCl3): δ 159.1 (NCON), 137.2 (Cipso), 133.4 (OCH2CH=CH2), 129.1, 128.2, 
126.4 (C-Ar), 118.2 (OCH2CH=CH2), 102.0 (CHPh), 97.5 (C-1), 82.2, 71.5, 68.9, 68.8, 
62.6, 55.7 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: calcd for 
C33H40N2O11 (m/z), 640.26; found, 641.39 [M+H]
+. Anal Calcd for C33H40N2O11: C, 
61.86; H, 6.29; N, 4.37. Found: C, 62.02; H, 6.40; N 4.45. 
 
N-(1-O-allyl-4,6-O-benzylidene-2,3-N,O-carbonyl-2-deoxy-α-D-glucopyranos-2-
yl)-N’-(1-O-allyl-4,6-O-benzylidene-2-deoxy-3-methoxycarbonylα-D-
glucopyranos-2-yl)-urea (26b) and N,N’-Bis(1-O-allyl-4,6-O-benzylidene-2-
deoxy-3-methoxycarbonyl-α-D-glucopyranos-2-yl)-urea (27b). Compound 10 (32.3 
mg, 46.7 μmol) was dissolved in CH2Cl2 (1.4 mL), cooled to -60°C and treated with a 
1.5 M solution of NaOMe in MeOH (155 mL). After 40 min stirring at -60°C sat. 
NH4Cl (5 mL) was added. The mixture was immediately diluted with EtOAc (30 mL), 
heated to rt and washed with water. The organic layer was collected, dried over 
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anhydrous Na2SO4, filtered and concentrated to give a residue, that, after flash-
chromatography (silica gel; 7:1 to 5:1 toluene-ethyl acetate), afforded, as first eluted 
compound, 26b (11.5 mg, 34%) as a white powder. [α]D +66 (c 0.5; CH2Cl2); 
1H NMR 
(400 MHz, CDCl3): δ 7.91 (d, 1H, JH,NH 9.5 Hz, NH), 7.49-7.34 (m, 10H, H-Ar), 5.90 (m, 
2H, 2 OCH2CH=CH2), 5.75 (d, 1H, J1,2 2.8 Hz, H-1A), 5.62 (s, 1H, CHPh), 5.52 (s, 1H, 
CHPh), 5.33 (dd, 1H, Jvic 17.2 Hz, Jgem 1.5 Hz, trans OCH2CH=CHH), 5.30 (dd, 1H, Jvic 
17.2 Hz, Jgem 1.5 Hz, trans OCH2CH=CHH), 5.23 (m, 3H, H-3B, 2 cis OCH2CH=CHH), 
4.91 (d, 1H, J1,2 3.7 Hz, H-1B), 4.80 (dd, 1H, J3,2 11.7 Hz, J3,4 10.1 Hz, H-3A), 4.36-4.21 
(m, 6H, H-2B, H-6aA, H-6aB, H-6bA, 2 OCHHCH=CH2), 4.15 (dd, 1H, Jgem 12.8 Hz, Jvic 
5.9 Hz, OCHHCH=CH2), 4.05 (m, 2H, H-4A, OCHHCH=CH2), 3.98 (td, 1H, J5,6a= J5,6b 
10.3 Hz, J5,4 9.4 Hz, H-5B), 3.90 (d, 1H, J5,4 6.8 Hz, H-5A), 3.87 (dd, 1H, J2,3 11.7 Hz, J2,1 
2.8 Hz, H-2A), 3.78 (t, 1H, J6,5=Jgem 10.3 Hz, H-6bB), 3.76 (s, 3H, OCH3), 3.74 (t, 1H, 
J4,3=J4,5 9.4 Hz, H-4B); 
13C NMR (50 MHz, CDCl3): δ 155.3, 154.7, 151.8 (COOCH3, 
NCON, OCON), 136.9, 136.4 (2 Cipso), 133.1, 133.0 (2 OCH2CH=CH2), 129.3, 129.1, 
128.3, 128.2, 126.2, 126.1 (C-Ar), 118.5, 118.3 (2 OCH2CH=CH2), 101.6, 101.4 (2 
CHPh), 97.0, 96.3 (C-1A, C-1B), 79.8, 79.2, 74.6, 74.0, 69.7, 69.0, 68.7, 68.5, 65.4, 62.9, 
60.9, 55.2, 52.9 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, C-6A, C-6B, 2 
OCH2CH=CH2, OCH3). MALDI TOF-MS: calcd for C36H40N2O14 (m/z), 724.25; 
found, 747.11 [M+Na]+. Anal Calcd for C36H40N2O14: C, 59.66; H, 5.56; N, 3.87. Found: 
C, 59.48; H, 5.47; N 3.80. 
Second eluted compound 26b (12.1 mg, 34%) was recovered as a white powder. [α]D 
+84.1 (c 1.5; CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.46-7.35 (m, 5H, H-Ar), 5.87 (m, 
1H, OCH2CH=CH2), 5.52 (s, 1H, CHPh), 5.30 (bd, 1H, Jvic 17.2 Hz, trans 
OCH2CH=CHH), 5.23 (bd, 1H, Jvic 10.3 Hz, cis OCH2CH=CHH), 5.09 (t, 1H, J3,2=J3,4 
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10.0 Hz, H-3), 4.90 (d, 1H, J1,2 3.6 Hz, H-1), 4.85 (d, 1H, JH,NH 9.6 Hz, NH), 4.27 (dd, 
1H, Jgem 10.2 Hz, J6a,5 4.8 Hz, H-6a), 4.18 (m, 2H, H-2, OCHHCH=CH2), 4.00 (dd, 1H, 
Jgem 12.8 Hz, Jvic 6.1 Hz, OCHHCH=CH2), 3.91 (dt, 1H, J5,4=J5,6b 9.9 Hz, J5,6a 4.8 Hz, H-
5), 3.75 (m, 5H, H-4, H-6b, OCH3); 
13C NMR (100 MHz, CDCl3): δ 156.2, 155.9 
(COOCH3, NCON), 137.0 (Cipso), 133.2 (OCH2CH=CH2), 129.1, 128.3, 126.2 (C-Ar), 
118.2 (OCH2CH=CH2), 101.6 (CHPh), 97.6 (C-1), 79.1, 74.5, 68.8, 68.7, 62.9, 55.1, 53.4 
(C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2, OCH3). MALDI TOF-MS: calcd for 
C37H44N2O15 (m/z), 756.27; found, 779.38 [M+Na]
+. Anal Calcd for C35H36N2O13: C, 
58.72; H, 5.86; N, 3.70. Found: C, 58.50; H, 5.68; N 3.65. 
Alternatively, compound 27b could be obtained by dissolving 10 (42.4 mg, 61.3 μmol) in 
chloroform (1.4 mL) and then treating it with methanol (0.6 mL) and triethylamine (0.1 
mL). The solution was stirred at rt for two days. The reaction was quenched by adding 
some drops of 0.1M HCl. The mixture was immediately diluted with CH2Cl2 (25 mL) 
and washed with water. The organic layer was collected, dried and concentrated. 
Column chromatography (silica gel; 7:1 to 5:1 toluene-ethyl acetate) on the residue 
afforded 27b (24.9 mg, 54%). 
 
N-[3-O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-1-O-allyl-4,6-O-benzylidene-2-
deoxy-α-D-glucopyranos-2-yl]-N’-(1-O-allyl-4,6-O-benzylidene-2,3-N,O-
carbonyl-2-deoxy-α-D-glucopyranos-2-yl)-urea (29). A mixture of 26a (39.0 mg, 
58.6 μmol) and 28 (70.8 mg, 117 μmol) was coevaporated three times with toluene, the 
residue was dried and then mixed with freshly activated AW-300 4Å molecular sieves, 
suspended under argon in 1:1 v/v CH2Cl2/THF (1.5 mL). The mixture was stirred at -
30°C for 15 min. A 24.6 mg/mL solution of TMSOTf in CH2Cl2 (27.4 μL, 3.0 μmol) 
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was then added. The mixture was stirred for 75 min at -30°C. Few drops of Et3N were 
then added. The mixture was filtered over a Celite pad and concentrated. The residue 
was subjected to column chromatography (silica gel; 12:1 to 8:1 toluene/ethyl acetate) to 
give 29 (48.1 mg, 76%) as a colourless oil. [α]D +23.1 (c 1.7; CH2Cl2); 
1H NMR (400 
MHz, CDCl3): δ 8.08 (d, 1H, JH,NH 10.0 Hz, NH), 7.39-7.25 (m, 25H, H-Ar), 5.86 (m, 
1H, OCH2CH=CH2), 5.69 (m, 2H, H-1A, OCH2CH=CH2), 5.54 (s, 1H, CHPh), 5.51 (s, 
1H, CHPh), 5.35 (d, 1H, J1,2 3.6 Hz, H-1C), 5.31 (dd, 1H, Jvic 17.2 Hz, Jgem 1.5 Hz, trans 
OCH2CH=CHH), 5.22 (dd, 1H, Jvic 10.5 Hz, Jgem 1.5 Hz, cis OCH2CH=CHH), 5.09 (dd, 
1H, Jvic 17.0 Hz, Jgem 1.5 Hz, trans OCH2CH=CH2), 5.06 (dd, 1H, Jvic 10.5 Hz, Jgem 1.5 
Hz, cis OCH2CH=CH2), 4.89 (d, 1H, Jgem 11.5 Hz, OCHHPh), 4.87 (d, 1H, J1,2 3.5 Hz, 
H-1B), 4.83 (d, 1H, Jgem 11.7 Hz, OCHHPh), 4.73 (d, 1H, Jgem 11.6 Hz, OCHHPh), 4.66 
(d, 1H, Jgem 11.7 Hz, OCHHPh), 4.65 (t, 1H, J3,4=J3,2 10.0 Hz, H-3A), 4.56 (d, 1H, Jgem 
11.6 Hz, OCHHPh), 4.55 (d, 1H, Jgem 11.5 Hz, OCHHPh), 4.35 (dt, 1H, J2,3=J2,NH 10.0 
Hz, J2,1 3.5 Hz, H-2B), 4.31-4.17 (m, 5H, H-2A, H-6aA, H-6bA, OCH2CH=CH2), 4.12 (q, 
1H, J5,6=6.4 Hz, H-5C), 4.05-3.72 (m, 11H, H-2C, H-3B, H-3C, H-4A, H-4B, H-5A, H-5B, 
H-6aB, H-6bB, OCH2CH=CH2), 3.49 (d, 1H, J4,3 2.0 Hz, H-4C), 0.88 (d, 3H, J6,5 6.4 Hz, 
H-6C); 
13C NMR (100 MHz, CDCl3): δ 154.9, 152.4 (OCON, NCON), 139.0, 138.6, 
138.2, 137.3, 136.4 (3 Cipso Bn, 2 Cipso benzylidene), 133.4, 133.0 (2 OCH2CH=CH2), 
129.3-125.9 (C-Ar), 118.0, 117.9 (2 OCH2CH=CH2), 101.6, 101.4 (2 CHPh), 97.2, 96.6, 
96.5 (C-1A, C-1B, C-1C), 80.6, 79.8, 79.4, 77.9, 76.0, 74.7, 73.6, 73.3, 72.2, 71.7, 69.1, 69.0, 
68.9, 68.5, 66.7, 65.1, 62.9, 61.2, 55.0 (C-2A, C-2B, C-2C, C-3A, C-3B, C-3C, C-4A, C-4B, C-
4C, C-5A, C-5B, C-5C, C-6A, C-6B, 3 OCH2Ph, 2 OCH2CH=CH2), 16.3 (C-6C). MALDI 
TOF-MS: calcd for C61H66N2O16 (m/z), 1082.44; found, 1105.21 [M+Na]
+. Anal Calcd 
for C61H66N2O16: C, 67.64; H, 6.14; N, 2.59. Found: C, 67.48; H, 6.00; N 2.50. 
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N-[3-O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-1-O-allyl-4,6-O-benzylidene-2-
deoxy-α-D-glucopyranos-2-yl]-N’-(1-O-allyl-4,6-O-benzylidene-2-deoxy-α-D-
glucopyranos-2-yl)-urea (30). A solution of compound 29 (36.6 mg, 33.8 μmol) in 3:1 
v/v dioxane/water (2.1 mL) was treated with triethylamine (260 μL). After 30 hours 
stirring at 80°C, silica gel (600 mg) was added. The mixture was immediately cooled to rt 
and concentrated. Flash-chromatography (silica gel; 6:1 to 2:1 toluene/ethyl acetate) 
afforded 30 (20.8 mg, 58%) as white amorphous crystals. [α]D -3 (c 0.7; CH2Cl2); 
1H 
NMR (400 MHz, CDCl3): δ 7.40-7.27 (m, 25H, H-Ar), 5.88 (m, 1H, OCH2CH=CH2), 
5.78 (m, 1H, OCH2CH=CH2), 5.54 (s, 2H, 2 CHPh), 5.30 (dd, 1H, Jvic 17.2 Hz, Jgem 1.4 
Hz, trans OCH2CH=CHH), 5.28 (d, 2H, J1,2 3.1 Hz, H-1A, H-1B), 5.23 (dd, 1H, Jvic 10.4 
Hz, Jgem 1.4 Hz, cis OCH2CH=CHH), 5.17 (dd, 1H, Jvic 17.2 Hz, Jgem 1.4 Hz, trans 
OCH2CH=CH2), 5.14 (dd, 1H, Jvic 10.4 Hz, Jgem 1.4 Hz, cis OCH2CH=CHH), 5.05 (bs, 
2H, 2 NH), 5.01 (d, 1H, J1,2 3.8 Hz, H-1C), 4.89 (d, 1H, Jgem 11.5 Hz, OCHHPh), 4.82 (d, 
1H, Jgem 11.9 Hz, OCHHPh), 4.75 (s, 2H, OCH2Ph), 4.65 (d, 1H, Jgem 11.5 Hz, 
OCHHPh), 4.57 (d, 1H, Jgem 11.9 Hz, OCHHPh), 4.28 (dd, 1H, J2,3 10.0 Hz, J2,1 3.5 Hz, 
H-2A), 4.23 (dd, 1H, J2,3 10.0 Hz, J2,1 3.5 Hz, H-2B), 4.16 (dd, 1H, Jgem 13.4 Hz, Jvic 6.8 Hz, 
OCHHCH=CH2), 4.09-3.68 (m, 16H, H-2C, H-3A, H-3B, H-3C, H-4A, H-4B, H-5A, H-5B, 
H-5C, H-6aA, H-6bA, H-6aB, H-6bB, 3 OCHHCH=CH2), 3.53 (d, 1H, J4,3 2.0 Hz, H-4C), 
0.96 (d, 3H, J6,5 6.4 Hz, H-6C); 
13C NMR (50 MHz, CDCl3): δ 158.9 (NCON), 138.7, 
138.5, 137.6, 137.3, 137.1 (3 Cipso Bn, 2 Cipso benzylidene), 133.7, 133.2 (2 
OCH2CH=CH2), 129.0-125.9 (C-Ar), 118.4, 117.9 (2 OCH2CH=CH2), 101.7, 101.1 (2 
CHPh), 97.9, 97.4, 97.3 (C-1A, C-1B, C-1C), 81.7, 81.5, 79.2, 79.1, 77.5, 74.9, 74.5, 73.7, 
73.3, 71.8, 71.7, 68.8, 68.7, 68.6, 67.2, 63.0, 62.5, 55.6, 55.1 (C-2A, C-2B, C-2C, C-3A, C-3B, 
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C-3C, C-4A, C-4B, C-4C, C-5A, C-5B, C-5C, C-6A, C-6B, 3 OCH2Ph, 2 OCH2CH=CH2), 
16.5 (C-6C). MALDI TOF-MS: calcd for C60H68N2O15 (m/z), 1056.46; found, 1078.61 
[M+Na]+. Anal Calcd for C60H68N2O15: C, 68.17; H, 6.48; N, 2.65. Found: C, 68.08; H, 
6.42; N 2.60. 
 
N-(1-O-allyl-3-O-α-L-fucopyranosyl-2-deoxy-α-D-glucopyranos-2-yl)-N’-(1-O-
allyl-2-deoxy-α-D-glucopyranos-2-yl)-urea (31). A solution of 30 (10.0 mg, 9.5 μmol) 
in 9:1 v/v MeOH/HCOOH (500 μL) was treated with Pd/C (3 mg) under Ar 
atmosphere. After 1h in an ultrasound bath, the mixture was filtered over a Celite pad 
and concentrated. The residue was lyophilized to give pure 31 (4.2 mg, 72%) as a white 
foam [α]D +37 (c 0.3; H2O); 
1H NMR (400 MHz, D2O): δ 5.04 (d. 1H, J1,2 3.9 Hz, H-1), 
4.89 (d, 1H, J1,2 3.4 Hz, H-1), 4.82 (d, 1H, J1,2 3.6 Hz, H-1), 4.34 (q, 1H, J5,6 6.6 Hz, H-
5C), 3.88-3.40 (m, 19H, H-2A, H-2B, H-2C, H-3A, H-3B, H-3C, H-4A, H-4B, H-4C, H-5A, H-
5B, H-6A, H-6B, 2 OCH2CH2CH3), 1.62 (m, 4H, 2 OCH2CH2CH3), 1.16 (d, 3H, J6,5 6.6 
Hz, H-6C), 0.93 (t, 6H, Jvic 7.4 Hz, 2 OCH2CH2CH3); 
13C NMR (100 MHz, D2O): δ 
160.1 (NCON), 100.0, 98.3 (C-1A, C-1B, C-1C), 79.0, 72.6, 72.5, 70.9, 70.8, 70.7, 69.3, 
68.9, 67.8, 61.4 (C-2C, C-3A, C-3B, C-3C, C-4A, C-4B, C-4C, C-5A, C-5B, C-5C, C-6A, C-6B, 
OCH2CH2CH3), 55.0, 54.7 (C-2A, C-2B), 22.8 (OCH2CH2CH3), 16.0 (C-6C), 10.7 
(OCH2CH2CH3). MALDI TOF-MS: calcd for C25H46N2O15 (m/z), 614.29; found, 637.10 
[M+Na]+. Anal Calcd for C25H46N2O15: C, 48.85; H, 7.54; N, 4.56. Found: C, 48.60; H, 
7.78; N 4.39. 
 
1-O-Allyl-4,6-O-benzylidene cyclic pseudodisaccharide (32). Compound 26a (36.8 
mg, 55.2 μmol) was dissolved in DMF (2.0 mL) under Ar atmosphere. The solution was 
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treated with DBU (10.2 μL, 68.4 μmol) and then heated to 50°C. After overnight 
stirring, it was cooled to rt, diluted with ethyl acetate (20 mL) and washed with 0.1 M 
HCl and then water. The organic layer was collected, dried over anhydrous Na2SO4, 
filtered and concentrated to give a residue, that, after flash-chromatography (silica gel; 
6:1 to 2:1 toluene-ethyl acetate), afforded 32 (15.7 mg, 43%) as a white powder. [α]D 
+32 (c 0.9; CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ 7.49-7.33 (m, 5H, H-Ar), 5.85 (m, 
1H, OCH2CH=CH2), 5.52 (s, 1H, CHPh), 5.28 (m, 3H, H-3, OCH2CH=CH2), 5.00 (d, 
1H, JH,NH 9.8 Hz, NH), 4.92 (d, 1H, J1,2 3.8 Hz, H-1), 4.29 (dd, 1H, Jgem 10.2 Hz, J6a,5 4.8 
Hz, H-6a), 4.20 (dd, 1H, Jgem 12.5 Hz, Jvic 5.4 Hz, OCHHCH=CH2), 4.07 (dt, 1H, 
J2,3=JH,NH 9.8 Hz, J2,1 3.8 Hz,  H-2), 3.99 (dd, 1H, Jgem 12.5 Hz, Jvic 5.4 Hz, 
OCHHCH=CH2), 3.94 (ddd, 1H, J5,6b 10.3 Hz, J5,4 9.6 Hz, J5,6a 4.8 Hz, H-5), 3.77 (t, 1H, 
Jgem=J6b,5 10.3 Hz, H-6b), 3.73 (t, 1H, J4,3=J4,5 9.6 Hz, H-4); 
13C NMR (100 MHz, CDCl3): 
δ 155.5 (OCON), 136.8 (Cipso), 132.7 (OCH2CH=CH2), 129.2, 128.2, 126.3 (C-Ar), 119.2 
(OCH2CH=CH2), 101.8 (CHPh), 96.6 (C-1), 78.3, 75.1, 68.9, 68.8, 63.2, 56.4 (C-2, C-3, 
C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: calcd for C34H38N2O12 (m/z), 
666.24; found, 689.37 [M+Na]+. Anal Calcd for C34H38N2O12: C, 61.25; H, 5.75; N, 4.20. 
Found: C, 61.08; H, 5.66; N 4.11. 
 
1-O-Allyl cyclic pseudodisaccharide (33).  Compound 32 (36.0 mg, 54.1 μmol) was 
dissolved in 4:1 v/v dioxane/water (1.0 mL) and then treated with (±)-camphor-10-
sulfonic acid (31.1 mg, 134 μmol). After 4 hours stirring at 60°C, silica gel (500 mg) was 
added and the mixture was evaporated. The residue was subjected to flash-
chromatography (silica gel; 95:5 to 86:14 v/v chloroform/methanol) affording 33 (25.9 
mg, 98%) as a white powder. [α]D +104 (c 0.9; D2O); 
1H NMR (400 MHz, D2O): δ 6.00 
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(m, 1H, OCH2CH=CH2), 5.38 (d, 1H, Jvic 17.2 Hz, trans OCH2CH=CHH), 5.28 (d, 1H, 
J1,2 3.7 Hz, cis OCH2CH=CHH), 5.07 (d, 1H, J1,2 3.7 Hz, H-1), 4.87 (dd, 1H, J3,2 10.0 Hz, 
J3,4 9.2 Hz, H-3), 4.25 (dd, 1H, Jgem 12.7 Hz, Jvic 5.5 Hz, OCHHCH=CH2), 4.15 (dd, 1H, 
J2,3 10.0 Hz, J2,1 3.7 Hz, H-2), 4.09 (dd, 1H, Jgem 12.7 Hz, Jvic 5.5 Hz, OCHHCH=CH2), 
3.91-3.73 (m, 4H, H-4, H-5, H-6a, H-6b); 13C NMR (50 MHz, D2O): δ 158.6 (OCON), 
134.0 (OCH2CH=CH2), 119.1 (OCH2CH=CH2), 96.4 (C-1), 79.6, 72.4, 69.2, 67.3, 60.8, 
55.8 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). MALDI TOF-MS: calcd for 
C20H30N2O12 (m/z), 490.18; found, 513.00 [M+Na]
+. Anal Calcd for C20H30N2O12: C, 
48.98; H, 6.17; N, 5.71. Found: C, 48.78; H, 6.04; N 5.61. 
 
N,N’-Bis(1-O-allyl-4,6-O-benzylidene-2-deoxy-α-D-galactopyranos-2-yl)urea (34). 
A solution of compound 25 (74.8 mg, 0.25 mmol) in 3:1 v/v dioxane/water (3.6 mL) 
was treated with triethylamine (450 μL). After 14 hours stirring at 80°C, silica gel (1.25 
g) was added. The mixture was immediately cooled to rt and concentrated. Flash-
chromatography (silica gel; 99:1 to 98:2 chloroform-methanol) afforded 34 (44.2 mg, 
63.9%) as a white powder. 1H NMR (400 MHz, CDCl3): δ 7.50-7.31 (m, 5H, H-Ar), 5.83 
(m, 1H, OCH2CH=CH2), 5.37 (s, 1H, CHPh), 5.28 (bd, 1H, NH), 5.23 (bd, 1H, Jvic 17.3 
Hz, trans OCH2CH=CHH), 5.10(bd, 1H, Jvic 10.3 Hz, cis OCH2CH=CHH), 4.94 (d, 1H, 
J1,2 3.2 Hz, H-1), 4.18 (bd, 1H, Jgem 12.3 Hz, H-6a), 4.20 (dd, 1H, Jgem 12.8 Hz, Jvic 5.2 Hz, 
OCHHCH=CH2), 4.11 (dd, 1H, Jgem 12.9 Hz, Jvic 4.9 Hz,), 4.13-4.08 (m, 2H, H-2, 
OCHHCH=CH2), 3.98-3.94 (m, 2H, H-6b, OCHHCH=CH2), 3.83 (bd, 1H, H-3), 3.58 
(s, 1H, H-5); 13C NMR (100 MHz, CDCl3): δ 159.5 (NCON), 137.8 (Cipso), 133.6 
(OCH2CH=CH2), 128.9, 128.0, 126.4 (C-Ar), 117.6 (OCH2CH=CH2), 101.1 (CHPh), 
97.9 (C-1), 75.63, 69.2, 69.0, 68.5, 63.0, 51.4 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2). 
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MALDI TOF-MS: calcd for C33H40N2O11 (m/z), 640.26; found, 641.44 [M+H]
+. Anal 
Calcd for C33H40N2O11: C, 61.86; H, 6.29; N, 4.37. Found: C, 62.12; H, 6.36; N 4.48. 
